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Over the last few decades, learning and memory processes have been extensively 
studied from a variety of perspectives. Long-term potentiation (LTP), the long lasting 
strengthening of synaptic communications, is a key cellular event associated with learning at 
the organism level. Even now, 45 years since the first reported LTP recording, a precise 
molecular mechanism of LTP is still not fully elucidated. Understanding the cellular basis of 
learning and memory formation is important for the development of novel therapeutic 
approaches for patients with Alzheimer’s disease or post-traumatic stress disorder, or even 
development of effective education curricula. LTP and its connection with learning have been 
studied using genetic, pharmaceutical and electrophysiological methods that provided 
valuable understanding of these processes. An optogenetic approach, that can manipulate the 
specific biochemical signalling associated with LTP with higher temporal and spatial 
precision in a genetically defined neuronal population, can provide a better causal and 
correlative link between LTP and learning. The main goal of this thesis is to generate a new 
optogenetic tool, which can be ultimately used to influence LTP, utilizing our current 
knowledge of the molecular mechanisms involved in LTP. 
The cellular signalling, targeted in this thesis optogenetically, is the one associated with 
receptor tyrosine kinase B (TrkB), the receptor for brain-derived neurotrophic factor (BDNF). 
BDNF and TrkB are implicated in LTP and learning; therefore, optogenetic manipulation of 
these proteins could directly alter LTP and possibly animal behaviour. TrkB is a typical 
tyrosine kinase receptor that is located in the plasma membrane and activated through the 
receptor dimerization (mediated by the extracellular domain upon BDNF binding) and 
autophosphorylation (mediated by the intracellular kinase domain). TrkB activates three main 
signalling enzymes: phospholipase C-γ1 (PLCγ1), extracellular signal-regulated kinase 
(ERK) and AKT kinase. To trigger TrkB signalling in living cells upon blue light stimulation, 
the kinase domain of TrkB (TrkB(kd)) was attached to a photoreceptor, cryptochrome 2 
(Cry2), as a freely diffusive cytosolic recombinant protein. Upon blue light illumination, 
Cry2 forms homo-oligomers and hetero-oligomers with its binding partner, CIB1. CIB1 was 
tethered to the plasma membrane. In this design, the intention was to trigger the 
oligomerization of TrkB(kd)-Cry2 and its recruitment to the membrane via Cry2/CIB1 
heterodimerization upon blue light exposure. This led to the activation of TrkB(kd) and 
consequently initiated biochemical signalling cascades at the plasma membrane. 
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In this thesis, the designed two-component TrkB system was shown to trigger PLCγ1, 
ERK and AKT signalling pathways in non-neuronal HEK293 cells as well as in cultured 
neurons in a light-dependent manner. During the validation process, I discovered that, 
without the membrane-tethered CIB1 component, TrkB(kd)-Cry2 alone activated ERK and 
AKT signalling without elevation of intracellular Ca
2+
 that is related to the functional 
activation of PLCγ1. Additionally, a mutation was introduced in TrkB(kd) that prevented 
activation of PLCγ1, but still allowed ERK and AKT pathways to be triggered upon light 
stimulation. These two observations might have a practical application for dissecting 
biochemical signalling by TrkB, which is still not completely understood in LTP. Preliminary 
experiments in DRG neurons demonstrated that varying the amount of light caused 
contradictory responses of a growth cone, attraction or repulsion, when TrkB(kd)-Cry2 and 
CIB1 were used. The TrkB(kd)-Cry2 component alone was not able to change the growth 
cone turning in DRG neurons. These results suggest important roles of PLCγ1 and Ca
2+
 in 
axon steering over short timescales (minutes), but minimal effects of ERK and AKT on these 
timescales. Finally, the TrkB system was successfully introduced into the amygdala region of 
a freely behaving rat. 
In this study, the process of designing and validating the optogenetic TrkB tool is 
presented as a part of broad project that ultimately aims to manipulate LTP and learning. This 
new photoactivatable TrkB system has several advantages over previously published 
optogenetic tools, which make it unique for in vivo applications in subsequent studies. This 
tool (1) can be packaged into recombinant adeno-associated viral vectors (AAV), (2) cannot 
be activated by endogenous BDNF due to the lack of TrkB extracellular domain, (3) provide 
separate controls of different biochemical pathways when used without membrane-tethered 
CIB1 or when specific mutation is introduced into TrkB(kd). Together this provides an 
exciting new approach to investigate how manipulation of BDNF/TrkB signalling affects 











Introduction and literature review 
 
1.1 Basis of learning and memory formation 
 
One of the most fascinating functions of the brain is the ability to acquire, store and 
retrieve information. Over the last few decades, learning and memory processes at the 
systematic, cellular and molecular levels remain the focus of intense research. Learning is the 
act of acquiring new information, whereas memory refers to recall of learned information. 
Human memory is often categorized based on qualitatively different systems of 
information storage. According to this classification, there are two major memory systems in 
the brain: declarative (explicit) and non-declarative (implicit or procedural). Declarative 
memory can be defined as conscious storage of information about events and facts, such as 
people, places or objects. This type of memory can be verbalized. Establishing new 
declarative memories requires the medial temporal lobe structures (especially the 
hippocampus). In contrast, non-declarative memory includes motor skills, habits, procedures 
and any other information for which acquisition and retrieval do not depend on a conscious 
effort. Implicit memory involves different brain structures depending on the type of learning, 
for instance, cerebellum, amygdala or cortex (Mayford et al., 2012; Purves, 2004). The 
clinical case studies of Henry G. Molaison (known as Patient H.M.) provided valuable 
insights into the memory organization in the brain. H.M. had suffered from disabling 
epileptic seizures and was subject to a bilateral temporal medial lobe resection (including the 
hippocampus). After the surgery, H.M. was unable to form new declarative memories, 
whereas his ability to form procedural memories was intact (Annese et al., 2014; Lombroso 
and Ogren, 2009; Purves, 2004). This clinical case provided the important classification of 
memory as well as the localization of memory storage in the brain. However, the study did 
not provide insight into molecular mechanisms of memory. 
In addition to the declarative and non-declarative classification of memories, memory 
can be also categorized according to the length of time that information is retained. These 
temporal categories of memory include short-term (immediate), working and long-term 
memory (Purves, 2004). Short-term memory is the routine ability to retain information for a 
brief moment (a memory of ongoing experiences). Working memory is the ability to hold 
information in mind for a period of time required for a cognitive process. For instance, the 
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performance of a simple mathematical calculation requires the information to be temporarily 
retained, utilized and then discarded (Slaughter, 2002). Finally, long-term memory is the 
storage of information in more permanent form for days, weeks or lifetime (Purves, 2004). 
This type of memory is created when short-term memories are converted into long-term ones 
in a process known as consolidation, which involves the hippocampus. The role of the 
hippocampus in consolidation was discovered from the studies on patient H.M., who was 
able to recall old memories without the ability to consolidate new ones into long-term 
memories (Annese et al., 2014). 
In neuroscience, a general hypothesis postulates that long-term memory storage 
requires long-lasting changes in neurons. Synapses, the subcellular structures that mediate the 
communications between two neurons, have been proposed to be the cellular site of memory 
storage (Mayford et al., 2012). In 1949, Donald Hebb proposed the mechanism of neuronal 
adaptation during learning and memory formation. He argued that synaptic connections could 
be considered as the basis of mental associations (Hebb, 1949). His theoretical concept 
suggested that the modulation of synaptic connectivity is a key property of the mechanism of 
learning and memory. The objective of this chapter is to overview what is known about the 
cellular and molecular mechanisms underlying learning and memory formation, especially as 
relates to Hebbian plasticity. 
 
1.1.1 Hebbian theory of synaptic plasticity 
 
The Hebbian theory explains the basic mechanism for synaptic plasticity, which is 
defined as a change in the efficiency in synaptic signalling. The Hebbian plasticity theory 
proposes that memories are formed through increasing the efficiency of synaptic transmission 
called “synaptic strength” (Hebb, 1949; Vitureira and Goda, 2013). As a general rule, this 
synaptic transmission is initiated at presynaptic termini of synapses and involves 
neurotransmitter release. The released neurotransmitters diffuse across synaptic clefts and 
bind to the neurotransmitter receptors on the surface of postsynaptic cells (Vitureira and 
Goda, 2013). Synaptic efficiency is controlled by the neurotransmitter release probability (the 
likelihood of neurotransmitter exocytosis from the presynaptic neuron upon arrival of an 
action potential) and the number of available neurotransmitter receptors in the postsynaptic 
neuron (Del Castillo and Katz, 1954; Vitureira and Goda, 2013). According to the Hebbian 
theory, the long-lasting stimulation of a synapse, for instance during a learning process, may 
increase the efficiency of that synapse. Considering changes to parameters mentioned 
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previously, how can synaptic connections become strengthened as we learn? Firstly, when 
the neurotransmitter release probability is higher, then more glutamate (neurotransmitter) 
may be released from the presynaptic neuron. Secondly, the number of available 
neurotransmitter receptors on the postsynaptic site may be increased. Finally, these receptors 
may be more responsive to glutamate which may lead to the longer period of their open state 
and to the higher influx of ions to the postsynaptic cell (Lombroso and Ogren, 2009). These 
mechanisms can mediate a stronger response to a prolonged stimulation. 
Moreover, the increased synaptic efficiency seems to correlate with an increased size of 
synapse. On the postsynaptic neurons, dendritic spines, small protrusions from dendritic 
branches, underwent enlargement upon repetitive glutamate uncaging protocol, known to 
induce structural synaptic plasticity (Matsuzaki et al., 2004). These results suggest that spines 
can be critical sites for memory storage. Showing that stimulated spines displayed long-
lasting changes follows the Hebbian concept of learning. 
In Hebbian plasticity, three critical features can be highlighted: synapse specificity, 
associativity and cooperativity. The induction of Hebbian plasticity is synapse specific and 
associative because strengthening of a presynaptic input onto a postsynaptic cell is possible 
when both pre- and postsynaptic neurons are coactivated at the same time to become 
associated (Mayford et al., 2012; Vitureira and Goda, 2013). In other words, Hebbian 
plasticity generates positive feedback which means that when a synapse is activated once, it 
can undergo further potentiation with greater ease (Vitureira and Goda, 2013). Association 
also refers to the process when a weak input is coupled with strong one and as a result of this, 
the weak input alone can become strengthened (Mayford et al., 2012). Finally, Hebbian 
plasticity is cooperative because numerous inputs have to be activated simultaneously to 
depolarize the adjacent postsynaptic neuron (Mayford et al., 2012). These features also 
describe durable forms of Hebbian synaptic plasticity, including long-term potentiation (LTP) 
and long-term depression (LTD). This chapter discusses mostly LTP as a model of changes in 
the strength of synaptic effects during learning and implicated in the memory formation. 
A particularly challenging question in neuroscience has been: how do synaptic changes 
take place during learning? A crude, but very effective, approach to reveal the brain regions 
responsible for specific learning and memory formation is a controlled lesion in rodents, akin 
to the clinical case of H.M. (Elgersma and Silva, 1999). However, this approach does not 
reveal how learning processes change the connection between neurons. In 1970s, Eric Kandel 
and his colleagues made direct observations of synaptic changes during learning in the sea 
slug Aplysia californica. They described two forms of synaptic plasticity in this organism. 
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Touching the animal’s siphon resulted in the gill withdrawal, but after repeated occurrences 
of this stimulation, the slug’s response exhibited habituation such that the gill withdrawal 
became weaker. In the next experiment, touching the siphon was paired with an electrical 
stimulation to the animal’s tail which triggered the strong gill withdrawal once again. This 
synaptic plasticity is called sensitization (Carew et al., 1971; Castellucci et al., 1978). The 
Kandel’s group identified the set of synapses involved in the gill withdrawal behaviour. 
Moreover, their results provided an explanation for short- and long-term changes in synapses 
underlying associative and non-associative learning in a simple invertebrate system. 
The direct observations of synaptic plasticity during mammalian learning are difficult 
because of the complexity of a brain. Nevertheless, there is strong evidence that synaptic 
plasticity is associated with emotional (fear) learning in amygdala in animals and humans 
(Adolphs et al., 1994; Davis et al., 1994). In these studies, fear conditioning, as a model for 
emotional learning in animals, was used. Measurements of synaptic strength in amygdala 
slices from fear-conditioned rats showed synaptic alterations induced by whole-animal 
emotional learning in comparison with naïve animals (McKernan and Shinnick-Gallagher, 
1997). Similar observations were made in freely behaving rats that underwent fear-
conditioning (Rogan et al., 1997). Interesting data were published by Johansen and 
colleagues in 2014 who provided evidence that Hebbian mechanism is necessary, but not 
sufficient, to generate synaptic plasticity in the lateral amygdala of rats under moderate 
training conditions. Direct manipulations of amygdala pyramidal cells (important for storing 
aversive memories) using light suggested that another form of synaptic plasticity has to be 
co-activated to form associative and aversive memories (Johansen et al., 2014). These results 
displayed the existence of different forms of synaptic plasticity. They showed that the direct 
relationship between synaptic plasticity and memory formation is more complex than a 
simple correspondence. Synaptic plasticity is not a unitary process which means that it can be 
seen as many processes harmonizing together during learning to create memories. 
 
1.2 Synaptic mechanism of learning and memory 
 
The Hebbian theory highlights that synapses are the critical sites for memory induction 
and storage. This synaptic hypothesis represents a concept that the creation of memories and 
their retention is associated with alterations in the strength of individual synapses between 
neurons. Two electrophysiological phenomena, LTP and LTD, are thought to occur to 
generate changes in synapse strength (Malenka and Nicoll, 1999; Slaughter, 2002). 
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LTP is a long-lasting enhancement of synaptic activity, classically evoked by brief 
high-frequency electrical stimulation of synapse. In contrast to LTP, LTD can be described as 
a long-term reduction of synaptic activity that is classically induced by low-frequency 
prolonged stimulation (Bear and Malenka, 1994). LTP is now used as a model of synaptic 
changes during learning and memory formation, is studied extensively. For example, a simple 
PubMed search with the keywords “long-term potentiation” retrieves more than 16,000 
scientific articles. This section aims to summarize the existing understanding of LTP and its 
relationship with learning and memory formation. 
 
1.2.1 Long-term potentiation as a neurobiological model of learning and memory 
 
The first official report of LTP (then called long-lasting potentiation) was published in 
1973. This paper highlighted immediately the possible role of LTP in the explanation of 
learning and memory processes (Bliss and Lomo, 1973). One of these authors described how 
LTP was discovered “by chance, not by pursuit of an idea. I happened to be in the right labs 
at the right time, presented with experimental preparations hiding secrets ready to be 
uncovered with the methods at hand” (Lomo, 2015). The experiments in question were 
conducted in the dentate gyrus of the hippocampal formation in anaesthetized rabbits. The 
recording electrode was placed beneath the molecular layer of the dentate area to record 
excitatory postsynaptic potentials (EPSPs) in granule cells evoked by the electrical 
stimulation of perforant fibres (Bliss and Lomo, 1973). When brief bursts of high-frequency 
electric stimulation (known as tetanus) of the perforant path were done, the amplitude of the 
recorded EPSP in granule cells increased for a very long period, sometimes up to ten hours 
after the last train (Bliss and Lomo, 1973; Lomo, 2015). The occurrence of LTP was 
subsequently confirmed in the dentate gyrus in rats (Douglas and Goddard, 1975) and in vitro 
in hippocampal slices from guinea pigs (Schwartzkroin and Wester, 1975). The terminology 
long-term potentiation (instead of “long-lasting”) and the acronym LTP were then 
standardized in the field (Alger and Teyler, 1976; Douglas and Goddard, 1975; Lomo, 2015). 
LTP has common features related to Hebbian synaptic plasticity: associativity and 
cooperativity (as explained in Section 1.1.1). The obvious characteristic of LTP is its 
duration, which can be hours, days or probably even a lifetime. LTP is also input-specific 
which means that the increase in synaptic strength is confined to active synapses (Malenka 
and Nicoll, 1999; Vitureira and Goda, 2013). 
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As more aspects of LTP have been studied, different phases of LTP have now been 
defined: an early phase, that is dependent on short-term second messenger alterations, and a 
late phase which involves the alterations in gene transcription and de novo protein synthesis 
(Luscher and Malenka, 2012). By altering the stimulation conditions, either electrically or 
chemically, it is possible to manipulate the phases of LTP (Molnar, 2011). The synaptic 
changes during LTP evolve in overlapping stages that require specific molecular events. 
Firstly, an LTP-inducing stimulus activates necessary molecular players within 
approximately one minute (induction) (Murakoshi et al., 2017). The initiated changes in the 
synapse recruit additional processes to ensure their durability (expression lasting for minutes 
to hours) and finally, these changes need to be maintained (maintenance lasting for days) 
(Luscher and Malenka, 2012). The main purpose of the next section is to describe the 
molecular mechanisms involved in the induction, expression and maintenance of LTP. 
 
1.2.2 Molecular mechanism of LTP 
 
The precise molecular mechanisms underlying the induction, expression and 
maintenance of the different forms of LTP have been the focus of thousands of research 
groups around the world. Understanding the molecular changes associated with LTP and 
memory formation and storage have significant implication for the development of 
therapeutic approaches. This might be especially relevant in treatment of patients with 
Alzheimer’s disease and drug addiction, two conditions where LTP is disrupted (Crary J. F. 
et al., 2006; Luscher and Malenka, 2011). 
Of the different forms of LTP that have been studied (Malenka and Bear, 2004), the N-
methyl-D-aspartate receptor (NMDAR)-dependent LTP at CA1 hippocampal excitatory 
synapses is one of the most well-characterized forms of LTP and is more common in CNS 
synapses (Malenka and Bear, 2004; Nicoll, 2003). The molecular mechanism of this type of 
LTP, as a prototypical form of synaptic plasticity, is presented in this section. 
The NMDAR-dependent LTP is induced and expressed in the postsynaptic neurons 
(Luscher and Malenka, 2012; Nicoll, 2003). The coincidence detection of presynaptic 
glutamate release and strong depolarization of postsynaptic cells is involved in the induction 
of NMDAR-dependent LTP. This coincidence detection leads to a rise of intracellular Ca
2+
 in 
postsynaptic spines. Three simultaneous events are required to trigger LTP: (1) NMDAR 
activation (Collingridge et al., 1983); (2) large rise in postsynaptic Ca
2+
 (Lynch et al., 1983); 
(3) depolarization of postsynaptic cells (Malinow and Miller, 1986). This coincident activity 
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is mostly accomplished by NMDAR and also α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR), the two main types of ionotropic ligand-gated 
ion channels for glutamate. 
The excitatory neurotransmitter, glutamate, is released from synaptic vesicles in the 
presynaptic terminal into the synaptic cleft (Errington et al., 2003). Then, glutamate diffuses 
and reaches the postsynaptic membrane where it binds to NMDA and AMPA-type glutamate 





) and upon activation Na
+
 influx is favoured leading to the 
depolarization of the postsynaptic neuron (Malinow and Miller, 1986). AMPARs are 
tetrameric and may be composed of one subunit type, or a mixture of four subunit types: 
GluA1, GluA2, GluA3 and GluA4. (Luscher and Malenka, 2012; Madden, 2002). The 
composition of subunits in AMPARs, especially the presence of GluA2, has an influence on 
biophysical properties of AMPARs (Anggono and Huganir, 2012). These receptors can be 
also permeable to Ca
2+
 (Liu and Zukin, 2007). NMDARs are voltage-dependent glutamate 




 to enter the postsynaptic cells (Ascher and Nowak, 1988). 
Similarly to AMPARs, NMDARs are tetramers composed of two GluN1 subunits and two 
additional GluN2 or GluN3 subunits (Paoletti et al., 2013). NMDARs have slower kinetics 
than AMPARs, but higher affinity for glutamate (Luscher and Malenka, 2012). The 
activation of NMDARs requires two simultaneous events: binding of glutamate to the 
receptor and strong depolarization of postsynaptic membrane. Strong depolarization is 
necessary because at near-resting membrane potentials, Mg
2+
 blocks the ion pore of NMDAR 
to prevent ion conductance. The Mg
2+
 block of the channel is relieved when the membrane is 
depolarized (Nowak et al., 1984). 
The significance of NMDARs in the LTP induction is supported by experiments in 
which specific antagonists, such as AP5 or CPP, completely inhibited the generation of LTP 
(Collingridge et al., 1983). In a typical LTP paradigm, LTP is induced when Na
+
 influx 
through AMPARs leads to depolarization of the postsynaptic cells, which relieves the Mg
2+
 
block of NMDARs leading to high level of Ca
2+
 influx. This increase in Ca
2+
 concentration 
within the dendritic spines triggers the activation of intracellular cascades responsible for 
LTP confined to this specific synapse (Lombroso and Ogren, 2009; Luscher and Malenka, 
2012; Malenka and Bear, 2004). 
After the influx of Ca
2+
, the activation of Ca
2+
/calmodulin dependent protein kinase II 
(CaMKII), particularly isoform α, is an important event associated with LTP induction 
(Lisman et al., 2002). It has been shown that approximately one minute of CaMKIIα activity 
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is sufficient for LTP induction (Murakoshi et al., 2017). CaMKIIα is found in high 
concentrations in the postsynaptic density (Lee and Yasuda, 2009). X-ray crystallography 
studies and single particle electron microscopy have revealed that CaMKIIα is a large 
supramolecular structure consisting of 10–14 subunits (Chao et al., 2011; Kanaseki et al., 
1991; Myers et al., 2017). Each subunit comprises an N-terminal catalytic kinase domain 
followed by a regulatory segment (or autoinhibitory domain), which is characteristic for 
calmodulin-regulated protein kinases, and C-terminal association (or hub) domain. The 
regulatory segment contains the regulatory phosphorylation site Thr286 (R1), the 
intramolecular clamp segment (R2) and the calmodulin-recognition motif (R3) (Chao et al., 
2010; Chao et al., 2011). The intramolecular clamp segment fastens the regulatory segment to 
the kinase domain when CaMKIIα is autoinhibited. Finally, the association domain is 
responsible for the oligomerization process which helps subunits assemble into a large 
holoenzyme (Chao et al., 2010; Chao et al., 2011; Lisman et al., 2012). CaMKIIα is activated 
by binding Ca
2+
-bound calmodulin (CaM) that displaces the autoinhibitory domain. One of 
the key substrates of the catalytic domain of CaMKIIα is the Thr286 residue on CaMKIIα 
itself. The phosphorylation of Thr286 prevents the autoinhibitory domain from binding to the 
catalytic kinase domain. Hence, the partial activation of CaMKIIα by Ca
2+
-bound CaM can 
lead to autophosphorylation of CaMKIIα, at which point the complex becomes constitutively 
active without further stimulation (Miller and Kennedy, 1986). A point mutation at T286A in 
CaMKIIα, that blocked autophosphorylation, led to LTP inhibition (Giese et al., 1998). 
Several genetic manipulations were developed to investigate the physiological function of 
CaMKIIα in LTP, as follows. The injection of a truncated and constitutively active form of 
CaMKIIα into CA1 hippocampal pyramidal cells enhanced excitatory postsynaptic currents 
(EPSCs) (Lledo et al., 1995). In contrast, the application of inhibitory peptides (CN27, CN21, 
CN19) derived from a fragment of an endogenous inhibitor of CaMKIIα reversed LTP in 
hippocampal slices (Coultrap and Bayer, 2011; Sanhueza et al., 2011). The activated open 
form of CaMKIIα was shown to bind NMDARs (Leonard et al., 1999). This interaction was 
inhibited by the above mentioned inhibitory peptides in vitro (Vest et al., 2007). 
CaMKIIα is thought to increase AMPAR-mediated transmission during LTP (Lisman 
et al., 2012). It can occur through two mechanisms. Firstly, the conductance of AMPARs is 
increased by phosphorylation at Ser831 of the GlaA1 subunit by CaMKIIα (Benke et al., 
1998). Secondly, the AMPAR-mediated transmission can be enhanced by the insertion of 
AMPARs into a synapse. It was revealed that this insertion is mediated by an auxiliary 
subunit of AMPARs, stargazin. The phosphorylation of stargazin by CaMKIIα allows 
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AMPARs to bind to the postsynaptic density protein 95 (PSD-95) (Opazo et al., 2010). The 
synaptic associated protein 97 (SAP97) is believed to be involved in AMPARs exocytosis to 
the postsynaptic membrane during LTP because SAP97 interacts with GluA1 subunit and is 
transported into dendritic spines upon phosphorylation by CaMKIIα (Mauceri et al., 2004). 
In comparison to the induction process of LTP, the maintenance of LTP is not well 
understood. LTP is maintained for a long period of time and this process requires protein 
synthesis. The autonomous activity of CaMKIIα was thought to be involved in maintenance 
of LTP. However, the inhibition of CaMKIIα by CN21 inhibitory peptide, used in rat 
hippocampal slices, prevented the induction of LTP, but not LTP maintenance (Buard et al., 
2010). Another kinase, protein kinase M zeta (PKMζ), has been recognized as a protein 
which can be responsible for LTP maintenance (Ling et al., 2002). Once again, the role of 
PKMζ in LTP maintenance has been questioned by a genetic study, in which PKMζ knock-
out mice exhibited intact LTP (Volk et al., 2013). Many gene knock-outs seem to impact LTP 
maintenance (Korte et al., 1998; Nagy et al., 2006; Oikawa et al., 2012) and suggest the 
overall process is complex. 
The brain-derived neurotrophic factor (BDNF) and its receptor, tyrosine receptor kinase 
B (TrkB), have emerging roles in both early and late LTP (Lin et al., 2018; Mei et al., 2011). 
As BDNF/TrkB signalling is a pathway of interest in my thesis, its implication in LTP is 
discussed in the next section. 
 
1.2.3 BDNF/TrkB signalling in LTP 
 
In canonical signalling, TrkB is activated by BDNF-induced dimerization, which leads 
to autophosphorylation of tyrosine residues in TrkB kinase domains (Cunningham and 
Greene, 1998; Cunningham et al., 1997). As a consequence of the TrkB activation, three 
main signalling pathways are triggered: the phospholipase C-γl (PLCγ1)-Ca
2+
 pathway, the 
Ras/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase 
(PI3K)/AKT signalling pathways (Kaplan and Miller, 2000). The full-length TrkB receptor 
consists of extracellular, transmembrane and intracellular domains. Two alternatively spliced 
variants, TrkB.T1 and TrkB.T2, which do not contain the entire intracellular kinase domain, 
have been identified (Klein et al., 1990; Middlemas et al., 1991). The full-length TrkB 
structure and the action of this receptor are described in more detail in Chapter 2 (see Section 
2.1). Even though neurotrophins and their receptors have been indentified in some 
invertebrates as reviewed by Bothwell (2006), bona fide genes encoding TrkB or BDNF were 
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not identified in Drosophila melanogaster and Caenorhabditis elegans (Beck et al., 2004; 
Benito-Gutierrez et al., 2006). The full-length TrkB as well as truncated TrkB.T1 and 
TrkB.T2 are abundantly expressed in a mammalian brain (Escandon et al., 1994; Otani et al., 
2017). The full-length and truncated TrkB receptors are expressed in pre- and post-synaptic 
compartments of neurons (Kryl et al., 1999). In the excitatory neurons, TrkB colocalizes with 
NMDAR in dendrites, whereas in axons TrkB overlaps with synaptic vesicle proteins (Gomes 
et al., 2006). TrkB was also coimmunoprecipitated with NR2B subunit of NMDAR (Mizuno 
et al., 2003). Moreover, BDNF was shown to enhance phosphorylation of NR1 and NR2B 
subunits leading to increased NMDAR activity in hippocampal neurons (Levine et al., 1998; 
Lin et al., 1998). As mentioned in Section 1.2.2, NMDAR plays a crucial role in LTP 
expression, suggesting that BDNF/TrkB signalling is implicated in LTP. TrkB and BDNF 
have been indeed proven to play a significant role in mediating and modulating synaptic 
plasticity (as extensively reviewed by Korte and Schmitz (2016)). 
The early evidence implicating of TrkB-mediated signalling in LTP has been deduced 
from the BDNF studies. The level of mRNA encoding BDNF was increased in CA1 neurons 
from hippocampal slices at 4 h after stimulation with an electrical paradigm inducing LTP 
(Patterson et al., 1992). The experiments on homozygous and heterozygous BDNF knock-out 
mice revealed a strong impairment of LTP in those animals (Korte et al., 1995). Moreover, 
this severe reduction in LTP expression could be restored by viral expression of BDNF in 
CA1 region or treatment of slices from BDNF-deficient mice with recombinant BDNF (Korte 
et al., 1996; Patterson et al., 1996). The local application of BDNF to mature dentate granule 
cells in hippocampal slices, with the concomitant weak burst of synaptic stimulation, induced 
robust LTP (Kovalchuk et al., 2002). These results suggested that BDNF can facilitate LTP 
induction. Taken together, the above evidence demonstrates the involvement of BDNF in 
LTP so, by the extrapolation, TrkB, as a receptor for BDNF, is thought to play a role in LTP. 
Using a rabbit polyclonal antiserum, recognizing TrkB specifically and preventing 
TrkB-activated signalling, Kang et al. (1997) demonstrated that TrkB is involved in an early 
and late phase of LTP. Mice in which trkB gene was knocked-out conditionally in the 
forebrain during postnatal development exhibited impaired LTP in CA1 region (Minichiello 
et al., 1999). Contrary to the knock-out approach, the knock-in method allowed researchers to 
create two transgenic mouse lines with targeted mutations in TrkB: one in a site responsible 
for PLCγ1 activation and second in a site mediating ERK and AKT activation. The 
hippocampal LTP induction was reduced in mice with mutated PLCγ1-docking site, whereas 
in mice with mutated ERK/AKT-docking site LTP was unaltered (Minichiello et al., 2002). 
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These results were confirmed by Gruart et al. (2007) and Korte et al. (2000). The inhibition 
of TrkB-mediated PLCγ1 signalling in hippocampal CA1 and CA3 regions by virus encoding 
a pleckstrin homology (PH) domain of PLCγ1 caused the significant reduction of LTP 
(Gartner et al., 2006). Mice with a mutated PLCγ1-docking site in the kinase domain of 
TrkB, but normal ERK/AKT-docking site, showed impaired LTP at amygdalar synapses 
(Musumeci et al., 2009). The genetic mouse models, described above, provided solid 
evidence implicating TrkB in LTP. However, using knock-out or knock-in approaches can 
have long-term or developmental impacts that may overshadow a role of the specific pathway 
in LTP. 
The studies mentioned above on transgenic mice highlighted the importance of a 
PLCγ1-docking site in LTP, but do not eliminate the involvement of TrkB-mediated ERK 
and AKT activation in LTP. It was shown that PLCγ1 signalling plays roles in the early and 
late phase of hippocampal LTP (Minichiello et al., 2002). The ERK inhibitor, PD 098059, 
attenuated the induction of LTP in the CA1 area of hippocampal slices, whereas the 
expression of established LTP was not affected (English and Sweatt, 1997). These results 
were supported electophysiologically in freely behaving adult rats (Ying et al., 2002). In the 
dentate gyrus, local application of ERK inhibitor, U0126, blocked LTP maintenance and Arc 
protein expression, suggesting that the ERK pathway has a role in the late phase of LTP, 
which is dependent on the protein synthesis (Panja et al., 2009). AMPAR insertion is crucial 
for hippocampal LTP (see Section 1.2.1). The BDNF/TrkB signalling was shown to be 
involved in this process (Zhang et al., 2018), possibly through activation of the PI3K pathway 
(Man et al., 2003). The existing evidence provides a strong correlation between BDNF/TrkB 
signalling and the process of LTP. Nevertheless, it is unclear whether TrkB activity itself is 
sufficient to induce LTP (Kang and Schuman, 1995; Kovalchuk et al., 2002). Additionally, 
the precise TrkB-mediated downstream signalling implicated in the early or late stages of 
LTP is not well-understood, nor is it understood whether this key action is pre- or post-
synaptic site. 
TrkB is present at pre- and post-synaptic sites (Kryl et al., 1999). The early results on 
cultured hippocampal neurons indicated that BDNF can enhance synaptic transmission and 
they suggested a presynaptic action of BDNF. The application of BDNF to cultured 
hippocampal neurons increased the frequency of mEPSCs, but not the amplitude, suggesting 
the presynaptic action of BNDF (Lessmann et al., 1994; Paul et al., 2001). The early evidence 
on the role of BDNF/TrkB signalling in synaptic transmission might have pointed to the 
presynaptic action of these proteins in LTP. Xu et al. (2000) showed that a deletion of TrkB 
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from hippocampal CA1 postsynaptic cells did not affect induction of LTP, indicating the 
presynaptic function of TrkB. Presynaptic BDNF was also implicated in the presynaptic 
component of LTP at hippocampal Schaffer collateral synapses (Zakharenko et al., 2003). 
The field potential recording in hippocampal CA3 presynaptic cells from BDNF knock-out 
mouse slices demonstrated reduction in LTP at mossy fiber synapses, suggesting that 
presynaptic component plays a role in LTP (Schildt et al., 2013). Finally, at corticostriatal 
synapses, axonal NMDARs are involved in LTP induction by stimulating a secretion of 
presynaptic BDNF (Park et al., 2014). However, Levine et al. (1995) reported that application 
of BDNF to cultured hippocampal neurons could increase the frequency and amplitude of 
EPSCs, suggesting pre- and postsynaptic action of BDNF/TrkB signalling. The postsynaptic 
function of BDNF in LTP was also postulated by Kovalchuk et al. (2002), who showed the 
induction of LTP in postsynaptic cells by BDNF. At the thalamo-amygdala synapses in 
heterozygous BDNF knock-out mice, LTP was abolished, suggesting a postsynaptic site of 
BDNF action (Meis et al., 2012). The pre- and postsynaptic site of BDNF/TrkB action in 
LTP was shown by the inhibition of their downstream target, PLCγ1. Blocking PLCγ1 
signalling at both sites reduced LTP (Gartner et al., 2006); however, this interpretation 
assumes that PLCγ1 was exclusively activated by BDNF/TrkB under this condition. A recent 
systematic approach of conditional BDNF and TrkB knock-out in hippocampal CA1 and 
CA3 regions revealed distinct roles of pre- and postsynaptic BNDF/TrkB signalling in LTP. 
Most recently it has been shown that presynaptic BDNF and postsynaptic TrkB are 
responsible for LTP induction, whereas either presynaptic or postsynaptic TrkB, as well as 
postsynaptic BDNF are implicated in LTP maintenance (Lin et al., 2018). 
The postsynaptic action of BDNF/TrkB is likely to be associated with structural LTP 
(sLTP), the structural changes in spines after LTP induction. After LTP induction, spine 
enlargement is widely observed in addition to the functional electrical changes in synapses 
(Matsuzaki et al., 2004). Two-photon glutamate uncaging, which mimics synaptic stimulation 
occurring during LTP induction, revealed TrkB activation in an individual dendritic spine. 
Moreover, this activation was dependent on NMDAR, CaMKII and postsynaptically secreted 
BDNF (Harward et al., 2016). 
The presented literature provides solid connections between BDNF/TrkB signalling and 
LTP. Nevertheless, a lack of a tool that can manipulate biochemical processes in a fast 
timescale in defined pre- or postsynaptic cells means that many aspects cannot be easily 
addressed. BNDF/TrkB signalling appears to have both pre- and postsynaptic functions 
during LTP and it is difficult to precisely dissect these actions at each site. As it was 
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demonstrated that BDNF can decrease inhibitory postsynaptic currents (Frerking et al., 
1998), it would be of interest to investigate the roles of excitatory neurons and the inhibitory 
cells in LTP. Finally, a direct causal link, showing the connection between a specific 
BDNF/TrkB downstream pathway, LTP and a specific behavioural paradigm, remains to be 
resolved. To address these controversies, this thesis presents a novel tool that can be used to 
activate TrkB signalling in defined cells with temporal resolution. 
It is noteworthy that in addition to LTP phenomenon, BDNF/TrkB signalling plays 
many diverse roles in different cell types of the nervous system. TrkB has been shown to 
mediate axon outgrowth and to support the survival of rat sympathetic neurons (Atwal et al., 
2000). BDNF/TrkB has been demonstrated to play a role in axon elongation and a growth 
cone formation in motoneurons (Dombert et al., 2017). Finally, BDNF acts as a chemotropic 
guidance cue so the growing axon of Xenopus spinal neuron has been attracted toward the 
concentration gradient of BDNF (Ming et al., 1997). The role of BDNF/TrkB in axon 
guidance has been described elaborately by Cohen-Cory et al. (2010) and by Thiede-Stan and 
Schwab (2015). These diverse implications of BDNF/TrkB signalling in different functions 
of the nervous system suggest that the tool developed in this project might have potential 
broader applications beyond LTP and memory formation. Nevertheless, the manipulation of 
synaptic plasticity by controlling BDNF/TrkB signalling in a high spatiotemporal manner is 
the main rationale behind designing the new TrkB-based approach. 
 
1.3 Relationship between LTP and animal learning and memory 
 
Despite strong theoretical implication of LTP for the behavioural aspects of learning, it 
has been technically challenging to demonstrate the direct link between LTP and 
learning/memory either correlatively or causally. One of the significant obstacles to observe 
LTP expression during behavioural training is a difficulty in localizing particular synapses in 
a brain that underwent potentiation during learning. In this section, a few examples that 
provide evidence for LTP and learning correlation are listed. 
Rogan et al. (1997) discovered that LTP-like procsess, measured as field potentials, 
was evoked in the amygdala in vivo after a fear conditioning paradigm in freely behaving 
rats. The fear conditioning is a common paradigm for studying associative learning, in which 
animals usually learn to associate a foot shock (an aversive unconditioned stimulus, US) with 
a tone (a neutral conditioned stimulus, CS) that leads to stereotypical fear behaviour - 
freezing (a toned-driven conditioned response, CR) (Maren, 1999). The fear conditioning 
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evoked the synaptic potentiation in a similar manner to the high-frequency electrical 
stimulation (Maren and Fanselow, 1995; Rogan and LeDoux, 1995; Rogan et al., 1997). 
Similarly, Whitlock et al. (2006) detected LTP induction in the hippocampus of rats that 
underwent an inhibitory avoidance paradigm, in which animals learn to pair a foot shock with 
a dark place. In this study, the inhibitory avoidance training increased the phosphorylation at 
Ser831 of GluA1 subunit of AMPAR and increased a surface expression of GluA1 and 
GluA2, processes occurring during LTP expression (Lee et al., 2000). Although these 
examples are consistent with the hypothesis that LTP is the cellular mechanism of learning, 
they only suggest a correlation between LTP and learning without providing any causal links 
between these two events. 
In 2014, a group of researchers from the University of California, San Diego examined 
LTP in fear learning with the utility of optogenetic methods (Nabavi et al., 2014). This study 
showed that the expression of fear behaviour was eliminated by an optogenetic LTD 
induction protocol that reversed LTP. The fear behaviour was reinstated by an optogenetic 
LTP induction protocol. These results, which are discussed in detail in Section 1.4.2, 
provided a more direct causal link between LTP/LTD and leaning processes, but still raise 
questions of a molecular mechanism involved in these processes. 
 
1.3.1 BDNF/TrkB signalling in learning and memory 
 
Since BNDF/TrkB signalling is involved in structural and functional LTP, many studies 
have been searching how this signalling influences learning and memory processes. One of 
the most extensive studies has been performed to link BNDF/TrkB signalling with 
hippocampal-dependent learning. The spatial learning, using a radial arm maze task, 
increased the level of BNDF mRNA in mouse hippocampus. Moreover, the reduction of 
BDNF expression by antisense oligonucleotides impaired acquisition and retention of spatial 
memories (Mizuno et al., 2000). The same task induced phosphorylation of TrkB, tyrosine 
kinase Fyn and NR2B subunit of NMDAR in the hippocampus (Mizuno et al., 2003). Using a 
tyrosine kinase inhibitor, the acquisition of spatial memories was delayed (Mizuno et al., 
2003). Mice that underwent treadmill training exhibited enhancement in hippocampus-related 
aversive learning and this was also accompanied by increase in TrkB expression (Liu et al., 
2008b). The homozygous conditional knock-out mice of TrkB showed impaired spatial 
learning (Minichiello et al., 1999). The heterozygous knock-in mice, carrying the mutation in 
PLCγ1-docking site of TrkB, exhibited disrupted acquisition of associative learning, which 
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suggested that PLCγ1 pathway is implicated in this type of learning (Gruart et al., 2007). 
Other transgenic mice overexpressing TrkB.T1, a dominant-negative receptor which acts as 
the inhibitor of full-length TrkB, showed an impairment in spatial memory (Saarelainen et 
al., 2000). Finally, heterozygous mice, overexpressing the full-length TrkB, displayed an 
improvement in spatial learning (Koponen et al., 2004). 
In addition to the numerous studies on the role of BDNF/TrkB in hippocampal learning, 
a correlation between BDNF/TrkB and amygdalar learning has been unveiled. The 
application of TrkB inhibitor, K252a, and the dominant-negative isoform, TrkB.T1, resulted 
in the inhibition of acquisition of fear memories (Rattiner et al., 2004). Blocking normal 
function of the full-length TrkB by TrkB.T1 in the amygdala impaired the extinction of 
learned fear memories (Chhatwal et al., 2006). In addition to these results, the inhibition of 
TrkB anterograde axonal transport disrupted fear memory extinction, suggesting the 
presynaptic role of TrkB (Li et al., 2017). The conditional BDNF knock-out and sequestering 
TrkB function by the dominant-negative TrkB.T1 in the amygdala affected consolidation of 
appetitive and aversive emotional learning (Heldt et al., 2014). Knock-in studies revealed that 
mice carrying the mutation in PLCγ1-docking site of TrkB displayed the impairment in 
acquisition of fear memories, whereas mice with the mutation in ERK/AKT-docking site 
exhibited the disruption during consolidation (Musumeci et al., 2009). This reveals 
differential effects of the distinct TrkB signalling pathways on learning phases that could not 
be observed with LTP measurement in brain slices. This observation deserves further 
investigation with other approaches. 
 
1.4 Optogenetics as a novel approach to investigate learning and memory processes 
 
Optogenetics refers to the combination of genetics and optics to control processes in 
specific cells within living tissue (Deisseroth, 2011), achieving high spatial and temporal 
manipulation of a genetically-defined population of neurons. Optogenetics can be described 
as the expression of light-sensitive proteins in living cells, resulting in the ability to modulate 
cell behaviours with light. Many years before the introduction of this technique, Francis 
Crick made an observation that “a method by which all neurons of just one type could be 
inactivated, leaving the others more or less unaltered” is needed (Crick, 1979) and “the ideal 
signal would be light, probably at an infrared wavelength to allow the light to penetrate far 
enough” (Crick, 1999). Optogenetics can overcome several limitations of the current genetic, 
pharmacological and electrophysiological approaches. Moreover, optogenetics can 
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complement the classical techniques to acquire a comprehensive investigation of neural 
functions. 
Various optogenetic tools, such as opsins, phototropins or cryptochromes, for 
manipulating neuronal behaviours and functions are presented in the next section. 
 
1.4.1 Optogenetic tools for neuronal and biochemical control 
 
Most modern optogenetic experiments utilize the light-inducible microbial opsins such 
as channelrhodopsin-2 (ChR-2) and halorhodopsin (HR) (Boyden et al., 2005; Johansen et 
al., 2014; Nabavi et al., 2014; Zhang et al., 2007). These opsins transport ions across the 
membrane either as ion channels or transporters (ion pumps) to directly control the 
membrane excitability by depolarization or hyperpolarization (Zhang et al., 2007). These 
tools serve as a valuable approach for mapping circuits and detecting connectivity in a 
nervous system. However, they do not contribute to our understanding of the cellular and 
molecular biochemical pathways that affect animal behaviour. For such types of 
investigation, alternative optogenetic tools have been developed over the past decade. 
To manipulate biochemical pathways, other natural photosensors, such as Light, 
Oxygen or Voltage sensing domains (LOV), phytochrome and cryptochrome have been 
utilized (Kennedy et al., 2010; Pham et al., 2011; Reichhart et al., 2016). The first LOV 
domains were discovered in plant phototropins, photoreceptor threonine/serine kinases that 
utilize a flavin mononucleotide (FMN) cofactor as a chromophore (Christie et al., 1999; 
Huala et al., 1997). Although FMN is the common chromophore, LOV domains binding a 
flavin adenine dinucleotide (FAD) are also known in the literature (Losi et al., 2018). Both 
FMN and FAD are ubiquitously present in cells. Phototropins in plants regulate numerous 
processes including phototropism, chloroplast relocation and leaf movement (Kagawa et al., 
2001; Sakai et al., 2001). Blue light illumination triggers the structural rearrangements in 
LOV domains (Harper et al., 2003). This leads to the activation of an effector protein tethered 
with LOV (Pham et al., 2011; Wu et al., 2009). The LOV2-Jα, a photosensor domain from 
Avena sativa, is an attractive optogenetic tool due to its solubility, small size, ubiquity of the 
cofactor that is present in most cell types and its reversible action (Christie et al., 2012). 
LOV2-Jα in fusion with other protein domains and peptides has been used to control 
biochemical processes. Wu et al. (2009) designed a recombinant protein by fusing LOV2-Jα 
with a small GTPase, Rac1, which resulted in a photoactivatable Rac1 that increased cell 
motility upon illumination. The LOV-Jα domain was used to generate a local Ca
2+
 signal at 
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the plasma membrane by attaching LOV-Jα to a fragment of stromal interaction molecule 1 
(STIM1) which interacts with Orai1 to activate store-operated calcium entry (Pham et al., 
2011; Varnai et al., 2009). LOV2-Jα was applied to control a protein translocation to the 
nucleus and, consequently, to control gene transcription (Yumerefendi et al., 2015). 
Cryptochromes are another extensively studied group of blue-light photoreceptors. 
They are photolyase-like proteins that regulate circadian rhythm in Drosophila and floral 
initiation in a plant, Arabidopsis thaliana (Emery et al., 1998; Liu et al., 2008a). 
Cryptochromes consist of two domains: a photolyase-homologous region (PHR) domain and 
a C-terminal extension domain. PHR binds non-covalently to FAD (Brautigam et al., 2004; 
Liu et al., 2011). It has been shown that the photoexcited cryptochrome 2 (Cry2) from 
Arabidopsis thaliana can interact with a cryptochrome-interacting basic-helix-loop-helix 
protein (CIB1) (Liu et al., 2008a). This dimerization between Cry2 and CIB1 was used by 
Kennedy et al. (2010) to induce protein translocation, transcription and DNA recombination 
in mammalian cells upon light illumination. They also observed that the isolated PHD 
domain of Cry2 is sufficient to dimerize with the full-length and truncated CIB1 (Kennedy et 
al., 2010). In addition to light-mediated heterodimerization between Cry2 and CIB1, Cry2 
oligomerizes upon blue light illumination (Bugaj et al., 2013). The latest versions of 
Cry2/CIB1 were designed to reduce dark activity, change lifetime of the excited state and 
affinity of dimerization (Taslimi et al., 2016). The heterodimerization of Cry2/CIB1 was used 
to activate Raf1 and neurite outgrowth in PC12 cells (Zhang et al., 2014), to activate AKT 
(Katsura et al., 2015) and recruit CaMKII and AMPAR to the postsynaptic density in 
hippocampal neurons (Sinnen et al., 2017). The self-oligemerization of Cry2 was used to 
activate receptor tyrosine kinases (RTKs) and to manipulate intracellular Ca
2+
 in 
hippocampal neurons (Kyung et al., 2015). 
With the development of these light-responsive domains, it is possible to create an 
optogenetic tool to control cellular signalling implicated in learning and memory formation. 
 
1.4.2 Optogenetics in studying learning and memory 
 
The application of optogenetic techniques, surpassing the limited temporal resolution of 
genetic manipulations such as knock-in and knock-out, and the lack of genetic selectivity 
associated with electrical and pharmacological approaches, can provide more direct causal 
link between cellular events and behavioural consequences. Investigating learning and 
memory processes with optogenetic approaches in behaving animals can complement 
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existing knowledge on brain functions. For instance, recent studies have provided a strong 
connection between LTP and learning or between structural changes in dendritic spines and 
learning/memory formation in vivo (Hayashi-Takagi et al., 2015; Nabavi et al., 2014). 
One of the interesting studies aimed to test a correlation between synaptic plasticity in 
the lateral amygdala and production of aversive memories in freely behaving rats (Johansen 
et al., 2014). The authors hypothesized that during threat conditioning in rats, the presynaptic 
activity evoked by conditioned stimulus (tone) and paired with convergent depolarization of 
the pyramidal neurons of the lateral amygdala, should generate synaptic plasticity in the 
postsynaptic pyramidal neurons and produce aversive memories. To address this hypothesis, 
the optogenetic inhibition of membrane excitability of the pyramidal neurons in the lateral 
amygdala was applied during learning process. This significantly reduced learning-induced 
plasticity and memory formation in rats (Johansen et al., 2014). 
Strong evidence that the formation of aversive memories in vivo is associated with LTP 
was provided by Professor Roberto Malinow’s group using optogenetic control of 
presynaptic termini (Nabavi et al., 2014). These experiments used a chimeric variant of ChR-
2 to control the presynaptic termini projecting to the amygdala from the auditory cortex and 
medial geniculate nucleus. Optical control of vesicular release at the axonal termini in the 
lateral amygdala was used to induce LTP or LTD depending on the stimulation frequency 
and duration (Nabavi et al., 2014). An optical conditioned stimulus was paired with an 
aversive unconditioned stimulus (foot shock) which resulted in a conditioned response in 
freely behaving rats (freezing). In the same animals, LTD, evoked optogenetically, caused 
that animals did not display freezing. One day later, animals were exposed to an optical LTP 
protocol, after which rats exhibited freezing. Taken together, the aversive memories could be 
inhibited with LTD and reactivated with LTP (Nabavi et al., 2014). Thus far, this provides 
the strongest causal link between LTP and memory. 
A study with in vivo two photon imaging and optogenetic approach established links 
between structural synaptic plasticity and motor learning in the cortex (Hayashi-Takagi et al., 
2015). In this set of experiments, a photoactivatable Rac1 (described in Section 1.4.1.) was 
injected in the cortical layer II/III of the mouse primary motor cortex to induce single-spine 
shrinkage upon blue light illumination (Hayashi-Takagi et al., 2015). These data suggested 
that motor learning in mice increased spine volume. The photoactivation of Rac1 decreased 
this volume and erased the acquired motor skills in behaving mice (Hayashi-Takagi et al., 
2015). This report described, for the first time, how learning and memory formation can 
initiate the structural rearrangements in individual spines. 
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By using optoSTIM1 (see Section 1.4.1) to elevate intracellular Ca
2+
 in neurons, it was 
demonstrated that the light-stimulated mice exhibited approximately two-fold increase in 
freezing behaviour, indicating that the light-activated Ca
2+
 signal can reinforce contextual 
fear memories (Kyung et al., 2015). This provided more causal connection between Ca
2+
 
responses and learning/memory processes. 
Another recent elegant study used light to release a CaMKII inhibitory peptide, paAIP2 
(Murakoshi et al., 2017). Upon light activation, paAIP2 was able to impair the acquisition of 
inhibitory avoidance learning in the amygdala of freely behaving mice. Interestingly, 
CaMKII inhibition by paAIP2 had no effect after the initial phase of memory acquisition, 
contradictory to some existing literature on CaMKII functions in memory (Lisman et al., 
2012). Although more investigation is necessary to confirm and interpret these results, they 
supported our understanding of CaMKII activation and memory formation in vivo. 
 
1.5 Aims of the study 
 
While it has been shown that BDNF/TrkB signalling plays an important role in 
modulating synaptic plasticity, a direct link between BNDF/TrkB signalling, LTP and 
memory processes remains to be investigated in the intact adult brain. The numerous studies 
employing BDNF or TrkB knock-out or knock-in mice highlighted the importance of 
BDNF/TrkB in synaptic plasticity and learning/memory processes, although there are 
concerns that developmental abnormalities in the genetically altered animals can affect 
synaptic plasticity at different stages and, consequently, affect animal behaviour. Moreover, it 
is technically difficult to influence BNDF/TrkB expression in a defined neuronal population 
with knock-out or knock-in approaches. Other difficulties arise from the lack of a targeted 
method for dissecting BNDF/TrkB-mediated signalling pathways with a spatiotemporal 
resolution. 
To investigate a role of BDNF/TrkB signalling in LTP and learning in the adult nervous 
system of rodents, this study undertook an optogenetic approach to manipulate TrkB activity 
with light. To achieve the final goal, this project has two principal research aims: 
1. Develop a light-inducible TrkB system which can evoke canonical TrkB-mediated 
signalling pathways. 
2. Validate whether the tool can mimic TrkB action in living cells upon light 
stimulation. 
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In this thesis, a workflow for developing the photoactivatable TrkB system is presented. 
In Chapter 2, the generation of the TrkB system, its different configurations and ability to 
recapitulate the activation of TrkB-mediated signalling pathways in non-neuronal cells upon 
light are described. In Chapter 3, the utility of the initially validated TrkB system in neurons 
is presented. Finally, in Chapter 4, potential propositions of the TrkB system’s application in 


































Like other members of receptor tyrosine kinases (RTKs), TrkB possesses an N-terminal 
extracellular domain, a transmembane region and a C-terminal intracellular kinase domain. 
The extracellular domain is organized into five sub-domains. Domains 1 and 3 are cysteine-
rich and flank the leucine-rich domain 2. Domains 4 and 5 are immunoglobulin-like regions, 
with domain 5 being responsible for ligand-binding specificity. The kinase domain is flanked 
by the juxtamembrane region and the C-terminal tail (Bertrand et al., 2012; Middlemas et al., 
1991; Schneider and Schweiger, 1991). 
The activation of TrkB is mediated through binding with neurotrophins: BDNF, NT-4 
and to a lesser extent, with NT-3 (Ip et al., 1992; Klein et al., 1991). According to the model 
based on early studies of the tyrosine receptor kinase A-nerve growth factor (TrkA-NGF) 
complexes, and the structural similarity to other RTKs, TrkB is activated by dimerization 
upon ligand binding (Cunningham and Greene, 1998; Cunningham et al., 1997). However, 
the exact mechanism of BDNF-induced activation of TrkB at the molecular level remains still 
under discussion (Shen and Maruyama, 2012; Zahavi et al., 2018). Nevertheless, it has been 
shown that the homodimerized TrkB receptors autophosphorylate their tyrosine residues 
(Y701, Y705, Y706) within a structurally flexible activation loop that leads to 
conformational changes in their kinase domains making them easily accessible to substrates 
(Ahmed and Hristova, 2018; McCarty and Feinstein, 1998). Other phosphotyrosines within 
the intracellular kinase domain provide docking sites for effector proteins. A phosphorylated 
tyrosine 515 (Y515) at a juxtamembrane position of TrkB serves as a binding site for SHC 
(Src homology 2 domain) adaptor proteins to trigger Ras/ERK (extracellular signal-regulated 
kinase) and PI3K (phosphatidylinositol 3-kinase)/AKT signalling pathways (Minichiello et 
al., 1998; Stephens et al., 1994). A phosphotyrosine 816 (Y816) in the C-terminal tail of the 
intracellular domain is a binding site for phospholipase C-γl (PLCγ1) (Middlemas et al., 
1994). Figure 2.1 shows a simplified schematic of the structural organization of TrkB and the 
canonical signalling pathways activated by TrkB. 
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Figure 2.1 The canonical signalling pathways activated by TrkB. TrkB, a member of the tyrosine 
kinase family, can activate three main intracellular pathways upon binding brain-derived neurotrophic 
factor (BDNF). Recruitment of adaptor proteins to tyrosine 515 (Y515) triggers Ras/ERK 
(extracellular signal-regulated kinase) and PI3K (phosphatidylinositol 3-kinase)/AKT signalling 
pathways, which promote differentiation, growth, survival and synaptic plasticity in neuronal cells. 
Phosphorylation of TrkB tyrosine 816 leads to activation of phospholipase C-γl (PLCγ1), which 
catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) to inositol-1,4,5-
trisphosphate (Ins(1,4,5)P3) and diacylglycerol (DAG). Ins(1,4,5)P3 can promote the release of Ca
2+
 
from the internal store and DAG can activate protein kinase C (PKC). These pathways are thought to 
be involved in synaptic plasticity. Figure was adapted from Minichiello (2009). 
 
The involvement of RTKs in many important processes from development to 
maintenance of the central and peripheral nervous system has increased the interest in 
creating a tool to achieve precise control of neurotrophin activity. Such approach might 
provide better understanding of RTKs signalling and, if well-designed, a form of therapy, e.g. 
to induce axon outgrowth in neurodegenerative disease and spinal cord injury. Alfa et al. 
(2009) activated TrkA receptor by using a small chemically induced dimerizer (CID). In this 
approach, the intracellular domain of TrkA between 1410 and 2458 nucleotides (NCBI 
Reference Sequence: NM_021589), containing the juxtamembrane and activation loop 
region, was fused to an N-terminal myristoylation sequence for membrane localization and to 
two tandem FK506 binding protein domains (FKBPF36V). In a CID system, two copies of 
FKBPF36V were brought together via a chemical inducer, AP20187 (Lin et al., 2013). The 
dimerization of the chimeric intracellular domains of TrkA by using AP20187 activated the 
PI3K/AKT and ERK1/2 cascades in PC12 cells. This meant that the effect of AP20187-
induced dimerization was the same as when NGF binds to the full-length TrkA. The CID-
TrkA approach was independent from the native ligand activation as the extracellular domain 
of TrkA was not present in this construct (Alfa et al., 2009). A similar CID system was also 
used to activate another RTK, fibroblast growth factor receptor 1 (FGFR1), in a fibroblast 
growth factor (FGF)-independent manner (Welm et al., 2002). Although the CID strategy 
could mimic the action of NGF on TrkA and FGF on FGFR1, it exhibits a few drawbacks: 
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(1) CID is practically irreversible as a chemical stimulus cannot be removed easily and fast; 
(2) pulse application of a chemical activator is difficult; (3) the delivery of CID to specific 
regions of tissue in vivo or to an individual cell is problematic (lack of spatial resolution); (4) 
the action of CID on signalling pathway is limited by diffusion of a chemical compound (lack 
of temporal control) (Leopold et al., 2018). 
To overcome some of the disadvantages arising from the CID approach, an optogenetic 
strategy has been developed to control proteins optically. In this section, previous 
achievements using light-activated RTKs are discussed. The summary of the main strategies 
applied for RTK activation with light is presented in Figure 2.2. Chang et al. (2014) utilized 
the homodimerization properties of cryptochrome 2 (Cry2) from Arabidopsis thaliana upon 
blue light illumination to activate TrkA, TrkB and TrkC signalling (Fig. 2.2 A). Their main 
focus was on the photoactivatable TrkB (optoTrkB). In this system, the intracellular domain 
of full-length TrkB was linked to the N-terminus of a truncated version of Cry2 (498 amino 
acid-long photolyase homology region, PHR). The chimeric construct was visualized by 
monomeric yellow fluorescent protein, mCitrine, fused to the C-terminus of Cry2. It was 
shown that the resulting optoTrkB could activate the canonical TrkB signalling pathways 
upon light illumination in a reversible manner in HeLa and PC12 cell lines (Chang et al., 
2014). Nevertheless, the extracellular domain of optoTrkB remained intact so the chimeric 
receptor could be still stimulated by the endogenous BDNF in addition to light stimulation. A 
very high expression level of optoTrkB in a cell membrane may result in light- or BDNF-
independent activation of receptor molecules due to limited space (artefacts caused by RTKs 
overexpression were described by (Dikic et al., 1994; Traverse et al., 1994)). This stimulus-
independent activity of optoTrkB was evident in HeLa cells, where the background activity 
of ERK signalling was increased in the dark. Interestingly, in PC12 cells the background 
activity of ERK was not elevated in the dark, which demonstrates that the action of optoTrkB 
may be expression level-dependent in different cell types (Chang et al., 2014). The optoTrkB 
approach for in vivo application is also limited by the size of the chimeric receptor (4.683 
kilobase pairs (kbp) for the full-length TrkB-Cry2(PHR)-mCitrine insert only without any 
additional elements required for viral expression), which excludes the use of the recombinant 
adeno-associated virus (rAAV) for optoTrkB delivery due to packaging limit of rAAV (4.7 
kbp – 5.2 kbp between 5’ and 3’ inverted terminal repeats (ITR)) (Choi et al., 2014; 
Holehonnur et al., 2015). Although other viral vectors can be used to deliver optogenetic 





Figure 2.2 The main strategies applied for the activation of receptor tyrosine kinases (RTKs). 
(A) TrkA, TrkB and TrkC receptors were activated with blue light illumination due to the fusion of 
each full-length receptor to the photolyase homology region of cryptochrome 2 (Cry2(PHR)) (Chang 
et al., 2014). (B) The intracellular kinase domains (KD) of RTKs in membrane were attached to 
Cry2(PHR) or a light-oxygen-voltage domain (LOV) for the activation mediated by blue light (Duan 
et al., 2018; Grusch et al., 2014; Han et al., 2016; Kim et al., 2014). To create the red-light inducible 
RTKs, their kinase domains were linked to the cyanobacterial phytochrome 1 (CPH1) (Reichhart et 
al., 2016). (C) In another strategy, the kinase domain of TrkA was fused to Cry2(PHR) and the 
activation by blue light was achieved by the oligomerization of TrkA-Cry2(PHR) in the cytosol or by 
the translocation of TrkA-Cry2(PHR) to the membrane where a Cry2-binding protein (CIB1) was 
targeted (Duan et al., 2018). (D) The clustering process of endogenous RTKs by using a Src 
homology 2 domain (SH2) linked to Cry2(PHR) was used to activate pathways with blue light (Bugaj 
et al., 2015). This approach was called CLICR (Clustering Indirectly using Cryptochrome 2). The 
specific strategies of TrkB activation were marked in red. Abbreviations: ED, extracellular domain; 
TD, transmembrane domain; KD, kinase domain; P, phosphorylation sites to mark activation of RTKs 
(does not represent the exact numbers of phosphotyrosines in a kinase domain after activation); MYR, 
myristoylation tag; CAAX, prenylation tag. 
 
lasting transgene expression efficiency and lack of inflammatory or immune response in an 
infected animal (Holehonnur et al., 2015). 
Since the development of optoTrkB by Chang et al. (2014), and during the realization 
of this research project, many light-inducible RTKs have been developed. Grusch et al. 
(2014) created an optogenetically-activated FGFR1 (optoFGFR1) by linking the intracellular 
catalytic domain to an N-terminal myristoylation signal (for membrane localization) to create 
a chimeric receptor that was insensitive to an endogenous ligand (Fig. 2.2 B). The C-terminus 
of FGFR1 was fused to a light-oxygen-voltage (LOV) domain from the yellow-green alga 
Vaucheria frigida. Blue light-induced dimerization of optoFGFR1 led to the activation of 
ERK, AKT and PLCγ1 pathways in HEK293 cells (Grusch et al., 2014). The similar 
photoactivatable FGFR1, using Cry2(PHR) as a photodimerizer, was developed and tested in 
HeLa cells by Kim et al. (2014) (Fig. 2.2 B). In both approaches, the photoactivatable FGFR1 
was still localized in membrane and could potentially contribute to light-independent 
dimerization of the receptors when the expression level is high. 
Similarly, another group employed the homooligomerization feature of Cry2 to activate 
endogenous RTKs in three different cell types: HEK293T, NIH 3T3 fibroblasts and rat 
hippocampal adult NCSs (Bugaj et al., 2015). The strategy was called CLICR (Clustering 
Indirectly using Cryptochrome 2). In this approach, a Src homology 2 domain (SH2) from 
PLC, which serves as a binding protein towards RTKs, was fused with the N-terminus of 
mCherry-Cry2 (‘m’ stands for monomeric fluorescent protein) (Fig. 2.2 D). Upon blue light 
illumination, it was hypothesized that SH2-mCherry-Cry2 could bind weakly activated RTKs 
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and cause their clustering and activation. Two RTKs: FGFR1 and a platelet-derived growth 
factor receptor β (PDGFRβ) were activated with light by using SH2-mCherry-Cry2 
oligomerization (Bugaj et al., 2015). Thanks to this approach, unregulated activation of RTKs 
due to overexpression could be avoided as 3T3 cells expressing SH2-mCherry-Cry2 did not 
exhibit elevated signal activation in comparison with wild-type cells (Bugaj et al., 2015). 
Nevertheless, SH2 lacks specificity so SH2-mCherry-Cry2 can activate a broad range of 
RTKs upon light stimulation. 
The strategies described above utilized blue light illumination at 470 or 488 nm to 
induce dimerization of LOV domain from Vaucheria frigida or Cry2 (Bugaj et al., 2015; 
Grusch et al., 2014; Kim et al., 2014). In the next studies, a red-light induced 
homodimerization domain was developed and applied to activate FGFR1 and TrkB in 
HEK293 cells (Reichhart et al., 2016). The cyanobacterial phytochrome 1 from Synechocystis 
(CPH1S) was linked to the C-terminus of the intracellular domain of TrkB (Fig. 2.2 B). The 
extracellular domain of TrkB was replaced by the myristoylation sequence to ensure 
membrane localization of the chimeric receptor. Red light illumination at 630 nm was 
sufficient to activate TrkB-CPH1S and trigger ERK and AKT signalling pathways. The 
advantage arising from this approach is that red light illumination can penetrate more deeply 
than blue light so this tool seems to be more suitable for in vivo application. However, using 
CPH1S for protein activation in vivo upon red light has a significant limitation. This is a 
requirement for supplementation with the tetrapyrrole phycocyanobillin (PCB), the 
chromophore for CPH1S, which is not synthesized by mammalian cells (Reichhart et al., 
2016). 
The next two studies developed photoactivatable TrkC and TrkA by using Cry2 
oligomerization. Han et al. (2016) generated optoTrkC to examine whether intracellular 
signalling triggered by TrkC is responsible for synapse development. The blue-light inducible 
optoTrkC was created as a fusion of the cytoplasmic region of mouse TrkC (between 454 and 
825 amino acid) to the N-terminus of Cry2(PHR) (Fig. 2.2 B). The membrane insertion of 
optoTrkC was achieved by the N-terminal myristoylation sequence and the chimeric receptor 
was visualized by the near-infrared fluorescent protein (iRFP682). The activation of 
optoTrkC was studied by its ability to activate three canonical pathways: ERK, AKT and 
PLCγ1 in cultured hippocampal neurons (Han et al., 2016). The action of TrkC was inert to 
the endogenous ligand, NT-3, but optoTrkC was still localized in the membrane, which could 
increase the background signalling. Very recent designs for optical activation of TrkA have 
been published (Duan et al., 2018) while this thesis was being written. In these studies, three 
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different strategies utilizing Cry2 system were compared to achieve the light-inducible 
activation of TrkA. The first approach is the same as that described by Chang et al. (2014) 
and involved the full-length TrkA linked to the N-terminus of Cry2 (Fig. 2.2 A). Secondly, 
they used a similar design to the chemical induction of TrkA (Alfa et al., 2009). However, 
instead of using two tandem FK506 domains for TrkA dimerization, Cry2 was fused to the C-
terminus of the intracellular domain of TrkA and this chimeric receptor was localized to the 
membrane by the myrisoylation tag (Fig. 2.2 B). The final tool, which is very similar to the 
approach developed in this PhD project, involved the co-expression of two components: (1) 
the intracellular domain of TrkA fused to Cry2 (without any membrane tag), and (2) a 
membrane-targeted Cry2 interaction partner, CIB1 (Fig. 2.2 C). The efficiency of these three 
strategies were evaluated in PC12 cells to check neurite growth upon blue light illumination 
and in cultured dorsal root ganglion (DRG) cells to examine whether blue light can promote 
neuronal survival. According to these results from PC12 and DRG cells, it was shown that 
the kinase domain of TrkA-Cry2 + CIB1 strategy is the most effective to mimic the activity 
of NGF (Duan et al., 2018). Thus, the results obtained by Duan et al. (2018) support the data 
described in this thesis. 
The studies described above highlight the increasing interest in optical activation of 
RTKs to evoke biological responses, such as: neuronal survival (Duan et al., 2018), neurite 
outgrowth (Chang et al., 2014; Duan et al., 2018) or synaptic development (Han et al., 2016). 
Inspired by the design of optoTrkB, in which the full-length TrkB was clustered by Cry2 
upon blue light illumination (Chang et al., 2014), this project aimed to develop a 
photoactivatable TrkB system that could be used in vivo, and particularly, to examine its 
usefulness for controlling learning and memory processes in behaving animals. In my 
approach, a two component system was created where the kinase domain of TrkB without 
any membrane-localization signal was attached to the N-terminus of Cry2 (denoted as 
TrkB(kd)-Cry2) and the second component, CIB1, was targeted to the plasma membrane. In 
principle, blue light illumination should cause the aggregation of TrkB(kd)-Cry2 and its 
recruitment to CIB1 in the plasma membrane to activate the canonical signalling cascades on 
membrane. The general idea of this system’s action is depicted in Figure 2.3. The approach 
has several potential advantages: (1) the activity is independent from the endogenous BDNF; 
(2) the stimulus-independent activation of TrkB(kd)-Cry2 is avoided as it is not attached to 
the membrane; (3) the system can be packaged into rAAV when split, or into lentiviral 
vectors as a single insert when a “self-cleaving” T2A peptide is used. 
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Figure 2.3 The schematic of the design developed and described in this thesis. The figure shows 
the predicted action of the photoactivatable TrkB. Blue light illumination is used to aggregate Cry2 
fused to the C-terminus of the kinase domain (kd) of TrkB and to recruit TrkB(kd)-Cry2 to the 
membrane-localized CIB1 protein. This light-induced reaction leads to activating TrkB-mediated 
signalling at the plasma membrane. 
 
As reviewed by Leopold et al. (2018), the process of designing a photoactivatable 
kinase usually starts from the choice of a target protein and a rational method for engineering 
this protein, and then, an appropriate optogenetic system needs to be selected. In the next 
step, the responsiveness of the opto-protein system should be validated using multiple tests. 
For this reason, the aim of this chapter is to show how a new light-inducible TrkB was 
created and subsequently, validated in non-neuronal cells, HEK293A and HeLa cell lines. 
The first validation was performed using an orange genetically encoded calcium indicator (O-
GECO1) to assess the activation of PLCγ1 pathway upon blue light illumination. The 
determination of ERK and AKT pathway activation was fulfilled using ERK1-mCherry and 
mCherry-AKT1PH sensors upon blue light. Afterwards, the results were confirmed by western 
blotting using phospho-specific antibodies which can distinguish between non-activated and 
activated states of PLCγ1, ERK and AKT. The results obtained from these experiments 









A summary of key resources used to develop and examine the photoactivatable TrkB 
system in non-neuronal cells is presented in Table A1 in Appendix. 
Water for the preparation of buffers and solutions was purified through Milli-Q Water 
Purification System (Millipore). Buffers/solutions were sterilized through mixed cellulose 
ester and polyethersulfone filters with 0.2 µm pore size. 
The standard LB broth was made based on a following recipe: 10 g/l tryptone, 5 g/l 
yeast extract, 10 g/l NaCl (and for the solid agar plate: 14 g/l agar). LB broth was autoclaved 
at 121°C for 20 min. Ampicillin was added to the cooled LB at final concentration of 100 
µg/ml. 
 
2.2.2 RNA extraction and cDNA synthesis 
 
To obtain cDNAs for the kinase domain of TrkB, full-length ERK1 and PH domain of 
AKT1, total cellular RNA was prepared with Tri-Reagent (Sigma-Aldrich) using 
manufacturer provided protocol. Briefly, RNA was extracted from adult female Sprague-
Dawley rat brain homogenized in Tri-Reagent (1 ml per 50 – 100 mg of tissue) in IKA 
3737001 T10 basic ULTRA-TURRAX Homogenizer system 115VAC (Cole-Parmer). After 
centrifugation of the homogenate at 12,000 × g for 10 min at 4°C, 0.2 ml of chloroform was 
added per 1 ml of the supernatant. The mixture was shaken for 15 s and incubated for 5 min 
at RT. The subsequent centrifugation step at 12,000 × g for 15 min at 4°C separated the 
resulting mixture into 3 phases. The upper aqueous solution contained RNA. The isolated 
RNA was precipitated by adding 0.5 ml of isopropanol per 1 ml of Tri-Reagent, incubated for 
10 min at RT and spun at 12,000 × g for 10 min at 4°C. The pellet of RNA was washed once 
using 70% ethanol (1 ml of ethanol per 1 ml of Tri-Reagent) and subsequently, air-dried for 
10 min. Finally, RNA was resuspended in 20 µl RNase-free water and its purity was checked 
using NanoDrop (ND-1000 Spectrophotometer, Thermo Fisher Scientific). Aliquoted RNA 
was stored at -80°C. 
In the experiments, which aimed to assess presence or absence of TrkB in HEK293A 
and HeLa cells, RNeasy Mini Kit (Qiagen) was used for the total RNA extraction and a 
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procedure of purification was provided by the manufacturer. After the quality check, RNA 
was stored at -80°C. 
Construction of cDNA libraries was performed by using the isolated RNAs and 
Maxima H Minus First Strand cDNA Synthesis Kit (Thermo Scientific). In each experiment, 
1 µg of RNA was used for a first strand cDNA synthesis. The mixture of RNA and the 
components of the cDNA Synthesis Kit were incubated for 30 min at 50°C. The reaction was 
terminated by heating at 85°C for 5 min. The reverse transcription reaction products were 
used directly in PCR or stored at -20°C. 
 
2.2.3 Plasmid construction 
 
2.2.3.1 Molecular cloning a photoactivatable TrkB system 
 
The whole list of constructs created for the purpose of this chapter is included in 
Section 2.3.1 (see Table 2.4). The amino acid sequences of two main components of the 
photoactivatable TrkB are enclosed in Appendix (see Table A2). 
Briefly, generation of the required DNA constructs was performed by standard 
molecular biology techniques: polymerase chain reaction (PCR) and 2-step overlapping PCR 
to introduce point mutations, digestion with restriction enzymes, ligation of a desired insert 
into a plasmid, transformation of DH5α bacterial strain and checking sequences by Sanger 
sequencing method (Sambrook et al., 1989). 
The cDNA of TrkB kinase domain (TrkB(kd) region between nucleotides 1359 and 
2463 in the sequence of the full-length TrkB (NCBI Reference Sequence NM_012731.2) was 
amplified from the rat brain cDNA library by PCR using following oligonucleotides: 
BamHI-ClaI-TrkB_kinase_5F: 5’-ccggatccatcgatatgaagttggcgagacattccaagtttg-3’; 
TrkB_kinase-AgeI-stop-XbaI_3RC: 5’-ggtctagactaaccggtgcctaggatgtccaggtagacg-3’. 
The amplified product of TrkB(kd) (~ 1.1 kbp) was fused with 5’-end of the codon-
optimized photolyase homology region (PHR) of cryptochrome 2 (Cry2(498); comprising 
498 amino acid residues from Cry2) through a flexible 27-base pair (bp) linker. The 
TrkB(kd)-Cry2(498) DNA frament was cloned into pcDNA3.1H vector, resulting in 
pcDNA3.1H-CMV-TrkB(kd)-Cry2(498). In addition, Cry2(498) was attached to the 5’-end 
of TrkB(kd) through a flexible 33-bp linker and inserted into pcDNA3.1H to create: 
pcDNA3.1H-CMV-Cry2(498)-TrkB(kd)). Both TrkB chimeric constructs contain a 
cytomegalovirus promoter (CMV). 
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Subsequently, a bicistronic lentiviral expression vector with TrkB(kd)-Cry2(498) and a 
membrane-localized CIB1 (CIB1(170)-eGFP-CAAX) under regulation of CMV promoter 
was created (pLenti-CMV-TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX). In this 
vector, the first gene containing 5’-TrkB(kd)-Cry2(498)-3’ was inserted at a 5’-end of a “self-
cleaving” peptide (T2A, 54 bp) (Liu et al., 2017). The second gene containing 5’-CIB1(170 
amino acids)-eGFP-prenylation CAAX motif-3’ was cloned at 3’ end of T2A. 
The following constructs: pcDNA3.1H-CMV-TrkB(kd)-Cry2(498); pcDNA3.1H-
CMV-Cry2(498)-TrkB(kd); pLenti-CMV-TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-
CAAX; pcDNA3.1H-CMV-CIB1(170)-eGFP-CAAX and pcDNA3.1H-CMV-CIB1(81)-
eGFP-CAAX were prepared by Dr John Lin. 
In the next cloning step, the insert: TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 
from the lentiviral expression plasmid was transferred into pcDNA3 vector for efficient 
expression in HEK293A cells. The construct: pcDNA3-CMV-TrkB(kd)-Cry2(498)-T2A-
CIB1(170)-eGFP-CAAX served as a template for further cloning. To create a bicistronic 
construct, in which Cry2(498) is fused to the N-terminal end of TrkB(kd), 5’-Cry2(498)-
TrkB(kd)-3’ was PCR-amplified from pcDNA3.1H-CMV-Cry2(498)-TrkB(kd) with the 
following oligonucleotides: 
HindIII-BamHI-Nlinker_5F: 5’-cccaagcttggatccggcaccggcagcacc-3’; 
TrkB-K-no stop-NheI_3RC: 5’-aaagctagcgcctaggatgtccaggtagacg-3’. 
This PCR product was used to replace 5’-TrkB(kd)-Cry2(498)-3’ from the bicistronic 
construct, resulting in the generation of pcDNA3-CMV-Cry2(498)-TrkB(kd)-T2A-
CIB1(170)-eGFP-CAAX. 
To test different versions of Cry2-CIB1dimerization system, longer Cry2(535) (1 – 535 
amino acids of Cry2) and truncated CIB1(81) (1 – 81 amino acids of CIB1), described by 
Taslimi et al. (2016), were cloned into the construct: pcDNA3-CMV-TrkB(kd)-Cry2(498)-
T2A-CIB1(170)-eGFP-CAAX. For this purpose, Cry2(535) flanked by the flexible linkers 
was PCR-amplified using the following primers: 
AgeI-N-linker_5F: 5’-gcaaccggtggcggcag-3’; 
C-Linker-no stop-NheI_3RC: 5’-tccgctagctcccgcgcctcctcc-3’. 





The PCR products of Cry2(535) and CIB1(81) were inserted into the corresponding sites in 
the bicistronic vector, resulting in: pcDNA3-CMV-TrkB(kd)-Cry2(535)-T2A-CIB1(81)-
eGFP-CAAX. 
To examine whether different orientation of Cry2(535)/CIB1(81) may result in better 
performance of the dimerizing system, a N-myristoylated CIB1(81) (MYR-CIB1(81)) was 
produced and inserted at 5’-end of T2A, whereas 5’-TrkB(kd)-Cry2(535)-3’ was fused to 3’-
end of T2A, resulting in: pcDNA3-CMV-MYR-CIB1(81)-eGFP-T2A-TrkB(kd)-Cry2(535). 
To create a bicistronic control construct with eGFP, the 5’-eGFP-3’ insert was cloned at 
3’-end of T2A, that led to tgeneration of pcDNA3-CMV-TrkB(kd)-Cry2(535)-T2A-eGFP. 
 
2.2.3.2 Introducing mutations into TrkB kinase domain and Cry2 
 
The site-directed mutagenesis of TrkB kinase domain and Cry2 was performed by two-
step overlap extension PCR. The sequences of the oligonucleotides used for introducing 
mutations into TrkB kinase domain (Y515F, K571A, Y816F) and Cry2 (W349R, D387A, 
E490G) are listed in Table 2.1 and Table 2.2, respectively. All mutated inserts were 
sequenced to confirm the presence of the intended point mutation. 
 
Table 2.1 The oligonucleotides for mutagenesis of TrkB kinase domain. 


















Table 2.2 The oligonucleotides for mutagenesis of Cry2(535). 















C-Linker-no stop-NheI_3RC tccgctagctcccgcgcctcctcc 
 
2.2.3.3 Generating reporters: ERK1, AKT1PH and O-GECO1 
 
The of full-length ERK1 cDNA (NCBI: NM_017347.2) and a pleckstrin homology 
domain (AKT1PH; amino acid 1 – 147) of AKT1 (NCBI: NM_033230.2) were amplified from 





Subsequently, the amplified products were ligated into pcDNA3.1H vector in a frame with 
mCherry at the C (ERK1) or N (AKT1PH) termini of the proteins. 
The orange fluorescent genetically encoded calcium indicator (O-GECO1) was 
obtained from Addgene (Wu et al., 2013). The region encoding O-GECO1 was transferred 
into pLenti-CMV vector between BamHI and EcoRI sites. This construct (pLenti-CMV-O-





2.2.4 Sanger sequencing of prepared plasmids 
 
The sequences for all subcloned cDNAs were confirmed by sequencing analyses. The 
Sanger sequencing was performed on site using 3500 Series Genetic Analyzer (Applied 
Biosystems) and Big Dye Terminator chemistry version 3.1 (Applied Biosystems) followed 
by the Agencourt CleanSEQ sequencing reaction clean-up system (Beckman Coulter). For 
each sequencing reaction, 250 ng of plasmid DNA was used. Compositions of sequencing 
reactions, conditions of sequencing cycle and purification of sequencing mixtures were 
performed as described by manufacturer instructions. The on-site sequencing usually allowed 
600 – 850 bp of a good-quality readout. 
The Sanger sequencing of difficult templates or for single reads longer than 850 bp was 
performed at the Australian Genome Research Facility (AGRF) in Sydney. The sample 
preparation information is available at: www.agrf.org.au. 
 
2.2.5 Cell cultures and transfection 
 
HEK293A (Invitrogen) and HeLa (American Type Culture Collection, ATCC) cells 
were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco) supplemented with 
8% fetal bovine serum (FBS; Gibco) and 1% Penicillin-Streptomycin solution (Sigma-
Aldrich) at 37°C in a humidified 5% CO2 environment. A routine subculturing was 
performed by washing cells with 5 ml of Dulbecco’s Phosphate Buffered Saline (DPBS; 
Sigma-Aldrich) supplemented with 20 mM HEPES and 1 mM EDTA and final pH adjusted 
to 7.4. Cells were trypsinized with TrypLE Express (Gibco) and subcultured in 10-cm dishes 
every 3 – 4 days. 
The HEK293A cells stably expressing O-GECO1 (O-GECO1-HEK293A) were 
prepared by lentiviral infection of HEK293A. For this purpose, lentiviral particles containing 
O-GECO1 gene were produced by transient transfection of HEK293A cells in a 10-cm dish 
using X-tremeGENE 9 (Roche). X-tremeGENE 9 reagent was mixed with DNA (7.55 µg 
combined total of pLenti-CMV-O-GECO1, pMD2.G, psPAX2) in 2:1 ratio volume:weight (2 
µl of X-tremeGENE per 1 µg of DNA) and added to cells (~90% confluent in the day of 
transfection). The crude medium containing viral particles was collected 24 h and 48 h after 
transfection. This crude medium with lentivirus was used to infect HEK293A resulting in O-
GECO1-HEK293A stable cell line. 
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Two methods of transfection of HEK393A, O-GECO1-HEK293A and HeLa cells were 
used: polyethylenimine (PEI) and X-tremeGENE 9 transfection. In brief, for live cell 
imaging, HEK293A, O-GECO1-HEK293A or HeLa cells were seeded on glass coverslips  
(ø 13 mm, Thermo Fisher Scientific) in a 24-well plate ~24 h before transfection. For 
HEK293A and O-GECO1-HEK293A, coverslips were coated with poly-L-lysine (PLL; at a 
final concentration of 50 µg/ml) and collagen (at a final concentration of 500 µg/ml). Cells 
were transfected at ~50% confluency. Then, 0.1 µg of total DNA for HEK293A/O-GECO1-
HEK293A (0.05 µg of each DNA in cotransfection experiments) and 0.2 µg of total DNA for 
HeLa (0.1 µg of each DNA in cotransfection experiments) per well of a 24-well plate were 
used. DNA was mixed with 0.1 M PEI (pH 7.0) in 2:1 ratio (e.g., 0.2 µg DNA + 0.1 µl PEI). 
The DNA:PEI mixture was incubated for 15 min at RT and added to cells in FBS-free 
medium. The cells had medium replaced with FBS-containing DMEM after 3 h from the 
addition of DNA:PEI. In X-tremeGENE transfection method, DNA was mixed with X-
tremeGENE reagent in 1:3 ratio (e.g., 0.1 µg DNA + 0.3 µl X-tremeGENE) and incubated for 
20 min at RT. Then, DNA:X-tremeGENE mixture was dropped to cells and medium was not 
replaced. Cells were placed in the incubator under aluminium foil to protect from light. In 
each method of transfection, cells were imaged ~48 h after transfection. The light stimulation 
experiments were performed in HEK293A cells with similar transfection efficiency of 
vectors expressing the TrkB system. The conditions of transfection were kept the same for 
each TrkB vector and enabled to achieve the transfection efficiency estimated at 50% to 70% 
of GFP-positive cells. The transfection efficiency was kept at this level as non-transfected 
cells within a field of view during imaging experiments could serve as an internal control to 
ensure that only GFP
+
 cells could be activated under light stimulation. 
For immunoblot analysis, 1.7 × 10
5
 HEK293A cells were seeded into a 3.5-cm dish. 
The transfection was performed ~24 h after seeding by mixing 0.75 µg DNA per plate with 
X-tremeGENE in 1:3 ratio weight:volume. The DNA and transfection reagent complex was 
incubated for 20 min at RT and after this time, it was added to cells. The incubation of cells 
under aluminium foil in the incubator was continued for ~48 h. 
 
2.2.6 Live-cell imaging, photostimulation and data acquisition 
 
Light activation of the chimeric TrkB system was examined by the observation of 
PLCγ1, ERK1/2 and AKT1 signalling pathways using the genetically encoded sensors: O-
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GECO1, ERK1-mCherry and mCherry-AKT1PH, respectively. Cells transfected with the 
required sensor and the photoactivatable TrkB system were imaged at RT. 
Live-cell imaging was performed using an Olympus BX51WI fluorescent microscope 
equipped with a Scientific CMOS camera and the water immersion objectives: 40×/NA0.8 
(Olympus) and 20×/NA0.5 (Zeiss). A white light LED (X-Cite 110LED, Excelitas 
Technologies) was the fluorescence light source. GFP (excitation at 470 nm) images were 
taken using a GFP filter cube: 472/30, FF495-Di03, FF01-520/35, whereas O-GECO1 
(excitation at 543 nm) and mCherry (excitation at 587 nm) were detected using a second filter 
cube: FF01-543-22, 562-Di03, FF01-593/40. Micro-Manager 1.4.22 software was used for 
microscope image acquisition. For blue light activation of Cry2-CIB1 and Cry2-Cry2 
interactions, a customized LED (Luxeon Star) was placed next to the recording chamber. The 
stimulation mode of the LED device was controlled by LED Driver Control Panel V3.1.0 
(Mightex). The light intensity and duration of light stimulation are stated in the text or in the 






Figure 2.4 A customized LED device for blue light stimulation during live-cell imaging. The light 
intensity and duration of illumination were set via LED Driver Control Panel V3.1.0 (Mightex). Blue 
light was irradiated from the side of the recording chamber not to disrupt imaging. 
 
2.2.6.1 Calcium imaging with O-GECO1 sensor 
 
The O-GECO1-HEK293A stable cell line transfected with the photoactivatable TrkB 
system was imaged at ~48 h post-transfection. Cells seeded on 13 mm-coverslips were 
transported in extracellular solution (ECS) in a dish wrapped in aluminium foil. The ECS was 
of the following composition: 140 mM NaCl, 2.8 mM KCl, 10 mM HEPES, 1 mM MgCl2, 2 
mM CaCl2, 10 mM D-glucose, pH 7.4, osmolarity between 290 and 310 mOsm/l. This ECS 
also served as recording solution in the microscope recording chamber. The O-GECO1, 
intensiometric fluorescent protein-based Ca
2+
 indicator, has an excitation maximum at 543 
nm and emission at 564 nm in Ca
2+
-bound state, which enables the imaging of Ca
2+
 changes 
independent from activation of Cry2-CIB1 dimerization with blue light (470 nm) (Wu et al., 
2013). Calcium imaging was performed using the O-GECO1/mCherry filter cube and either 
40× or 20× objectives. Images were obtained at a frame rate of 1 Hz and acquisition 
parameters were the same for all groups of cells to be compared. Blue light stimulation of 1 s 
pulse duration at 36.8 mW/cm
2
 (100 mA LED current) was delivered at 0.5 min from the 
beginning of the imaging timecourse (unless stated otherwise). The expression of the 
photoactivatable TrkB, visualized through the GFP filter cube, was checked at the end of 
each imaging session. Calcium imaging experiments in HeLa cells, co-transfected transiently 
with O-GECO1 and the photoactivatable TrkB constructs, were performed as described for 
HEK293A cells. 
In an experiment testing PLCγ1 inhibitor, U73122 (Sigma-Aldrich), the transfected O-
GECO1-HEK293A cells were pre-incubated with 2.5 µM U73122 diluted in ECS for 10 min 
at 37°C. After this time, cells were imaged as described above in ECS containing 2.5 µM 
U73122 for another 5 min at RT. The control cells were incubated with the same volume of 
DMSO (at final concentration of 0.125% v/v) for 10 min at 37°C. 
Calcium imaging in a nominally calcium-free solution was carried out as described 
above. ECS did not contain 2 mM CaCl2 and its osmolarity was 290 mOsm/l. In this 
experiment images were taken at a frame rate of 0.5 Hz and blue light (1 s pulse at 36.8 
mW/cm
2
) was irradiated at 5.5 min of the time-lapse. 
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Calcium imaging data were analyzed in ImageJ. In each experiment, only GFP-positive 
cells (expressing chimeric TrkB constructs) were quantified. Ca
2+ 
levels in GFP-positive cells 
were calculated as a change in O-GECO1 fluorescence intensity normalized to the baseline 
fluorescence (before blue light stimulation). Number of replicates/cells and statistical tests to 
assess significance were stated in the text or in the figure legends. Statistical analyses were 
performed in OriginPro 8. 
 
2.2.6.2 ERK1 and AKT1PH translocation assay 
 
The HEK293A and HeLa cells co-transfected with the photoactivatable TrkB system 
and ERK1-mCherry were imaged ~48 h after transfection. Cells were transported and imaged 
in the same ECS as for calcium imaging (Section 2.2.6.1). Images were collected every 30 s 
through the O-GECO1/mCherry filter cube and 40× objective. Blue light pulse (1 s at 36.8 
mW/cm
2
) was delivered at 3 min of a timecourse. The expression of the photoactivatable 
TrkB was validated at the end of each experiment and only GFP-positive cells were analyzed. 
The ERK1 translocation from cytosol to nucleus was calculated as a ratio between nuclear 
and cytosolic ERK1 intensities normalized to the background before light exposure. The 
formula to determine this ratio is: ratio = (Inucleus – Ibackground) / (Icytosol – Ibackground) where “I” is 
the average pixel intensity. The average pixel intensity was measured in a circular ROI 
covering the nucleus or in an elliptical ROI covering the cytoplasm. The average pixel 
intensity for background was measured from ROI outside cells. Statistical analyses were 
performed using OriginPro 8. Number of replicates/cells and statistical tests to assess 
significance were stated in the text or in the legends of figures. 
The HEK293A and HeLa cells co-transfected with the photoactivatable TrkB system 
and the mCherry-AKT1PH sensor were imaged in the exactly same manner as cells expressing 
the ERK1-mCherry sensor. The translocation of mCherry-AKT1PH from cytosol to 
membrane was not analyzed quantitatively. 
 
2.2.7 Harvesting cells, SDS-PAGE and western blotting 
 
Around 48 h post-transfection, HEK293A cells were illuminated with blue light. The 
LED (470 nm) used for illumination was customized and controlled by LED Driver Control 
Panel V3.1.0 (Mightex). Blue light intensity was measured using an optical power meter 
(Thorlabs, model S121C) by Dr John Lin and Ms Elise Devenish. Cells were illuminated 
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with continuous blue light set with an LED current of 100 mA (36.8 mW/cm
2
) for 30 s at RT. 
Figure 2.5 shows how cells plated into a 3.5-cm dish were subjected to blue light 
illumination. Control cells were kept on a disabled LED for 30 s at RT (dark condition). Cells 
were transported from an incubator to LED in a dark container and room lights remained off 
during experiments. After the incubation on the LED, cells were returned to the incubator and 
harvested after 10 min. 
Non-transfected cells were treated with BDNF (Invitrogen) at final concentration of 
100 ng/ml for 10 min. The control non-transfected cells were treated with a vehicle (in this 




Figure 2.5 A customized LED device for activation of cells grown on a 3.5-cm dish. The light 
intensity can be controlled via LED Driver Control Panel V3.1.0 (Mightex). As shown, light from 




After desired treatment, cells were washed twice with ice-cold PBS and lysed in 200 µl 
of RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% 
SDS, protease inhibitor cocktail (Roche), phosphatase inhibitor cocktail (Roche)) in the dark. 
Collected lysates were frozen in liquid nitrogen and stored at -80°C until use. Thawed lysates 
were clarified by centrifugation at 13,000 rpm (Heraeus Rotor 3325B), 4°C for 10 min. Then,  
 
Table 2.3 Primary and secondary antibodies used for immunoblotting analysis in 
HEK293A cells. 




Anti-Phospho-Akt  Phospho-Ser473 Rabbit monoclonal 1:2,000 





Mouse monoclonal 1:2,000 
Anti-p44/42 MAPK 
(Erk1/2) 
C-terminus of p44 
MAPK 
Rabbit polyclonal 1:1,000 
Anti-Phospho-PLCγ1 Phospho-Tyr783 Rabbit polyclonal 1:1,000 
Anti-PLCγ1 
Residues surrounding 
Leu1220 of PLCγ1 
Rabbit monoclonal 1:1,000 
Secondary antibody 
Anti-Mouse/HRP - Goat polyclonal 1:10,000 
Anti-Rabbit/HRP - Goat polyclonal 1:10,000 
 
supernatants were aspired and a Lowry-based assay (DC Protein Assay, Bio-Rad) was carried 
out to assess protein concentrations. The lysates were mixed with Bolt LDS Sample Buffer 
(Invitrogen) supplemented with DTT and denatured at 70°C for 10 min. 10 µg of total 
proteins for anti-ERK/anti-AKT antibodies and 20 µg of total proteins for anti-PLCγ1 
antibodies were resolved on Bolt 4 – 12% Bis-Tris Plus gels (Invitrogen) (two separate gels 
for phospho- and total-antibody to avoid stripping of the membrane when quantification was 
required) using a Mini Gel Tank (Life Technologies, cat#A25977). Proteins were transferred 
to a polyvinylidene fluoride (PVDF) membrane (Bio-Rad) using a Mini Blot Module (Life 
Technologies, cat#B1000) at 20 V, 4°C for 60 min. After transfer, the PVDF membranes 
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were incubated for 60 min at RT in 5% (w/v) non-fat dry milk in TBS buffer supplemented 
with 0.05% (v/v) Tween-20 (Sigma-Aldrich). Subsequently, the membranes were probed 
with primary antibodies diluted in 5% non-fat dry milk + TBS buffer + 0.05% Tween-20. 
Incubation was carried out overnight at 4°C. This was followed by an incubation for 60 min 
at RT with the appropriate horseradish peroxidase conjugated secondary antibody diluted in 
1% non-fat dry milk + TBS buffer + 0.05% Tween-20. The concentrations of primary and 
secondary antibodies used for immunoblotting are listed in Table 2.3 and ordering details are 
in Table A1 (see Appendix). Proteins were detected by using Immobilon Western 





2.3.1 The design of a light-activated TrkB system 
 
As illustrated in Figure 2.3, a light-inducible TrkB system, developed for the purpose of 
this project, consists of two components necessary for its activation. One component contains 
an intracellular kinase domain with the juxtamembrane and C-tail of TrkB linked to a 
photolyase homology region (PHR) of Cry2 (referred to as TrkB(kd)-Cry2 from here in). The 
sequence of TrkB(kd) corresponds to the sequence of TrkB between amino acids 454 and 821 
published (UniProtKB Q63604-1; TrkB isoform GP145-TrkB). The second component of the 
TrkB system is composed of a truncated CIB1 attached to an enhanced green fluorescent 
protein and a membrane localization sequence (referred to as CIB1-eGFP). Blue light 
illumination induces interactions between Cry2 and CIB1, and the expression of this 
dimerization module is not toxic for cells (Kennedy et al., 2010). Moreover, the activities of 
target proteins can be controlled with light when they are fused to Cry2/CIB1 (Chang et al., 
2014; Duan et al., 2018; Katsura et al., 2015; Kennedy et al., 2010; Taslimi et al., 2016). My 
two-component TrkB system is designed so that upon light illumination, TrkB(kd)-Cry2 can 
be recruited to CIB1-eGFP, which is localized in the membrane, and simultaneously, 
TrkB(kd)-Cry2 can oligomerized in the membrane through Cry2-Cry2 interactions. As 
described below, this process can activate downstream signalling pathways in a light-
dependent manner. 
To test the system in non-neuronal cells, TrkB(kd)-Cry2 and CIB1-eGFP were cloned 
into the mammalian expression vector pcDNA3.1H or pcDNA3, under transcriptional control  
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Table 2.4 Generated DNA constructs for non-neuronal studies. 
# The full name of construct 



















DNA constructs with wild-type TrkB(kd) and different Cry2 and CIB1 
10 pcDNA3-CMV-TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 












pLenti, pcDNA3.1H (H = hygromycin B antibiotic resistance) and pcDNA3 are the plasmid 
backbones. By using these backbones, the expression of required proteins is controlled under the 
cytomegalovirus promoter (CMV). CAAX, C-terminal prenylation signal (GKKKKKKSKTKCVIM); 
MYR, N-terminal myristoylation signal (MGCIKSKRKDNLN); T2A, “self-cleaving” peptide derived 
from thosea asigna virus 2A (EGRGSLLTCGDVEENPGP). 
 
of CMV promoter. The different truncations and combinations of Cry2 PHR domains (498 vs 
535 amino acids) and CIB1 (170 vs 81 amino acids) were tested (Kennedy et al., 2010; 
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Taslimi et al., 2016). The exact truncated form is acknowledged in a bracket from here in 
(e.g. TrkB(kd)-Cry2(498)). Moreover, two orientations of Cry2 to TrkB(kd) were examined, 
in which TrkB(kd) was fused to the N- or C-terminus of Cry2. Three amino acid point 
mutations in Cry2 (D387A, E490G, W349R) were investigated to determine their effects on 
the kinetics of TrkB signalling activation. To study whether the upregulation of canonical 
TrkB signalling is mediated through kinase activity specifically, the point mutations in 
TrkB(kd) (Y816F, Y515F, K571A) were introduced. For the attachment of CIB1 to the 
membrane, the N-terminal MYR and C-terminal CAAX tags were both tested. In most of the 
experiments, bicistronic constructs with a T2A sequence were used to promote equal levels 
of co-expression of Cry2 and CIB1 components. The T2A sequence is a “self-cleaving” 
peptide derived from a viral genome (T2A; thosea asigna virus 2A) (Szymczak and Vignali, 
2005). The “self-cleaving” is achieved by skipping the formation of a glycyl-prolyl peptide 
bond at the C-terminus of T2A by ribosome and when successful, it results in translation of 
two proteins (Donnelly et al., 2001; Liu et al., 2017). From here in, the application of the 
bicistronic vector is pointed by adding “T2A” between each component in the 
photoactivatable TrkB system. The list of created DNA constructs is presented in Table 2.4. 
 
2.3.2 Light-mediated activation of canonical TrkB pathways in HEK293A cells 
 
2.3.2.1 Light activation of optogenetic TrkB increases cytosolic calcium through PLCγ1 
signalling 
 
The phosphorylation of TrkB at Y816 provides a docking site for PLCγ1, which leads 
to the phosphorylation of PLCγ1 and its activation (Kim et al., 1991; Middlemas et al., 1994). 
Subsequently, activated PLCγ1 can cause Ca
2+
 to be released from the internal store (see Fig. 
2.1) (Berridge and Irvine, 1984; Disatnik et al., 1994; Widmer et al., 1993) and Ca
2+
 influx 
through a subsequent activation of a transient receptor potential cation channel 3 (TRPC3) 
(Amaral and Pozzo-Miller, 2007). 
Monitoring Ca
2+
 changes was used as a surrogate for PLCγ1 activity. A HEK293A cell 
line stably expressing the Ca
2+
 biosensor, O-GECO1, was transfected with the different 
variants of the TrkB tools. The cells transfected with pcDNA3-TrkB(kd)-Cry2(498)-T2A-
CIB1(170)-eGFP-CAAX, encoding both Cry2 and CIB1 components, showed the elevation 
of intracellular Ca
2+
 upon a single blue light pulse of 1 s (470 nm) (Fig. 2.6 A, B). Blue light 
illumination activated only eGFP positive cells, which indicated the expression of this TrkB 
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tool. The light-provoked Ca
2+
 increase was transient and returned to the baseline within 5 min 
(Fig. 2.6 B, black trace). The CIB1(170)-eGFP-CAAX component or TrkB(kd)-Cry2(498) 
alone was not sufficient to elevate intracellular Ca
2+
 in response to the blue light stimulation 
(Fig. 2.6 B, blue and red trace, respectively). A previous reported photoactivation of O-
GECO1 (Wu et al. (2013); Fig. 4 C) was not observed under our conditions of stimulation. 
 
Figure 2.6 Light activates the photoactivatable TrkB system. (A) In O-GECO1-HEK293A stable 
cell line co-expressing TrkB(kd)-Cry2(498) and the membrane-anchored CIB1(170), light 
illumination led to the elevation of intracellular Ca
2+
, as visualized with the orange fluorescent 
genetically encoded calcium indicator (O-GECO1), which is consistent with the activation of PLCγ1. 
The images show an example of a cell expressing TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 
which responded to blue light illumination. (B) The graph shows that both components (TrkB(kd)-
Cry2(498) and CIB1(170); black line) were necessary to elevate intracellular Ca
2+
 in cells. Either 





 changes were quantified as O-GECO1 fluorescence intensity normalized 
to the baseline fluorescence before blue light stimulation delivered at 0.5 min after the initiation of 
imaging (represented as a blue line). Results are presented as mean ± SEM calculated from one 
independent experiment performed in triplicates. The total numbers of cells used for quantification are 
as follows: 19 cells for TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX; from 27 cells for 





Figure 2.7 The effect of increasing LED light intensities on Ca
2+
 responses in O-GECO1-
HEK293A cells transfected with TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX. (A) Graphs 
represent raw Ca
2+
 transients in the individual cells (grey lines) and the mean (black lines) upon the 
increasing light intensities of 470 nm LED (36.8 mW/cm
2
 at 100 mA, 95.6 mW/cm
2
 at 300 mA, 148.1 
mW/cm
2
 at 500 mA, 191.8 mW/cm
2
 at 700 mA) delivered as a 1-s pulse. The light stimulation is 
indicated as a blue arrow. (B) Bar graph represents the percentage of TrkB system-positive cells, 
which responded upon the increasing powers of the blue light. 26% of non-stimulated cells responded 
upon the conditions of imaging (0 mA). This response was considered as a background activity of the 
system. However, more cells responded upon blue light stimulation (67% for 100 mA; 90% for 300 
mA; 88% for 500 mA; 97% for 700 mA). (C) Graph represents the peak values of Ca
2+
 transients for 
individual cells within each group showed in (A). The 100 mA current was the lowest intensity tested 
that gave the significant increase in the amplitude of Ca
2+
 in comparison to non-stimulated cells with 
blue light. Two cells, one in the 500 mA group and second in the 700 mA group, reached the 
intensiometric changes of 117× and 149×, respectively (not shown in the graph). This magnitude of 
changes is possible for O-GECO1 as described by Wu et al. (2013). Significance was compared 
between the response for 0 mA and the responses for the increasing blue light powers (100 mA, 300 
mA, 500 mA and 700 mA, respectively). The individual dot represents a maximal O-GECO1 intensity 
for a single cell (line = mean; ***P<0.001, **P<0.01, *P<0.05, unpaired Student’s t-test). The total 
number of cells tested from one independent experiment performed in triplicates is as follows: 38 
cells for 0 mA; 60 cells for 100 mA; 39 cells for 300 mA; 41 cells for 500 mA; 36 cells for 700 mA. 
 
Four different blue light (470 nm) intensities were tested. Each population of 
transfected cells was exposed to a 1-s light pulse with the LED current set at 0 mA 
(background activity caused by a live-imaging light and without blue light stimulation), at 
100 mA, 300 mA, 500 mA and 700 mA (Fig. 2.7). The estimated light intensities at each 
LED current were as follows: 36.8 mW/cm
2
 at 100 mA, 95.6 mW/cm
2
 at 300 mA, 148.1 
mW/cm
2
 at 500 mA, 191.8 mW/cm
2
 at 700 mA. The green light applied during the live-cell 
imaging without the exposure of blue light evoked the activation of Ca
2+
 signalling in 26% of 
cells expressing the photoactivatable TrkB system (Fig. 2.7 B). Nevertheless, the delivery of 
blue light at increasing intensities activated 67%, 90%, 88%, 97% for 100 mA, 300 mA, 500 
mA and 700 mA, respectively (Fig. 2.7 B). Moreover, the lowest blue light intensity, which 
gave the significant increase in the mean peak value of Ca
2+
 responses over the background 
activity (at 0 mA), was 100 mA (Fig. 2.7 C). The LED settings at 100 mA were used as 
default for the blue light stimulation. 
To test whether the Ca
2+
 transients can be evoked repeatedly, the 1-s blue light pulses 
were delivered three times to the same cells separated by 20 min intervals. Light-induced 
Ca
2+
 was detected in all instances in spite of smaller responses in second and third 
stimulation (Fig. 2.8). The 20 min between blue-light stimulation was sufficient to allow 
Cry2-CIB1 to come back to the unbound state because the reversal time of Cry2-CIB1 has 
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been reported as ~12.5 min (Kennedy et al., 2010). The activation of the TrkB system could 





 transients can be controlled in a reversible manner with light. Delivery of three 
1-s light pulses with 20-min interstimulus intervals evoked Ca
2+
 transients repetitively in O-GECO1-
HEK293A cells expressing TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX. The results are 
presented as mean ± SEM calculated from 25 cells. All responses were normalized to the baseline 
fluorescence before first light stimulation at 0.5 min. 
 
By using a correlation analysis, the existence of a relationship between the expression 
level of the photoactivatable TrkB system and the magnitude of Ca
2+
 transient was 
investigated. The O-GECO1-HEK293A cells were transfected with pcDNA3-CMV-
TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX and the standard Ca
2+
 imaging with the 
1-s blue light stimulation was performed as described before. The expression of 
photoactivatable TrkB was determined by measuring fluorescence intensity of eGFP. The 
expression level was correlated with the peak value of Ca
2+
 signal upon the blue light 
stimulation. Using a Pearson’s correlation coefficient (Pearson’s r), it was shown that 
expression level was a poor predictor of the magnitude of Ca
2+ 
signal (although the negative 
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sign of the regression slope was significant at P = 0.00015 (< 0.05); Fig. 2.9). In the same 
experiment, it was assessed that 76% of cells, expressing the TrkB system, responded to the 




Figure 2.9 The relationship between the expression level of TrkB system and the amplitude of 
Ca
2+
 response upon blue light illumination. In O-GECO1-HEK293A cells expressing TrkB(kd)-
Cry2(498)-T2A-CIB1(170)-eGFP-CAAX, the expression of the photoactivatable TrkB system 
(measured as the intensity of eGFP fluorescence) was a poor predictor of the magnitude of Ca
2+
 
signal (Pearson’s r = -0.407; n = 82 cells; P = 0.00015). The horizontal line at 2 separates cells with 
the amplitudes lower than 2, which were considered as non-responesive cells. 76% of cells responded 
to the light stimulation above this threshold. 
 
The order of domains in the fusion between TrkB(kd) and Cry2(498) appears to 
influence the effectiveness of this system. When Cry2(498) was linked to the N-terminus of 
TrkB(kd), the Ca
2+
 transients were evoked less efficiently upon blue light. Only 6% of the 
cells expressing the TrkB system in this order responded compared to 76% when Cry2(498) 
was linked to the C-terminus of TrkB(kd) (Fig. 2.10). 
To determine if the observed stimulatory effect of blue light is mediated through the 
specific PLCγ1 signalling cascade, the O-GECO1-HEK293A cells expressing TrkB(kd)-
Cry2(498)-T2A-CIB1(170)-eGFP-CAAX were treated with an aminosteroid inhibitor of PLC 
receptors (U73122) prior performing Ca
2+
 imaging. The U73122 inhibitor blocks PLC-




Figure 2.10 The fusion of Cry2(498) to the N-terminus of TrkB(kd) is less effective at elevating 
Ca
2+
. When TrkB(kd) was fused to C-terminus of Cry2 (498) (Cry2(498)-TrkB(kd)) only 6% of the 
cells expressing these proteins responded to the 1-s light stimulation compared to 76% of the cells 
with TrkB(kd) fused to the N-terminus of Cry2(498). Grey lines represent the Ca
2+
 traces for single 
cells, whereas black line represents the mean measured from 47 cells pooled from two independent 




 mobilization from intracellular stores associated with PLC activation (Jin et al., 
1994). The pre-incubation of O-GECO1-HEK293A cells expressing TrkB(kd)-Cry2(498)-
T2A-CIB1(170)-eGFP-CAAX with 2.5 µM U73122 for 10 min abolished light-evoked Ca
2+
 
responses (Fig. 2.11, compare A and B). These results suggest that PLC-mediated production 
of Ins(1,4,5)P3 is an essential step for the light-induced elevation of the intracellular Ca
2+
. 
To investigate the source of intracellular Ca
2+
, cells were incubated and imaged in a 
Ca
2+
-free solution. The Ca
2+
-free solution had the similar composition to ECS described in 
Section 2.2.6.1, but it did not contain 2 mM CaCl2. The transfected O-GECO1-HEK293A 
cells were imaged in this solution for 10 min at 0.5 Hz and 1-s blue light pulse was delivered 





 transients could be still activated with blue light, suggesting that  
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Figure 2.11 Light activation of TrkB signalling is consistent with PLCγ1-mediated Ca
2+
 
increase. (A) In O-GECO1-HEK293A cells transfected with TrkB(kd)-Cry2(498)-T2A-CIB1(170)-
eGFP-CAAX, blue light delivered at 0.5 min of a timecourse (arrow) led to the elevation of 
intracellular Ca
2+
 (left graph). Pre-treatment of cells with PLC inhibitor U73122 at the final 
concentration of 2.5 µM for 10 min reduced light-evoked Ca
2+
 signals (right graph). Ca
2+
 transients 
were quantified as changes in O-GECO1 fluorescence intensity normalized to the baseline 
fluorescence prior photostimulation. The grey lines are responses of the individual cells and the mean 
is shown in black. (B) The column scatter graph shows the peak responses of individual cells (grey 
dots) represented in the panel A for non-treated cells (-U73122; n = 154) and cells treated with the 





 was released from the internal store. Interestingly, Ca
2+
 responses in the Ca
2+
-free 
solution were more transient and recovered to the baseline within 1.5 min, whereas in the 
normal ECS, these responses came back to the baseline within 2.5 min (Fig. 2.12 A, B). This 
might suggest that in addition to the mobilization of the internal store, a different Ca
2+
 source 
can be involved in the light-mediated Ca
2+
 signalling when the extracellular Ca
2+
 is present. 
To investigate whether the elevation of Ca
2+
 signalling upon blue light requires the 
kinase activity of the photoactivatable TrkB, three different point mutations were introduced 
into TrkB(kd). Firstly, a mutation from tyrosine to phenylalanine at 515 amino acid of 
TrkB(kd) (TrkB_Y515F) was introduced as described in the literature (Easton et al., 1999).  
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Figure 2.12 Blue light mediates Ca
2+
 mobilization from an intracellular store. O-GECO1-
HEK293 cells, expressing TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX, responded to blue 
light stimulation in the Ca
2+
-free solution (A). In panel (B), Ca
2+
 traces upon blue light stimulation in 
the Ca
2+
-containing solution are presented. Grey lines represent a Ca
2+
 traces for a single cell, whereas 
black lines represent means quantified from 51 cells for (A) and from 30 cells for (B) from one 
independent experiment in triplicate and duplicate, respectively. Blue arrow shows the point of blue 
light delivery. 
 
The Y515 site lies within a juxtamembrane region of TrkB(kd) that binds to the SHC adapter 
proteins and consequently leads to the activation of AKT and ERK signalling pathways 








 responses are abolished by the mutations in TrkB kinase domain. (A) The 
outline represents DNA constructs consisting of mutated TrkB kinase domain in TrkB(kd)-Cry2(498)-
T2A-CIB1(170)-eGFP-CAAX. (B) In this panel, the example of a O-GECO1-HEK293A cell 
expressing the wild-type TrkB kinase domain (TrkB_WT) fused to the photoactivatable system is 
shown. Blue light illumination evoked Ca
2+
 transients, which was measured by the increase in the O-
GECO1 fluorescence. The graph shows the Ca
2+
 responses from 23 cells expressing the TrkB_WT 
system. (C) The substitution K to A at 571 aa of TrkB kinase domain (TrkB_K571A) caused the 
photoactivatable system to be incapable of activating PLCγ1 pathway, which was seen as a lack of 
Ca
2+
 responses evoked by blue light (as shown in the graph, n = 43 cells expressing TrkB_K571A 
system). (D) Similarly to TrkB_K571A results, introducing Y816F mutation in TrkB kinase domain 
(TrkB_Y816F) abolished light-evoked Ca
2+
 transients in cells expressing TrkB_Y816F (as seen in the 
graph, n = 42 cells). (E) A mutation Y515F, which is known to affect SHC phosphorylation leading to 
supression of Erk and Akt pathways, did not change Ca
2+
 responses in cells expressing TrkB_Y515F 
(as shown in the graph, n = 54 cells). Cells shown in B-E were obtained from one independent 
experiment in triplicate (total number of cells per condition was ≥10). (F) This graph summarises the 
peak Ca
2+
 responses upon blue light stimulation in each group of cells expressing various TrkB(kd) 
mutants (line = mean; ***P<0.001, unpaired Student’s t-test). Means were calculated from second 
independent experiment performed in triplicates. Overall, the experiment was performed as two 
independent experiments: first imaging session under 40× objective and second one under 20× 
objective. Cells from “20× objective” experiment were quantified and shown in graphs B-F. 
 
expected to attenuate the initiation of AKT and ERK pathways, but not to alter PLCγ1 
signalling. The second substitution was introduced at a lysine 571 which serves as a 
consensus ATP binding site within an active site of TrkB(kd) (Guiton et al., 1994). The 
mutation to alanine (TrkB_K571A) has been reported to abolish all kinase activity of TrkB as 
it completely eliminates a phosphoryl transfer (McCarty and Feinstein, 1998). The 
TrkB_K571A mutant was considered as a “kinase-dead” mutant so it was predicted to block 
the activity of the photoactivatable TrkB completely. Finally, a mutation of tyrosine 816, a 
residue previously identified to interact with PLCγ1 (Atwal et al., 2000; Middlemas et al., 
1994), to phenylalanine (TrkB_Y816F) was expected to abolish the light-mediated Ca
2+
 
increase, whereas the induction of AKT and ERK pathways should not be disturbed. 
As predicted, light did not evoke Ca
2+
 elevation in TrkB_K571A (kinase-dead) and 
TrkB_Y816F (unable to interact with PLCγ1) mutants (Fig. 2.13 C, D). The TrkB_Y515F 
mutant did not alter Ca
2+
 signalling (Fig. 2.13 E). These results indicate that the observed 
Ca
2+
 increase upon light requires the kinase activity of TrkB domain and is mediated through 
interaction with PLCγ1. 
Taking advantage of the recent development of a second generation Cry2-CIB1 
dimerizer with reduced background binding (Taslimi et al., 2016), a new Cry2-CIB1 pair was 






 responses can be evoked by TrkB system fused to different Cry2 and CIB1 
variants. (A) The schematic representations of chimeric proteins show a wild type TrkB kinase 
domain (TrkB(kd)) fused to 535 aa-long Cry2 mutants and 81 aa-CIB1 attached to eGFP-Caax. 
Cry2(535) component is connected with CIB1(81) by T2A sequence. The amino acid substitutions 
prepared in this project are presented within Cry(535) sequence. (B) The graphs show the Ca
2+
 traces 
in O-GECO1-HEK293A expressing different Cry(535) mutants upon blue light pulse. A wild type 
Cry2(535) as well as Cry2(535)_E490G (oligomerisation) mutant could trigger Ca
2+
 elevation upon 
light stimulation. A light-insensitive mutant (Cry2(535)_D387A), a fast-cycling mutant 
(Cry2(535)_W349R) and the Cry2(535) system without CIB1(81) (Cry2(535)_eGFP) component 
failed to trigger Ca
2+ 
responses. Grey lines represent traces of individual cells, whereas black lines are 
means. (C) The column scatter plot represents Ca
2+
 peak responses for each Cry2(535) mutant. Grey 
dots are responses of single cells. Black line is mean (***P<0.001, **P<0.01, unpaired Student’s t-
test). (n = 38 cells for Cry2(535)_WT; n = 50 cells for Cry2(535)_D387A; n = 42 cells for 
Cry2(535)_E490G; n = 37 cells for Cry2(535)_W349R; n = 35 cells for Cry2(535)_eGFP). All cells 
were pooled from one independent experiment performed in triplicate. 
 
to 535 amino acids (Cry2(535)), whereas CIB1 was truncated to 81 amino acids (CIB1(81)) 
as opposed to the initial pair of Cry(498) and CIB1(170). Taslimi et al. (2016) showed that 
Cry2(535) exhibited lower self-association in dark, while its interaction in light condition was 
still substantial. They also described new mutations affecting Cry2(535) photocycle kinetics, 
including a fast short-cycling W349R variant (Cry2535_W349R) with a half-life of 2.5 
minutes (Taslimi et al., 2016). In a separate study, a mutation E490G within Cry2 domain 
was shown to enhance a light-dependent clustering of Cry2, while retains binding to 
CIB1(170) (Taslimi et al., 2014). A light-insensitive mutant of Cry2 (D387A) was also 
created. The D387 is a part of FAD-binding pocket and once mutated, it interrupts the light-
dependent interaction between Cry2 and CIB1 (Liu et al., 2008a). These mutants were 
assessed in my standardized Ca
2+
 assay. 
When the new Cry2(535)/CIB1(81) was used in the place of the original 
Cry2(498)/CIB1(170), a blue light pulse could still trigger Ca
2+
 elevation (Fig. 2.14 B). 
Interestingly, this response lasted ~1.5 min and seemed to be more transient that the response 
compared to the Cry2(498)/CIB1(170) pair (see Fig. 2.6 B). This observation was also 
confirmed when the light stimulation was delivered to the cells after longer baseline period 
(Fig. 2.15). The Cry2(535)_E490G mutant was able to trigger Ca
2+
 responses (Fig. 2.14 B 
and C). The light insensitive Cry2(535)_D387A as well as the short-cycling 
Cry2(535)_W349A failed to evoke Ca
2+
 transients (Fig. 2.14 B and C). Similarly, Cry2(535) 
without CIB1(81) in the membrane did not show any elevation of Ca
2+





Figure 2.15 Cry2(535) and CIB1(81) pairs evokes transient Ca
2+
 response. O-GECO1-HEK293A 
cells, expressing TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX, responded to blue light 
stimulation delivered after 5.5 min of imaging. Grey line represents a Ca
2+
 trace for a single cell, 
whereas black line represents the mean quantified from 32 cells pooled from one independent 
experiment in duplicate. Blue arrow shows the point of blue light delivery. 
 
Similar to the results presented in Figure 2.9, the association between the expression 
level of TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX (measured as fluorescence 
intensity of eGFP) and magnitude of Ca
2+
 was correlated by using Pearson’s r. There was no 
significant linear relationship between the expression of the TrkB system with 
Cry2(535)/CIB1(81) and the amplitude of Ca
2+
 responses as the Pearson’s r equalled 0.072 
and P > 0.05 (Fig. 2.16). In this assay, it was assessed that 77% of the transfected O-GECO1-
HEK293A cells responded upon blue light illumination, which is consistent with the results 
obtained for TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX construct (refer to Fig. 2.9). 
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Figure 2.16 The relationship between the expression level of TrkB system with Cry2(535)-
CIB1(81) and the amplitude of Ca
2+
 response upon blue light illumination. In O-GECO1-
HEK293A cells, expressing TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX, the expression level 
was not significantly related to the amplitude of Ca
2+
 signal (Pearson correlation coefficient, r = 
0.072; n = 94 cells; P = 0.49). The horizontal line at 2 shows the cells with the amplitude lower than 
2, which were considered as non-responsive cells. Having this threshold, it can be seen that 77% of 
cells responded to the light stimulation. 
 
The PLCγ1 inhibitor, U73122, reduced the light-induced Ca
2+
 elevation in O-GECO1-
HEK293A cells expressing TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX (Fig. 2.17). 
These results are in agreement with observations for Cry2(498)/CIB1(170) pair (refer to Fig. 
2.11). It confirms that the light-triggered Ca
2+
 increase is mediated through the PLCγ1 
pathway in both cases. 
I also tested whether changing the membrane C-terminal lipidation anchor of CIB1(81) 
for a N-myristoylation tag (denoted as MYR) could also activate the signalling effectively. 
To achieve this, TrkB(kd)-Cry2(535) now had to be inserted after the T2A sequence. This 
configuration (MYR-CIB1(81)-eGFP-T2A-TrkB(kd)-Cry2(535)) did not activate Ca
2+
 




Figure 2.17 Light activation of TrkB(kd)-Cry2(535) with CIB1(81) is consistent with PLCγ1-
mediated Ca
2+
 increase. (A) In O-GECO1-HEK293A cells, transfected with TrkB(kd)-Cry2(535)-
T2A-CIB1(81)-eGFP-CAAX, blue light delivered at 0.5 min of a timecourse (arrow) led to the 
elevation of intracellular Ca
2+
 (left graph). Pre-treatment of cells with PLC inhibitor U73122 at the 
final concentration of 2.5 µM for 10 min reduced light-evoked Ca
2+
 signals (right graph). (B) The 
graph shows the peak responses of individual cells (grey dots) represented in the panel A for non-
treated cells (-U73122; n = 94) and cells treated with the inhibitor (+U73122; n = 98). Central line and 





Figure 2.18 Changing order of CIB1(81) and TrkB(kd)-Cry2(535) in the bicistronic construct 
disrupts functional expression of chimeric proteins. O-GECO1-HEK293 cells, expressing 
CIB1(81) attached to N-myristoylation signal and TrkB(kd)-Cry2(535) (MYR-CIB1(81)-eGFP-T2A-
TrkB(kd)-Cry2(535)) did not respond to blue light stimulation as robustly as cells, expressing 
TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX. Grey lines represent the Ca
2+
 traces for single 
cells, whereas black line represents the mean measured from 25 cells from one independent 
experiment performed in duplicate. Blue arrow shows the point of blue light delivery. 
 
2.3.2.2 Light activation of TrkB leads to the translocation of a cytosolic ERK1 to 
nucleus 
 
The autophosphorylation of TrkB at Y515 within its juxtamembrane region leads to 
recruitment of SHC adaptor proteins and subsequent activation of the Ras-mitogen-activated 
protein kinase (Ras-MAPK) signalling pathway (McCarty and Feinstein, 1998; Stephens et 
al., 1994). In a simplistic linear pathway model, the phosphorylated SHC adapters engage the 
binding of growth factor receptor‑bound protein 2 (GRB2) and son of sevenless (SOS), 
allowing thus Ras activation (Egan et al., 1993). Subsequently, Ras activation causes the 
recruitment and activation of Raf (Rapidly Accelerated Fibrosarcoma) in the membrane 
(Vojtek et al., 1993). The phosphorylated Raf leads to the activation of mitogen-activated 
protein kinase kinase (MEK), which, consequently, phosphorylates MAPK (Kyriakis et al., 
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1992). The most characterized MAPKs are extracellular signal-regulated kinases 1 and 2 
(ERK1 and ERK2). For the full activity, ERK1 and ERK2 have to be phosphorylated at 
threonine 202 and tyrosine 204 within their activation loops (Burack and Sturgill, 1997). 
Both ERK1 and ERK2 are activated in the cytoplasm and then translocated to the nucleus 
allowing the phosphorylation of their targets in this cell compartment (Khokhlatchev et al., 
1998). The nuclear translocation of ERK2 attached to GFP was examined by Horgan and 
Stork (2003) to reveal the mechanism of this movement. 
To assay ERK1/2 translocation from the cytoplasm to the nucleus upon ERK 
activation, ERK1-mCherry sensor was generated (refer to Table 2.4). Live-cell imaging to 
study ERK1-mCherry translocation upon blue light was performed in HEK293A cells by 
delivering a 1-s light pulse after 3 min of baseline imaging. This assay was used to test 
whether my photoinducible TrkB system can activate ERK-mediated signalling. 
Cells expressing ERK1-mCherry, but not the TrkB system, did not show detectable 
changes in ERK1 localization upon blue light stimulation (Fig. 2.19 A). In cells expressing 
the light-activated TrkB system, the transport of ERK1-mCherry to the nucleus could be seen 
upon light stimulation within ~10 min (Fig. 2.19 B). The TrkB_Y816F mutant (no interaction 
with PLCγ1) was still capable of inducing the translocation of ERK1-mCherry to the nucleus, 
suggesting ERK activation remained intact, as predicted (Fig. 2.19 C). The elimination of the 
kinase activity through the TrkB_K571A mutant abolished completely the translocation of 
ERK1-mCherry (Fig. 2.19 D). It was expected that the mutation at Y515 might attenuate the 
phosphorylation of ERK1 as described by Easton et al. (1999). Interestingly, the 
TrkB_Y515F mutant remained capable of triggering the translocation of ERK1-mCherry to 
the nucleus (Fig. 2.19 E) and there was no significant difference between responses obtained 
for TrkB_WT and TrkB_Y515F (Fig. 2.19 F, p = 0.66, unpaired Student’s t-test). The results 
for TrkB_Y515F suggest that TrkB can activate ERK1 independently of the Y515 site. Taken 
together, the photoactivatable TrkB system can activate a signalling pathway leading to 
ERK1 activation in a light-dependent manner. 
As it was shown in Figure 2.7 A and B, the imaging light (filtered with a 543-22 
interference filter) without the specific blue light stimulation caused the photoexctitation of 
Cry2/CIB1 in 26% of O-GECO1-HEK293A cells. Hence, the same question was asked for 
the ERK1-mCherry translocation upon imaging conditions. In this experiment, HEK293A 
cells were co-transfected with ERK1-mCherry and either TrkB-Cry2(498)-T2A-CIB1(170)-






Figure 2.19 Light activation of TrkB leads to ERK1 translocation to the nucleus in HEK293 
cells. The graphs represent a time-lapse of translocation of ERK1-mCherry (ERK1-mCh) to nucleus 
upon blue light stimulation. The images show the cells co-transfected with ERK1-mCh and TrkB-
Cry2(498)-T2A-CIB1(170)-eGFP-CAAX constructs with different mutations in TrkB(kd) (refer to 
Table 2.4) before and after blue light stimulation (left panels are the examples of an expression of the 
photoactivatable TrkB constructs). The cells transfected with ERK1-mCh alone did not undergo 
nuclear translocation upon light stimulation (A). In cells co-transfected with the photoactivatable 
systems with TrkB_WT (B), TrkB_Y816F mutant (C) and TrkB_Y515F mutant (E), light 
illumination led to the translocation of cytosolic ERK1-mCh to the nucleus, which is known to be 
associated with the phosphorylation of ERK1 by TrkB receptor. Elimination of the kinase activity 
with K571A mutation (D) did not lead to the translocation of ERK1-mCh to the nucleus. (F) The 
graph summarises the maximum responses of ERK1-mCh translocated to the nucleus within each 
group of cells (A-E) (each grey diamond represents an individual cell; line = mean; ***P<0.001, 
unpaired Student’s t-test). For each condition n cells were tested: n = 33 cells for (A); n = 29 cells for 
(B); n = 27 cells for (C); n = 37 cells for (D); n = 41 cells for (E) and data were pooled from two 
independent experiments each performed in duplicates. For (A-E), grey lines are responses of 
individual cells and the average is shown in black. These responses were measured as ratios of 
nuclear and cytoplasmic ERK1 normalized to the baseline before blue light stimulation. A single blue 
light pulse of 1 s was delivered at t = 3 min of a timecourse (arrow). Scale bars, 20 µm. 
 
pair was included as it has been shown to have lower background activity in the literature 
(Taslimi et al., 2016). Both Cry2(498)/CIB1(170) (Fig. 2.20 B) and Cry2(535)/CIB1(81) 
(Fig. 2.20 D) could trigger the activation of ERK1 as demonstrated by ERK1-mCherry 
recruitment to the nucleus. The light insensitive mutant of Cry2 (TrkB-Cry2(535)_D387A-
T2A-CIB1(81)-eGFP-CAAX) was also tested in the same configuration. This light 
insensitive construct, co-transfected with ERK1-mCherry sensor, did not cause ERK1 
translocation to the nucleus upon simultaneous imaging light and blue light illumination (Fig. 
2.21 B). These results suggest that under our imaging condition, some fraction of Cry2/CIB1 
in the cell can be activated, leading to detectable ERK translocation. 
In a previous Ca
2+
 imaging experiment (refer to Fig. 2.6 B and 2.14 B), the 
photoactivatable TrkB system without the membrane-tethered CIB1 component was not 
sufficient to initiate Ca
2+
 response in O-GECO1-HEK293A cells. Nevertheless, the effect of 
the TrkB system without CIB1 component (TrkB-Cry2(535)-T2A-eGFP) was tested in ERK1 
translocation assay. Intriguingly, TrkB-Cry2(535)-T2A-eGFP triggered the ERK1-mCherry 
translocation to the nucleus upon light irradiation (Fig. 2.22). Comparing the average 
maximum value for ERK1 translocation measured as a ratio of nuclear to cytoplasmic 
fractions for TrkB-Cry2(535)-T2A-eGFP (1.40 ± 0.34; n = 52; Fig. 2.22) and TrkB-
Cry2(535)-T2A-CIB1(81)-eGFP-CAAX (1.71 ± 0.31; n = 23; Fig. 2.21 A) suggests that the 
response evoked without CIB1 component is considerably lowered. Taken together, the 
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Figure 2.20 Imaging light is sufficient to induce ERK1 translocation to the nucleus in HEK293A 
cells co-expressing the photoactivatable TrkB and ERK1-mCherry. The graphs represent a time-
lapse of translocation of ERK1-mCherry to the nucleus upon blue light stimulation (A, C) as well as 
without blue light stimulation (B, D). The graphs (A) and (B) show the cells co-transfected with 
ERK1-mCherry and TrkB-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX constructs. In these cells, 
imaging light caused the activation of the TrkB system and triggered the ERK1 transport to the 
nucleus. In the next step, Cry2(535) and CIB1(81) pair, which is known to have lower background 
activity, was examine with and without blue light illumination (C, D). The imaging light sill caused 
the ERK1 translocation in the cells transfected with TrkB-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX. 
For each condition the following numbers of cells were tested: n = 20 cells for A; n = 22 cells for B; n 
= 15 cells for C; n = 15 cells for D. The data were pooled from one independent experiment in 
duplicate. Grey lines are responses of individual cells and the average is shown in black. A single blue 
light pulse of 1 s was delivered at t = 3 min of a timecourse (arrow) (A, C). A gap in panel D 
represents the frame at 5 min which was removed due to a visually detected artefact leading to the 




Figure 2.21 ERK1 translocation to the nucleus is mediated by the photoactivation of Cry2/CIB1 
system because the light-insensitive mutant of Cry2(535)_D387A failed to cause ERK1 
translocation. The graphs represent a time-lapse of translocation of ERK1-mCherry (ERK1-mCh) to 
nucleus upon blue light stimulation when cells were co-transfected with the light-responsive TrkB-
Cry2(535)_WT-T2A-CIB1(81)-eGFP-CAAX (A) or the light-insensitive mutant TrkB-
Cry2(535)_D387A-T2A-CIB1(81)-eGFP-CAAX (B). The examples of cells in which ERK1 
underwent light-dependent translocation are shown above each graph. The left photos are the 
examples of the expression of the constructs (labelled as “GFP”). The graph (C) represents the 
maximum response for individual cells from each group of cells shown in (A) and (B). For each 
condition the following numbers of cells were tested: n = 23 cells for A; n = 25 cells for B. The data 
were pooled from two independent experiments. Grey lines are responses of individual cells (A, B). 
The average response is shown in black (A, B). A single blue light pulse of 1 s was delivered at t = 3 
min of a timecourse (arrow) (A, B). Grey diamonds are the peak values for the individual cells and the 




Figure 2.22 The photoactivatable TrkB system, which consists of Cry2(535) without CIB1 
component in the membrane, can still activate ERK1 pathway in HEK293A cells. 
The graph represents a time-lapse of translocation of ERK1-mCherry (ERK1-mCh) to nucleus upon 
blue light stimulation when cells were co-transfected with the ERK1-mCh and TrkB
WT
-Cry2(535)-
T2A-eGFP. The examples of cells in which ERK1 underwent light-dependent translocation are shown 
above the graph. The left photo is the example of the expression of the construct (labelled as “GFP”). 
In this experiment, 52 cells were analyzed and pooled from two independent experiments each 
performed in triplicate and in quadruplicate. Grey lines are responses of individual cells, whereas the 
average response is shown in black. A single blue light pulse of 1 s was delivered at t = 3 min of a 
timecourse (arrow). Scale bar, 20 µm. 
 
2.3.2.3 Light activation of TrkB causes AKT1PH membrane accumulation 
 
The third canonical pathway that is activated by TrkB involves the phosphorylation of 
phosphatidylinositol 3‑kinase (PI3K) and AKT (Zheng et al., 2008). As is the case for 
stimulation of MAPK by TrkB, neither PI3K nor AKT interacts directly with TrkB. The SHC 
adaptors, bound to the phosphorylated Y515 of TrkB on one site and to GRB2 on the other 
site, allow, for instance, the association of GRB‑associated binder‑1 (GAB1) to GRB2 
(Holgado-Madruga et al., 1997). This leads to the activation of PI3K, 
3‑phosphoinositide‑dependent protein kinase 1 (PDPK1) and finally, AKT (Holgado-
Madruga et al., 1997; Zheng et al., 2008). In the classical model of AKT regulation, AKT is 




Figure 2.23 Light activation of TrkB signalling leads to AKT1PH membrane accumulation. 
Light-mediated activation of TrkB signalling induced the relocation of mCherry tagged pleckstrin 
homology (PH) domain of AKT1 protein (mCh-AKT1PH) to the plasma membrane (B), which is 
consistent with the signalling associated with TrkB receptor. Such effect was still evident in 
TrkB_Y816F mutant (C), confirming the sole association of Y816 to PLCγ1 activation and not 
AKT1. The K517A mutation abolished the kinase activity and AKT1PH relocation was not observed 
(D). The AKT1PH translocation was not seen in cells expressing AKT1PH alone (A). However, this 
transport was still present in cells co-expressing AKT1PH and TrkB_Y515F mutant (E), similarly to 
the results when ERK1-mCherry translocation was examined. Experiments were performed in 
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HEK293A cells co-expressing mCherry-AKT1PH and TrkB-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 
with different mutations in TrkB kinase domain (refer to Table 2.5). For each condition n > 10 cells 
were tested. A single blue light pulse of 1 s was delivered at t = 3 min of a timecourse. From the left 
images show eGFP fluorescence indicating the expression of the TrkB system; then images of 
mCherry-AKT1PH at 0 min of the time-lapse (before blue light stimulation); third images of mCherry-
AKT1PH at 5 min of the timecourse (and 2 min after blue light pulse); finally images of mCherry-
AKT1PH at 20 min (the end of the time-lapse). Cells are representative of cells from three independent 
experiments each performed in duplicates. 
 
C-terminal tail and at T308 within activation loop (Chu et al., 2018). It has been shown that 
PI3K activation can cause the translocation of an isolated N-terminal pleckstrin homology 
domain (PH) of AKT fused to a fluorescent protein to the membrane (Yang et al., 2012). The 
fluorescent-tagged AKT1PH has been useful for optogenetic application (Chang et al., 2014; 
Han et al., 2016). Therefore, the translocation of mCherry-AKT1PH to the membrane can be 
used as an assay for AKT activation. 
Following co-transfection of HEK293A cells with mCherry-AKT1PH and the 
photoactivatble TrkB system containing the wild-type or mutated TrkB(kd), blue light 
illumination caused an mCherry-AKT1PH fusion to be transported to the membrane in 
TrkB_WT, TrkB_Y816F mutant and TrkB_Y515F mutant (Fig. 2.23 B, C, E, respectively). 
The mutation Y816F within a kinase domain can abolish PLCγ1 activity without inhibiting 
the activitity of AKT and ERK, as expected. Similarly to the results from the ERK 
translocation assay (see Fig. 2.19 E), TrkB_Y515F showed that Y515 site was not necessary 
for the activation of AKT1PH. The kinase-dead mutant, TrkB_K571A, did not induce 
AKT1PH relocation (Fig. 2.23 D), demonstrating that AKT actication was dependent on TrkB 
kinase activity. 
The imaging light conditions were shown to trigger Ca
2+
 responses in 26% of tested 
cells (Fig. 2.7) and to induce ERK1 translocation from the cytoplasm to the nucleus (Fig. 
2.20). Similarly, the imaging conditions used for AKT1PH translocation could relocate the 
mCherry-AKT1PH fusion from the cytoplasm to the membrane (Fig. 2.24 B and D). However, 
the utilization of the TrkB system with the light-insensitive Cry2 mutant (TrkB-
Cry2(535)_D387A-T2A-CIB1(81)-eGFP-CAAX) did not evoke significant mCherry-
AKT1PH translocation upon blue light stimulation (Fig. 2.25 B), indicating this process 
requires Cry2/CIB1 interaction. 
Interestingly, mCherry-AKT1PH translocated to the plasma membrane upon light 
stimulation was observed to occupy similar microdomains as compared to CIB1(170)-eGFP-
CAAX or CIB1(81)-eGFP-CAAX components. This co-localization can be clearly seen in 
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Figure 2.23 (Panels B, E), Figure 2.24 (Panels A, C) and Figure 2.25 (Panel A) when the 
photos on the left-hand side, representing the expression of TrkB systems, are compared with 
the photos on the right-hand side, showing AKT1PH translocation at 20 min of timecourses. 
Similarly to the results presented in Figure 2.22 for the ERK1 translocation, the 
AKT1PH transport can occur in the absence of the membrane-anchored CIB1 component, and 
light-induced Cry2(535) oligomerization is sufficient to activate TrkB(kd) which 




Figure 2.24 Imaging conditions lead to AKT1PH translocation to the membrane. The panels 
represent a time-lapse of translocation of mCherry-AKT1PH (mCh-AKT1PH) to the membrane upon 
blue light stimulation (A, C) as well as upon live-imaging conditions without blue light stimulation 
(B, D). The left photos show the expression of indicated constructs. The images (A) and (B) show the 
cells co-transfected with mCherry-AKT1PH and TrkB-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 
constructs. In these cells, imaging light caused the activation of the the mCherry-AKT1PH transport to 
the membrane. In the next step, Cry2(535) and CIB1(81) pair (TrkB-Cry2(535)-T2A-CIB1(81)-
eGFP-CAAX), which is known to have lower background activity, was examined with and without 
blue light illumination (C, D, respectively). The TrkB photoactivatable system with this pair still 
caused the mCh-AKT1PH translocation upon imaging light. For each condition n > 10 cells were 
tested. A single blue light pulse of 1 s was delivered at t = 3 min of a timecourse (only for A, C). 
Photos show the cells at 0 min, 5 min and 20 min of the time-lapse. Cells are representative from two 





Figure 2.25 AKT1PH translocation to the membrane is caused by the activation of the 
photoactivatable TrkB system upon the imaging light conditions. The photos represent a time-
lapse of the mCherry-AKT1PH translocation to the membrane upon blue light stimulation when cells 
were co-transfected with the light-responsive Cry2(535)_WT (A) or the light-insensitive mutant 
Cry2(535)_D387A (B) in the TrkB system. According to these examples, AKT1PH underwent light-
dependent translocation as shown in the photos when Cry2(535)_WT is in the system (A), whereas 
the translocation was abolished when Cry2(535)_D387A was used. The left photos are the examples 
of the expression of the constructs. For each condition n > 10 cells were tested from two independent 




Figure 2.26 The photoactivatable TrkB system, which consists of Cry2(535) without CIB1 
component in the membrane, can still activate AKT1 pathway in HEK293A cells. The panels 
show two examples of the mCherry-AKT1PH translocation to the membrane upon blue light 
stimulation when cells were co-transfected with the mCherry-AKT1PH and TrkB
WT
-Cry2(535)-T2A-
eGFP. The left photos show the expression of the construct (labelled as “Cry2(535)
WT
_GFP”). The 
examples of mCHerry-AKT1PH translocation are shown at 0 min, 5 min and 20 min of the time-lapse. 
In this experiment, n > 10 cells were analyzed from one independent experiment in triplicate. A single 
blue light pulse of 1 s was delivered at t = 3 min of a timecourse. 
 
2.3.2.4 Biochemical confirmation of ERK and PLCγ1 activation by western blotting 
analyses 
 
Upon activation by TrkB, its downstream targets, PLCγ1, ERK and AKT, are 
phosphorylated (see Section 2.3.2.1, 2.3.2.2 and 2.3.2.3, respectively). Changes in 
phosphorylation states of these proteins upon a blue light exposure were assayed by western 
blotting. After 48 h post-transfection, the cells were stimulated by continuous and global 
exposure to blue light at 36.8 mW/cm
2
 for 30 s or were kept on a disabled LED source in 
dark. Then, the whole cell lysates were collected at 10 min after light termination. The 
endogenous ERK, PLCγ1, AKT proteins were analyzed using specific phospho-antibodies 






Figure 2.27 Immunoblot analyses of endogenous ERK, PLCγ1 and AKT proteins in HEK293A 
cells transfected with the photoactivatable TrkB system. (A) The two-component TrkB(kd) system 
consisting of Cry2(535) and CIB1(81) proteins as well as a single-component system with TrkB(kd)-
Cry2(535) activated endogenous ERK proteins upon blue light stimulation. The activation of ERK 
was measured by using antibody against phospho-ERK when phosphorylated at Thr202 and/or 
Tyr204. Phospho-ERK was examined in presence and absence of 30-s blue light stimulation. Total 
ERK is given to ensure that the total protein level remains unchanged. Representative images from 
one independent experiment. (B) The two-component TrkB(kd) system consisting of Cry2(535) and 
CIB1(81) proteins as well as the single-component system with TrkB(kd)-Cry2(535) activated 
endogenous PLCγ1 upon blue light stimulation. The PLCγ1 activity was examined by checking the 
level of phosphorylated protein at Tyr783 in presence and absence of 30-s blue light stimulation. 
Unfortunately, the phospho-PLCγ1 antibody detected unspecific bands below required 150 kDa band 
in HEK293A cells. Total PLCγ1 level was checked. Representative images from two independent 
experiments. (C) The two-component TrkB(kd)-Cry2(535) + CIB1(81) system could activate 
insignificantly endogenous AKT measured by the level of its phosphorylation at Ser473, whereas the 
one component TrkB(kd)-Cry2(535) system could not. The phospho-AKT was studied in presence 
and absence of 30-s blue light stimulation. Total AKT level was examined. Representative images 
from one independent experiment. In each experiment, phospho-proteins were examined 10 min after 
the 30-s light stimulation at 470 nm. Non-transfected cells were used as a control and as a further 
confirmation that they do not express endogenous TrkB. PMWM – protein molecular weight marker. 
 
Upon blue light stimulation of the cell population transfected with pcDNA3-CMV-
TrkB-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX, the level of phosphorylated ERK at 
T202/Y204 was increased approximately 29-fold compared to cells not illuminated with blue 
light (Fig. 2.27 A). The cells transfected with pcDNA3-CMV-TrkB-Cry2(535)-T2A-eGFP 
also exhibited increased phospho-ERK (~21-fold compared to the non-illuminated cells) 
upon light stimulation. In non-transfected cells, neither blue light stimulation nor BDNF 
treatment did elicit the phospohorylation of ERK (Fig. 2.27 A). Lack of response upon BDNF 
indicates that HEK293A cells do not express the endogenous TrkB. 
The same conditions were used to assess the phosphorylation level of PLCγ1 at Tyr783 
upon light exposure. Consistent with previous observations from live-cell imaging, the cells 
transfected with pcDNA3-CMV-TrkB-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX, when 
stimulated with light, showed 4.7-fold and 8.6-fold increase in phospho-PLCγ1 (data from 
two independent experiments) (Fig. 2.27 B). The transfection with pcDNA3.1H-CMV-
CIB1(81)-eGFP-CAAX as well as BDNF treatment did not cause phosphorylation of PLCγ1. 
Intriguingly, without the membrane-anchored CIB1, the cytosolic TrkB-Cry2(535) alone 
could phosphorylate PLCγ1 upon blue light stimulation (from two independent experiments: 
2.0-fold and 3.5-fold increase in the phosphorylation level compared to the unexposed cells). 
This observation was unexpected as no detectable Ca
2+




imaging experiments, when cells expressing this construct were stimulated with blue light 
(refer to Fig. 2.14 B). 
Finally, the phosphorylation state of AKT at Ser473 was examined upon blue light 
illumination. When cells were transfected with pcDNA3-CMV-TrkB-Cry2(535)-T2A-
CIB1(81)-eGFP-CAAX or pcDNA3-CMV-TrkB-Cry2(535)-T2A-eGFP, the background 
phosphorylation in the dark was high in comparison with non-transfected cells or cells 
transfected with pcDNA3.1H-CMV-CIB1(81)-eGFP-CAAX alone (Fig. 2.27 C). 
Nevertheless, blue light exposure of cells expressing TrkB-Cry2(535)-T2A-CIB1(81)-eGFP-
CAAX caused 1.6-fold increase in the phosphorylation level of AKT. The TrkB-Cry2(535) 
or CIB1(81) components, when used separately, did not raise the level of phospho-AKT 
above their baseline under blue light exposure (Fig. 2.7 C). 
 
2.3.3 Light-mediated activation of TrkB signalling in HeLa cells 
 
As it was shown in Figure 2.27 (Panels A, B) HEK293A cells did not respond to BDNF 
treatment, which suggests that endogenous TrkB receptors are not expressed, or are 
expressed at very low level, in this cell culture. Furthermore, it suggests that the 
photoactivatable TrkB system does not require endogenous TrkB for its action. To examine 
further whether the TrkB system acts completely independent from the endogenous 
expression of TrkB, a HeLa cell line was used as a model, as it is known from the literature 
that HeLa cells do not express the endogenous TrkB receptors (Chang et al., 2014). Using 
RNA sequencing data, deposited on The Human Protein Atlas website 
(www.proteinatlas.org), the TrkB transcript abundance in HEK293 and HeLa cells was 
estimated (Fig. 2.28 A). According to these results, TrkB was not expressed in HEK293 and 
HeLa cell lines. In an independent test, RT-PCR results obtained from RNA extracted from 
HEK293A and HeLa cells showed no band corresponding to the intracellular domain of TrkB 
(TrkB(kd)) in Hela (Fig. 2.28 A, lanes 2 and 3) and a faint band at the expected size for 
TrkB(kd) in HEK293A (Fig. 2.28 A, lanes 4 and 5). 
Having established that HeLa cells do not express endogenous TrkB, the Ca
2+
 imaging 
in HeLa cells co-expressing O-GECO1 and TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-
CAAX demonstrated that the photoactivatable TrkB acts without the endogenous TrkB upon 
light illumination (Fig. 2.28 B). Similarly, ERK and AKT pathways could also be activated 





Figure 2.28 The photoactivatable TrkB system works in HeLa cells. (A) The left graph represents 
RNA expression of TrkB gene in SH-SY5Y (shown as an example of the cell line which is enriched 
in TrkB expression), HEK293 and HeLa cell lines. The sequencing results are reported as Transcripts 
per Kilobase Million (TPM). The TPM of 1.0 is a threshold for expression of a gene that means that 
TrkB protein is expressed in SH-SY5Y but not in HEK293 and HeLa. Presented data  
were obtained from the Human Protein Atlas website available from 
https://www.proteinatlas.org/ENSG00000148053-NTRK2/cell#rna. The agarose gel photo (right) 
shows the results of RT-PCR using cDNA prepared from HeLa and HEK293A and primers against 
the intracellular domain of human TrkB. Lanes 2 and 3 are RT-PCR results from HeLa from two 
independent RNA extractions; lanes 4 and 5 from HEK293A from two independent RNA 
exptarctions; lane 6 is a negative control (no template control); lane 7 is a positive control 
(intracellular domain of TrkB) and this PCR product was used in the previous cloning experiments. 
(B) In HeLa cells co-expressing TrkB-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX and O-GECO1, light 
illumination led to the elevation of intracellular Ca
2+
 (black line). TrkB-Cry2(498) or CIB1(170)-
eGFP-CAAX component alone was not sufficient to evoke Ca
2+
 transients (blue and red lines, 
respectively). Intracellular Ca
2+
 changes were quantified as O-GECO1 fluorescence intensity 
normalized to the baseline fluorescence before blue light stimulation at 0.5 min. Results are presented 
as mean ± SEM calculated from 37 cells for TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX; 
from 18 cells for TrkB-Cry2(498); from 17 cells for CIB1(170)-eGFP-CAAX from two independent 
experiments. (C) Light activation of TrkB led to ERK1 translocation to the nucleus in HeLa cells. 
Photos are the representative HeLa cell co-expressing ERK1-mCherry and TrkB(kd)-Cry2(498)-T2A-
CIB1(170)-eGFP-CAAX before light illumination (0 min) and after light illumination (5 min and 20 
min). The graph shows the average ratio of nuclear to cytosolic ERK1 upon light illumination from 
two independent experiments each performed in duplicates (mean ± SEM from n = 16 cells in total). 
1-s light illumination was delivered at 3 min of the imaging. (D) Light activation of TrkB leads to 
AKT1PH translocation to the membrane in HeLa cells. Photos show a HeLa cell co-expressing 
mCherry-AKT1PH and TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX before light illumination 
(0 min) and after light illumination (5 min and 20 min). Representative image from two independent 
experiments. 
 
Taken together, these results proved that the action of the light-inducible TrkB can act 
independently from the endogenous expression of this protein. Whether the photoactivatable 




The increasing interest in light-inducible RTKs dictates the necessity for the 
development of new optogenetic approaches. The data presented in this chapter prove that the 
photoactivatable TrkB system can be re-designed without considerable engineering of the 
receptor and genetically encoded dimerizers to achieve desired outcome. In this PhD thesis, a 
new two-component light-controllable TrkB was created by fusing TrkB(kd) to Cry2 and 
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localizing CIB1 to the membrane. This has added a new tool to the existing RTKs toolbox 
and introduced new possibilities. 
This chapter aims to describe the photoactivatable TrkB system in non-neuronal cells, 
HEK293A and HeLa, prior proceeding with more complicated neuronal cells. The 
experimental results from HEK293A and HeLa cell lines confirm that the optogenetic TrkB 
system can activate signalling pathways associated with TrkB kinase activity, such as PLCγ1, 
ERK and AKT cascades, upon light illumination. The new TrkB system can be activated 
independently from its natural ligand, BDNF, as the extracellular domain of TrkB was 
excised. Removing the ligand-binding domain makes the system more suitable for in vivo 
application to ensure that any observed perturbations come from light rather than endogenous 
BDNF. Additionally, the new TrkB system consists of two components that can be used as a 
bicistronic system through a “self-cleaving” peptide, T2A, or as monocistronic vectors that 
can be packaged into recombinant viral AAV for in vivo studies. In this chapter, the utility of 
the bicistronic vectors was mostly presented. 
As hypothesized, the expression of TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX 
in cells can mimic native signalling, leading to the activation of PLCγ1, ERK and AKT 
proteins upon light (Table 2.5). In this system, the original truncated Cry2(498) (known in the 
literature as PHR domain) and the truncated CIB1(170) (known in the literature also as 
CIB1N) were utilized (Kennedy et al., 2010). Replacement of the original Cry2(498) and 
CIB1(170) with the second-generation dimerizers – a longer Cry2(535) and shorter 
CIB1(81), which were reported to lower background interactions (Taslimi et al., 2016) – 
results in constructs that can still activate the canonical signalling cascades mediated by the 
TrkB system. Interestingly, when the same 1-s light stimulation was used during live-cell 
imaging experiments, Ca
2+
 responses, triggered by TrkB(kd)-Cry2(535)-T2A-CIB1(81)-
eGFP-CAAX, were more transient than those induced by TrkB(kd)-Cry2(498)-T2A-
CIB1(170)-eGFP-CAAX. This observation can be possibly explained by lower affinity 
between Cry2(535) and CIB1(81). It has been reported that Cry2(535) shows weaker self-
association and lower background interaction with CIB1 in dark (Taslimi et al., 2016), which 
might also translate to a weaker or more transient interaction between Cry2 and CIB1 in the 
light. 
When the single component of CIB1(170 or 81)-eGFP-CAAX was tested without Cry2 
using live-cell imaging or western blotting, it did not evoke light-dependent activation of the 
canonical pathways (Table 2.5). When TrkB(kd)-Cry2(498 or 535) or TrkB(kd)-Cry2(535) 
were used without CIB1, they failed to mobilize Ca
2+
 release in live-cell imaging 
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experiments. The same TrkB(kd)-Cry2(535), when tested by western blotting, caused the 
phosphorylation of PLCγ1 upon blue light exposure. The explanation of this inconsistency 
might be that PLCγ1 is a cytosolic enzyme and is known to become membrane-associated 
under EGF treatment (Todderud et al., 1990; Wahl et al., 1992; Wang and Wang, 2003). I 
have shown that TrkB(kd)-Cry2(535) can phosphorylate PLCγ1 in the cytosol, but without 
membrane anchored CIB1, TrkB might fail to localized PLCγ1 to the membrane. 
Consequently, PLCγ1 might not be able to cleave the membrane phospholipid PtdIns(4,5)P2 
to DAG and Ins(1,4,5)P3, and Ca
2+
 elevation is prevented. This observation might be helpful 
in biochemical dissection of the TrkB-mediated signalling pathways upon light exposure. 
 
Table 2.5 The activation of the canonical pathways by the photoactivatable TrkB 
system tested by live-cell imaging and western blotting. 








TrkB(kd)-Cry2(498) -LCI NT NT 
CIB1(170)-eGFP-CAAX -LCI NT NT 




































CIB1(81)-eGFP-CAAX -WB -WB -WB 
MYR-CIB1(81)-eGFP-T2A-TrkB(kd)-Cry2(535) -LCI -LCI -LCI 
activated pathway; - not activated pathway; LCI, tested by live-cell imaging; WB, tested by western 
blotting; NT, not tested. 
 
It is noteworthy that different blue light durations were used between live-cell imaging 
(1 s) and immunoblotting (30 s), which could also affect the activation of PLCγ1. The light 
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dose-dependent activation of PLCγ1 pathway was reported previously by Han et al. (2016) 
with optoTrkC. In their system, PLCγ1-induced Ca
2+
 release associated with optoTrkC 
activity was only detected when higher blue light intensity (five 350-ms pulses at 32.47 
mW/cm
2
) was used (Han et al., 2016). 
Consistently, either live-cell imaging with ERK1-mCherry sensor or western blotting 
showed that TrkB(kd)-Cry2(535) alone can trigger the signalling cascade leading to ERK 
activation (Table 2.5). In cells, expressing TrkB(kd)-Cry2(535), the live-cell imaging assay 
involving AKT1PH translocation showed that the PH domain of AKT1 can be relocated from 
the cytoplasm to the plasma membrane after light stimulation. However, TrkB(kd)-Cry2(535) 
alone did not cause the apparent increase in the level of AKT phosphorylation at Ser473 
measured by immunoblotting (Table 2.5). It is noteworthy that the two-component TrkB 
system, even that it induced the robust light-dependent translocation of AKT1PH, caused only 
~1.6-fold increase of the endogenous AKT1 phosphorylation at Ser473 upon light 
stimulation. This lowered sensitivity of the immunoblotting assay might be due to the 
observation reported by Ebner et al. (2017), in which insulin promoted more sustain 
accumulation of mCherry-AKTPH (longer than 20 min), whereas the full-length AKT retained 
in the membrane for approximately 10 min. This can suggest that the observed in this study 
relocation of mCherry-AKT1PH upon light illumination in the live-cell imaging experiment 
might have different kinetics than the endogenous full-length AKT1 tested by western 
blotting. Following that, the phosphorylation of the endogenous AKT1 might be transient and 
have a peak earlier than 10 min post-stimulation which was not therefore captured by the 
immunoblotting. The inconsistency between the action of TrkB(kd)-Cry2(535) component, 
when tested by the live-cell imaging and western blotting, suggests that CIB1 component in 
the membrane might be necessary for AKT1 activation upon light. As it was observed, 
mCherry-AKT1PH was retained in the similar membrane domains as CIB1-eGFP-CAAX 
upon light illumination. This can be supported by the observation that the activation of AKT 
is restricted to discrete membrane locations (Ebner et al., 2017; Lucic et al., 2018). 
Differently, TrkB(kd)-Cry2(535) alone upon light stimulation can trigger AKT1 relocation to 
the membrane without its full-activation. A recent report can provide an explanation by 
showing that the AKT1PH domain engagement to the membrane is not the only factor 
necessary for the full AKT1 activation, but also the phosphorylation at Ser473 is required 
(Chu et al., 2018). Taken together, TrkB(kd)-Cry2(535) alone leads to the AKT1 relocation 
to the membrane where AKT1 might not be further activated. Nevertheless, either the two-
component or the one-component TrkB system elevated the baseline levels of phosphorylated 
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AKT1 in the dark, whereas a single CIB1 component did not (total AKT1 levels remained 
unchanged in each condition). This background elevation of AKT1 phosphorylation may be 
specific to the cell line used for the expression of the TrkB system as it has been shown by 
Chang et al. (2014) who reported that the full-length optoTrkB can cause increase in ERK 
phosphorylation in the dark state in HeLa, but not in PC12 cells. 
 
The orientation of TrkB(kd)-Cry2 and CIB1 around T2A affect the performance of the 
light-inducible system 
 
It has been shown in the literature that when Cry2/CIB1 pair is applied to activate a 
target protein, the orientation-specific effect should be taken into consideration (Che et al., 
2015; Hallett et al., 2016; Kennedy et al., 2010). For instance, Cry2 localized in the 
membrane has been reported to affect the light-induced interaction with CIB1 (Kennedy et 
al., 2010). 
For the purpose of this project, two bicistronic constructs were generated originally 
with the inserts: TrkB(kd)-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX and Cry2(498)-
TrkB(kd)-T2A-CIB1(170)-eGFP-CAAX. In these constructs, CIB1 component attached to 
the membrane by a C-prenylation tag, CAAX, was fused after the self-cleaving T2A 
sequence, whereas Cry2 and TrkB component in two orientations was linked before T2A 
peptide. Both of these constructs were tested to check their abilities to trigger Ca
2+
 responses 
upon light illumination (Table 2.5). In this assay, the TrkB(kd)-Cry2 orientation was more 
efficient than Cry2(498)-TrkB(kd) at activating the signalling cascade. Recently, it has been 
reported that the kinase domain of TrkA without the membrane-localization tag can be fused 
to the C-terminus of Cry2 and can successfully activate AKT and ERK pathways upon light 
(Duan et al., 2018). However, this design was used in a co-transfection experiment with 
CIB1-GFP-CAAX and without the self-cleaving peptide between Cry2 and CIB1. The 
differences in the actions between two constructs used in this project are likely due to the use 
of T2A sequence. The protein expressed upstream of the T2A peptide is linked to the 
complete sequence of T2A (except the C-terminal proline) (Donnelly et al., 2001; Liu et al., 
2017). This suggests that the T2A peptide might block the availability of C-terminal Y816 
within TrkB(kd) for its docking partner, PLCγ1, which consequently, might lead to the less 
efficient activation of Ca
2+
 signal. Consistent with the work published by Han et al. (2016), 
Cry2 is less sensitive to the presence of extra amino acids on its C-terminus. Moreover, it has 
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been shown that the peptide attached to C-terminal Cry2 can enhance the oligomerization of 
Cry2 (Park et al., 2017). 
Finally, CIB1 was attached to the membrane through the N-terminal myristoylation tag 
and upstream of T2A, whereas TrkB-Cry2 was linked downstream of T2A (MYR-CIB1(81)-
eGFP-T2A-TrkB(kd)-Cry2(535)). This orientation also failed to activate Ca
2+
 signalling 
(Table 2.5). It is possible due to three reasons: (1) N-terminus of CIB1 is involved in the 
membrane fusion; (2) eGFP as a quite bulky protein might act as a steric hindrance and block 
interaction between Cry2 and CIB1; (3) the expression of TrkB-Cry2 might not be sufficient. 
It is known that N-terminus of CIB1 is necessary for dimerization with Cry2 (Hallett et al., 
2016). The myristoylation sequence has been used previously to localize CIB1 component to 
the membrane. However, the direct fusion between the myristoylation tag and a fluorescent 
protein was made to leave the N-terminus of CIB1 accessible (MYR-FP-CIB1) (Katsura et 
al., 2015). Furthermore, the utility of T2A might decrease the expression of the gene, which 
is downstream of T2A (here: TrkB(kd)-Cry2) (Liu et al., 2017). 
 
The green-light imaging conditions can cause the photoexcitation of Cry2 
 
In the live-cell imaging experiments, the TRITC filter set was used to visualize the O-
GECO1/mCherry fluorescence changes caused by Ca
2+
, ERK and AKT activation. 
Unfortunately, this filter set can transmit excitation light down to approximately 530 nm. 
Consistently with the absorption spectra for Cry2 (Banerjee et al., 2007), the longer 
wavelengths above 500 nm and up to 550 nm can cause the residual cryptochrome activity 
(Ahmad et al., 2002). This was confirmed by Kennedy et al. (2010) who observed Cry2-
mCherry translocation to CIB1-Citrine under the high intensity illumination at 514 nm. Then, 
Tucker et al. (2014) reported that the illumination at 561 nm for prolonged period and at high 
intensity can excite Cry2/CIB1 interaction. 
These observations are in agreement with the results obtained in this project that the 
green light is able to activate Cry2/CIB1 system. Consequently, the imaging conditions led to 
ERK and AKT translocations upon activation of the TrkB system. It is worth mentioning that 
these two pathways were activated more easily with imaging light in almost all cells, whereas 
Ca
2+
 responses did not (only in approximately 26% of cells), likely due to the higher intensity 
imaging light used during ERK/AKT translocation experiments than during Ca
2+
 imaging and 
also possibly due to the chain activation of multiple proteins leading to ERK and AKT 
phosphorylation. This has been shown in case of optoTrkC activation where lower light 
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intensity could trigger ERK and AKT pathways, but not Ca
2+
 release (Han et al., 2016). To 
overcome spectral overlap between the imaging conditions and the absorption spectrum of 
Cry2, a near-infrared fluorescent protein IFP1.4 (excitation at 684 nm) (Shu et al., 2009) can 
be attached to ERK1 and AKT1PH to create sensors. These sensors and an appropriate filter 
set might potentially eliminate the activation of the photoactivatable TrkB upon light imaging 
conditions leading to ERK/AKT translocation dependent on specific blue light illumination. 
 
The stimulatory light effect is mediated through the kinase activity of TrkB 
 
The point mutations in TrkB(kd) confirmed that the light-mediated activation of the 
canonical pathways is through the kinase activity. The K571A mutation, which was described 
previously to abrogate TrkB kinase activity (Guiton et al., 1994; McCarty and Feinstein, 
1998), abolished Ca
2+
 increase as well as ERK and AKT translocation in the light state 
(Table 2.6). The mutation of Y816F inhibited the light-mediated Ca
2+
 increase, confirming 
the sole association of Y816 to PLCγ1 activation (Middlemas et al., 1994). Moreover, using 
the PLC inhibitor, U73122, suppressed light-triggered Ca
2+
 elevation, which also proved the 
involvement of PLCγ1 activity. The Y816F mutation did not block the activation of ERK and 
AKT pathways (Table 2.6). 
 
Table 2.6 The activation of canonical pathways by the photoactivatable TrkB system 
with mutation in the kinase domain of TrkB. 
















TrkB(kd)_K571A-Cry2(498)-T2A-CIB1(170)-eGFP-CAAX -LCI -LCI -LCI 
 activated pathway; - not activated pathway; LCI, tested by live-cell imaging. 
 
The mutation Y515F, previously identified to attenuate ERK and AKT phosphorylation 
(Easton et al., 1999), remained capable of the activation of ERK and AKT pathways upon 
light. Moreover, this mutant did not reduce the activation of ERK or AKT. As expected, 
Y515F did not alter Ca
2+
 responses in O-GECO1-HEK293A cells in light condition (Table 
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2.6). The ability to evoke ERK pathway by the Y515F mutant is in agreement with the 
previous studies showing BDNF-dependent activation of ERK signalling through fibroblast 
growth factor receptor substrate 2 (FRS2) which does not interact with Y515 and does not 
form a complex with SHC (Easton et al., 1999). Another study reported that the basal level of 
Ca
2+
, not coupled with the Ca
2+
 elevation by PLCγ1, gates AKT signalling by BDNF 
treatment in cortical neurons (Zheng et al., 2008). Moreover, it has been shown recently that 
the activation of protein kinase C (PKC) requires BNDF-TrkB signalling (Colgan et al., 
2018) and PLCγ1 is responsible for the PKC activation (Li et al., 2013). Furthermore, PKC 
has been indicated to trigger AKT and ERK pathways (Li et al., 2013; Shatos et al., 2009). 
As described, the crosstalk between the AKT, ERK and PLCγ1 pathways as well as the 
recruitment of distinct sets of effector proteins to TrkB could activate ERK and AKT 
independently from the Y515 site. 
 
The photoactivatable TrkB system can work without endogenous TrkB 
 
The experiments for the purpose of this chapter were conducted in HEK293A and 
HeLa cells, which do not express endogenous TrkB. In these cells, expressing the light-
inducible TrkB, the exposure to light was sufficient to activate PLCγ1, ERK and AKT 
pathways. However, it remains still unclear whether there can be a trans-activation between 
the light-dependent TrkB and the endogenous TrkB in our testing conditions. 
 
Taken together, the data presented in this chapter demonstrate the successful generation 
of the photoactivatable TrkB system. This chimeric receptor induced downstream TrkB 
signalling pathways upon light. The results are consistent with the activation of PLC, ERK 
and AKT signalling. The TrkB tool was controlled repeatedly. The introduction of Y816F 
mutation in TrkB(kd) abolished the activation of PLCγ1 while retaining the activities of ERK 
and AKT pathways, which can be used to dissect these cascades. Originally, the TrkB system 
was designed to work as a two-component tool; however, it was found that one component is 
sufficient to trigger signalling. This can be also used to dissect signalling. The developed tool 
acts independently from BDNF, which makes it attractive to in vivo applications. Finally, the 
approach can be generalized to other tyrosine kinase receptors, as confirmed by the optoTrkA 









Many optogenetic tools have been successfully used for manipulation of specific 
biochemical processes in neuronal cells as reviewed by Zhou et al. (2015). Among these 
approaches, the optical control of RTKs has been applied in primary neurons. The optoTrkB, 
developed by Chang et al. (2014), was demonstrated to activate AKT pathway in 
hippocampal neurons upon light illumination. Thanks to this experiment, the light-mediated 
formation of lamellipodia and filopodia, actin-based structures, in perisomatic regions of 
illuminated neurons was observed. Following this, filopodia formation could be induced with 
spatially restricted precision within a single hippocampal cell upon focal light stimulation. 
Chang et al. (2014) could also increase the neurite length and the number of branch points in 
hippocampal neurons upon the activation of optoTrkB with light. Han et al. (2016) showed 
that optoTrkC could activate AKT, ERK and PLCγ1 pathways in cultured hippocampal 
neurons upon light illumination. Moreover, they used optoTrkC to regulate synapse 
development in a light intensity-dependent manner. Finally, the recent results provided by 
Duan et al. (2018) demonstrated that optoTrkA could support survival of DRG neurons 
without NGF supplementation, with light exposure mimicking NGF function. 
The mentioned optoTrk receptors were introduced into cultured neurons by 
electroporation or liposome-based transfection without any further intention to apply them in 
vivo (Chang et al., 2014; Duan et al., 2018; Han et al., 2016). Conducting in vivo experiments 
on behaving animal requires the production of lentiviral or AAV vectors for transgene 
expression. Although the described optoTrk receptors were not packaged into any viral 
vectors, the wild-type TrkB receptors were delivered into specific brain regions by lentiviral 
or AAV infection. For instance, a lentiviral vector encoding a dominant-negative TrkB 
isoform (TrkB.T1) was constructed to infect the amygdala in vivo (Chhatwal et al., 2006; 
Heldt et al., 2014; Rattiner et al., 2004; Rattiner et al., 2005). The lentiviral vector was used 
to overexpress TrkB.T1, which lacks the entire kinase domain and acts as an inhibitor of 
BDNF signalling through native TrkB. This approach was applied to examine the 
involvement of TrkB in amygdala-dependent learning (Chhatwal et al., 2006; Heldt et al., 
2014; Rattiner et al., 2004; Rattiner et al., 2005). The same truncated TrkB.T1, as well as the 
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full-length TrkB, were packaged into AAV serotype 2 and used to investigate the role of 
TrkB in motor neuron degeneration (De Wit et al., 2006). Another example of delivering 
TrkB via viral vector in vivo was the packaging of the full-length receptor into AAV serotype 
7. This recombinant AAV7 was used to infect phrenic motoneurons for enhancing recovery 
after spinal cord injury (Martinez-Galvez et al., 2016). Finally, a bicistronic AAV2 encoding 
the full-length TrkB and mature BDNF was introduced in mouse retinal ganglion cells and 
this approach wasn believed to be useful as a gene therapy (Osborne et al., 2018). The 
mentioned approaches for in vivo studies utylized the intact full-length TrkB and this rceptor 
cannot be simply turned on or off with a temporal resolution. Moreover, the activation of 
TrkB relies on the availability of the endogenous BDNF (an exception is the tool provided by 
Osborne et al. (2018)). To overcome these limitations, the photoactivatable TrkB system, 
developed and described in Chapter 2, was therefore tested in neuronal cells. 
To validate the photoactivatable TrkB system in neurons, this transgene was introduced 
into a recombinant AAV vector. Infection with viral particles enabled the expression of the 
light-activated TrkB in a high proportion of cultured primary neurons (see Section 3.3.2) and 
subsequent infection of a required brain region for in vivo studies (see Section 3.3.5). The 
photoactivatable TrkB provides for the possibility of activating canonical signalling pathways 
in neurons with a spatiotemporal resolution. Moreover, TrkB signalling can be induced 
independently of endogenous BDNF. As mentioned in Chapter 1 (Section 1.2.3), 
BDNF/TrkB signalling contributes to the axon pathfinding process. BDNF acts as an 
attractive guidance cue (Ming et al., 1997). The axon guidance in dorsal root ganglion 
neurons (DRG) was therefore used as a proof-of-concept experiment to validate the 
functionality of the photoactivatable TrkB to change the growth cone motility upon light. The 
aim of this chapter is to present results, demonstrating that the photoactivatable TrkB can be 
controlled in a light-dependent manner in neurons in vitro. Furthermore, this TrkB system 
can be successfully expressed in the brain region of freely behaving rats. 
 
3.2 Materials and methods 
 
3.2.1 Ethical declaration 
 
The animal procedures were approved by the Animal Ethics Committee of the 
University of Tasmania (Ethics number: A0016936) and conformed to the requirements of 




The resources and reagents used for creating and validating the photoactivatable TrkB 
system in primary neuronal cells are summarized in Table A1 in Appendix. 
 
3.2.3 Plasmid construction 
 
For generation of recombinant AAV virus, some of the constructs tested in Chapter 2 
were cloned into an AAV transfer vector (Addgene #50977) (Lin et al., 2009) between two 
AAV2 inverted terminal repeat (ITR) sequences. Additional genetic elements were included 
for neuron-specific expression, which includes the sequence for human synapsin promoter 
(abbreviated as hSyn), woodchuck hepatitis virus posttranscriptional regulatory element 
(WPRE – full length or reduced length, see below) followed by a simian virus 40 (SV40) 
polyadenylation (poly(A)) signal. The hSyn promoter ensures neuron specific expression and 
WPRE increases the stability of the mRNA to enhance expression. In the TrkB plasmid, a 
truncated WPRE sequence (Choi et al.) was used to keep the insert below the packaging size-
limit of AAV particles, whereas the full-length WPRE was used in CIB1-containing 
plasmids. The reduced WPRE sequence was synthesized by IDT DNA (Singapore) as a 
gBlock fragment. The generated constructs are listed in Table 3.1. 
The sequences for all inserts were confirmed by sequencing analyses performed onsite 
or in AGRF in Sydney. Confirmed plasmids were purified on a midi- or maxi-scale. 
 
Table 3.1 Generated DNA constructs for neuronal studies. 
# The full name of constructs 
Sequence length 
between ITRs 
All DNA constructs for neuronal studies 
1 AAV2-hSyn-CIB1(81)-eGFP-CAAX 2.811 kbp 
2 AAV2-hSyn-CIB1(170)-eGFP-CAAX 3.081 kbp 
3 AAV2-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry 4.878 kbp 
4 AAV2-hSyn-TrkB(kd)-Y816F-Cry2(535)-T2A-mCherry 4.878 kbp 
5 AAV2-hSyn-TrkB(kd)-Cry2(535)-D387A-T2A-mCherry 4.878 kbp 
6 AAV2-hSyn-TrkB(kd)-Cry2(498)-T2A-mCherry 4.752 kbp 
7 AAV2-hSyn-TrkB(kd)-Y816F-Cry2(498)-T2A-mCherry 4.752 kbp 
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DNA constructs used for the production of AAV particles 
8 AAV2-hSyn-CIB1(81)-eGFP-CAAX 2.811 kbp 
9 AAV2-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry 4.878 kbp 
10 AAV2-hSyn-TrkB(kd)-Cry2(535)-D387A-T2A-mCherry 4.878 kbp 
The AAV2 backbone was used. The expression of required proteins was driven by a human synapsin 
promoter (hSyn). CAAX, C-terminal prenylation signal (GKKKKKKSKTKCVIM); T2A, “self-
cleaving” peptide (EGRGSLLTCGDVEENPGP); ITRs, inverted terminal repeats. 
 
3.2.4 AAV production and titration 
 
The recombinant AAV (rAAV2/8) particles expressing the photoactivatable TrkB 
system were produced based on the protocol provided by Lin (2013). The summary of 




Figure 3.1 The steps of rAAV2/8 production for the expression of the photoactivatable TrkB 
system. This flow chart also represents the validation methods, which include measurement of AAV 
genome copies by qPCR and infection of cultured neurons in order to visualize the fluorescent 
proteins attached to components of the TrkB system. The figure was modified after Lin (2013). 
 
In a first step of AAV production, HEK293A cells were plated in six 15-cm culture 
dishes per a single virus preparation. When cell reached ~90% confluency, they were 
transfected using PXR8, pXX6-80 and a desired transfer plasmid at 1:1:1 molar ratio using 
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the PEI method. PXR8 contains the AAV rep/cap genes and defines serotype 8. pXX6-80 
contains E2a, E4 and VA genes. A transfer plasmid contains the transgene of interest and 
other genetic elements between the AAV2 ITRs. The transfer plasmids were as follows: 
CIB1(81)-eGFP-CAAX, TrkB(kd)-Cry2(535)-T2A-mCherry or TrkB(kd)-Cry2(535)-
D387A-T2A-mCherry as listed in Table 3.1. The transfected cells were harvested at 
approximately 72 h post-transfection and mechanically scraped off the culture dish in buffer 
containing: 10 mM Tris (pH 7.6), 150 mM NaCl, 10 mM MgCl2 (0.5 ml per plate). The cells 
in suspension were lysed by freezing-thawing cycle and trituration through a 23-gauge 
needle. The cell lysate was then incubated with benzonase nuclease (1 µl per 5 ml of lysate) 
for 45 – 60 min at 37°C and was centrifuged at 4,000 rpm (Centurion Scientific Rotor 
BR5510) for 20 min at 4°C to remove cellular and solid debris. The supernatant containing 
rAAV2/8 particles was decanted into a fresh tube and further purified by using discontinuous 
iodixanol gradients. The gradient lyers were buffers with 15%, 25%, 40% and 58% iodixanol. 
The virus-containing supernatant was added on top of the 15% gradient buffer. The tubes 
with the gradients were then centrifuged at 48,000 rpm in a Beckman Type 70Ti rotor for 130 
min at 18°C. After centrifugation, the rAAV2/8 particles were extracted from the 40% – 58% 
interface. Finally, the viral particles were concentrated by utilizing a 10 kDa or 50 kDa MW 
cut-off (MWCO) Amicon centrifuge filter (Millipore). The 10 kDa MWCO Amicon allowed 
rAAV2/8 to be concentrated to a volume of ~500 µl, whereas the 50 kDa MWCO Amicon 
allowed concentration down to ~200 µl. The purified rAAV2/8 particles were aliquoted and 
stored at -80°C. 
The rAAV2/8 titration was performed by a quantitative polymerase chain reaction 
(qPCR) with primers targeting ITRs within the AAV2 vector. For this purpose, the AAV 
titration kit from Takara was used, and quantification of AAV genome copies was carried out 
(as described by the manufacturer) in the Corbett Rotor-Gene 6000. The titres of the 
generated rAAV2/8s are listed in Table 3.2. 
 
3.2.5 Primary cortical culture 
 
Cortical neurons were prepared as described by Southam et al. (2018) with some 
modifications in the protocol. The primary cortical cultures were obtained from cortices of 
embryonic day 18.5 (E18.5) rats (Sprague-Dawley). The dissected cortices were digested 
enzymatically in 0.025% (w/v) trypsin in HBSS for 5 min at 37°C. After this time, the 
solution was removed carefully and the tissue was washed once with 1 ml of Neurobasal 
 97 
medium supplemented with 10% (v/v) FBS, 2% (v/v) B-27, 2 mM GlutaMAX and 1% (v/v) 
penicillin-streptomycin solution (neuronal plating medium). The supernatant was aspired and 
the tissue was triturated in 1 ml of neuronal plating medium. Number of cells was counted. 
Cortical cells were plated onto 13 mm-coverslips coated with poly-L-lysine in 24-well 
culture plates at a density of 5 × 10
4
 cells per well containing neuronal plating medium. For 
western blotting analyses, cortical cells were plated onto 3.5-cm culture dishes coated with 
poly-L-lysine at a density of 2 × 10
5
 cells per dish with neuronal plating media. After 24 h 
from plating cells, neuronal plating medium was replaced with the same medium but without 
FBS. For long-term cultures, neuronal medium lacking serum was refreshed every 3 – 5 days. 
 
3.2.6 Transduction of neuronal cells in culture 
 
The cortical neurons plated onto coverslips in 24-well plates were infected with the 
generated rAA2/8 particles to check the expression of transgenes. For this purpose, different 
volumes of viruses were added per one well: 10 µl, 5 µl, 3 µl, 2 µl and 1 µl. Cells were 
imaged at 48 h to 5 days post-infection. The expression of TrkB(kd)-Cry2(535) and 
TrkB(kd)-Cry2(535)-D387A was verified by checking mCherry fluorescence, whereas 
CIB1(81) was checked by eGFP fluorescence under an Olympus BX51WI fluorescent 
microscope. 
The cortical neurons seeded onto 3.5-cm cultured dishes were co-infected with 5 µl 
rAAV2/8-CIB1(81)-eGFP-CAAX and 5 µl rAAV2/8-TrkB(kd)-Cry2(535)-T2A-mCherry or 
rAAV2/8-TrkB(kd)-Cry2(535)-D387A-T2A-mCherry when cells were at 9 DIV. For a single 
infection, 5 µl of each virus was added to neurons. After 6 days, and before harvesting cells 
for western blotting, the expression of mCherry and eGFP was validated under an Olympus 
IX73 fluorescence microscope. 
 
3.2.7 Harvesting cells, SDS-PAGE and western blotting 
 
The cortical neurons, transduced with rAAV2/8s, were harvested at 15 DIV for western 
blotting analyses. The overview of western blotting experiments on the infected neurons is 
presented in Figure 3.2. The protocol for treating neurons, harvesting them and western 
blotting is the same as for HEK293A (see section 2.2.7). 
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Before harvesting, the cortical neurons were exposed to continuous blue light 
illumination at 36.8 mW/cm
2
 for the time duration as indicated in the figure legends in the 




Figure 3.2 Functional expression of rAAV2/8 encoding the photoactivatable TrkB system in 
cultured cortical neurons. The diagram shows the steps for testing the functional expression of TrkB 
photodimerizing system in cortical neurons by western blotting. Neurons were infected at 9 DIV with 
rAAV2/8 carrying the photoactivatable TrkB. After 6 days, these transduced cells were treated with 
blue light. Subsequently, neurons were lysed and proteins were immunoblotted against 
phosphorylated ERK, AKT or PLCγ1 proteins, which served as the indicators of activation of 
canonical TrkB signalling pathways. 
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Non-infected cells were treated with BDNF (Invitrogen) at final concentration of 100 
ng/ml for 10 min. The control non-infected cells were treated with a vehicle (Molecular 
Biology Grade Water) for 10 min. 
After desired treatment, cells were lysed in 200 µl of RIPA buffer and protein 
concentrations were measured. 10 µg of total protein per lane was used for immunoblotting 
with anti-ERK/anti-AKT antibodies and 20 µg of total protein per lane was used for anti-
PLCγ1 antibodies. Protein samples were resolved on Bolt 4 – 12% Bis-Tris Plus gels 
(Invitrogen). Proteins were then transferred to a PVDF membrane at 20 V, 4°C for 60 min. 
For more detailed protocol of immunoblotting see Section 2.2.7. The concentrations of 
primary and secondary antibodies used for western blotting are listed in Table 2.3 and their 
ordering details in Table A1 (see Appendix). 
Densitometry analyses of chemiluminescence were performed using ImageJ. Statistical 
analyses were performed in OriginPro 8. 
 
3.2.8 Stereotactic AAV injection into a basolateral amygdala 
 
The stereotactic surgery to deliver virus, and immunohistochemistry to confirm the 
viral infection, were performed by Dr Zayra Millan from the School of Psychology at the 
University of New South Wales (UNSW). The procedures were approved by the UNSW 
Animal Care and Ethics Committee. 
Naïve male Long-Evans rats received a unilateral injection into the basolateral 
amygdala (BLA) using the following coordinates from bregma: anteroposterior = -2.85 mm, 
mediolateral = -4.85 mm and from a flat-skull position: dorsoventral = -8.85 mm. The mix of 
both viruses (0.3 µl of each virus): rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry (7.25 
× 10
10
 copies/ml) and rAAV2/8-hSyn-CIB1(81)-eGFP-CAAX (3.07 × 10
11
 copies/ml) was 
infused at a rate of 0.1 µl/min via a 31-gauge needle. After surgery, rats were allowed to 
recover for 4 weeks. After this time, rats were perfused with paraformaldehyde and brains 
were fixed and sectioned to conduct immunofluorescence histochemistry for mCherry and 
eGFP detection in BLA. 
 
3.2.9 Analyses of growth cone motility upon light illumination 
 
The measurement of growth cone motility upon light illumination was performed by Dr 
Macarena Pavez from the School of Medicine at the University of Tasmania. In this 
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experiment, thoracic dorsal root ganglion neurons (DRG) were used as a common model for 
assessing axon pathfinding (Gasperini et al., 2009; Mitchell et al., 2012). The cells were 
prepared from rat (E16 – E18) embryos (Sprague-Dawley) based on the protocol described 
previously by Gasperini et al. (2009). The isolated DRG neurons were supplemented with 
NGF so their survival was mediated by TrkA. Dissociated DRG neurons were electroporated 
with the following DNA constructs: pcDNA3-CMV-TrkB(kd)-Cry2(535)-T2A-CIB1(81)-
eGFP-CAAX, pcDNA3-CMV-TrkB(kd)-Cry2(535)-D387A-T2A-CIB1(81)-eGFP-CAAX, 
pcDNA3-CMV-TrkB(kd)-Cry2(535)-T2A-eGFP (see Table 2.4), the included CMV 
promoter can mediate stronger expression one day after transfection than the hSyn promoter 
(Kugler et al., 2003b). This was crucial as the growth cone turning experiments were 
conducted after overnight incubation. The electroporation was conducted according to the 
instructions provided with the Nucleofector Kit (Lonza, Switzerland). The transfected cells 
were plated onto laminin-coated coverslips and imaged using an oil-immersion objective 
(100×/NA0.95) and NIS-Elements AR 4.00.12 software (Nikon, Japan). Growth cones 
extending from the DRG neurons transfected with the TrkB system were stimulated with blue 
light (485 nm) using a digital mirror device (Mightex, USA), which restricted the 
illuminatation area to one side of the growth cone. The growth cones expressing TrkB(kd)-
Cry2(535)-T2A-CIB1(81)-eGFP-CAAX were stimulated with two light protocols: 2-s pulse 
delivered every 5 min or 10-s pulse every 2 min. The growth cone turning experiment was 
conducted for 15 min. The angle of turning was measured between the initial and the final 
trajectories of the distal 10 µm of axon, as described previously (Gasperini et al., 2009). A 
positive angle represented turning towards illuminated side of the growth cone (attraction), 
whereas a negative angle represented turning away from the illuminated side (repulsion). The 
growth cone turning was analyzed using ImageJ and statistical analyses were performed in 




3.3.1 Design of rAAV vectors for neuronal expression of the photoactivatable TrkB 
system 
 
Adeno-associated viral vectors have been described as efficient tools for gene delivery 
in vitro and in vivo into neuronal cells (Choi et al., 2014; Royo et al., 2008). To conduct 
further experiments in cultured neurons and, ultimately, in behaving animal models, the 
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photoactivatable TrkB system was inserted into an AAV2 transfer plasmid. For the 
expression of transgene in neurons, the total genomic material between the ITRs of the AAV 
vector cannot exceed 5.2 kbp including the necessary expression elements (e.g., promoter, 
transgene and poly(A) signal). For the promoter elements, the hSyn promoter was used, as it 
has small size (~0.4 kbp), is neuron specific and can maintain stable expression over time 
(Kugler et al., 2003a) compared to α-CaMKII promoter (specific for subset of neurons, 1.3 
kbp in size), EF-1α promoter (not neuron specific, 1.2 kbp), CAG promoter (not neuron 
specific, 1.6 kbp) and CMV promoter (not neuron specific, 0.4 kbp). 
The CIB1(81)-eGFP-CAAX or CIB1(170)-eGFP-CAAX components were inserted 
into the expression vector consisting of a non-modified WPRE and poly(A) (0.8 kbp in total). 
All AAV vectors encoding TrkB(kd)-Cry2 components possessed the truncated WPRE and 
poly(A) (0.4 kbp in total) (Choi et al., 2014) that permitted the larger TrkB(kd)-Cry2 to be 




Figure 3.3 AAV viral vector designs for expressing the photoactivatable TrkB system in 
neurons. Each component of the photoactivatable TrkB system was generated as a separate AAV 
viral vector. The transgene, encoding CIB1(81)-eGFP-CAAX, was inserted between two ITRs in 
AAV2 which also contains: a human synapsin promoter, WPRE and poly(A). All these additional 
elements in AAV2-CIB1(81)-eGFP-CAAX vector derived from AAV2-oChIEF-tdTomato plasmid 
(Addgene #50977) (Lin et al., 2009). The transgene, encoding TrkB(kd)-Cry2(535)-T2A-mCherry, 
was also inserted into the backbone of AAV2-oChIEF-tdTomato vector but WPRE and poly(A) 
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cassettes were truncated to increase AAV packaging limit. Thanks to this truncation, the additional 
0.4 kbp could be packaged. The shorter WPRE and poly(A) elements were synthesized as described 
by Choi et al. (2014) (based on pAAV-CW3SL-EGFP vector with KJ411916 accession number at 
GeneBank). 
 
3.3.2 Expression of the light-activated TrkB system in cortical culture 
 
Recombinant AAV particles (referred to as rAAV2/8 from here in) were generated 
using CIB1(81)-eGFP-CAAX, TrkB(kd)-Cry2(535)-T2A-mCherry and TrkB(kd)-Cry2(535)-
D387A-T2A-mCherry as the expression cassettes (see Table 3.1 for the transfer plasmids) 
and capsid proteins from AAV serotype 8. The produced rAAV2/8s are compiled in Table 
3.2. According to this table, the viruses made in batches no. 1 and 3 had lower concentrations 
than the corresponding viruses in batches no. 2 and 4. It is due to the concentration of the 
virus in the final step of purification. The viruses in batches no. 1, 3 and 5 were concentrated 
using 10 kDa MWCO Amicon filter, whereas the batches no. 2 and 4 were concentrated 
using 50 kDa MWCO filter, which enabled to achieve more concentrated samples. 
 
Table 3.2 Generated rAAV2/8 particles encoding the photoactivatable TrkB system for 
in vitro neuronal studies and in vivo application. 
Batch # rAAV2/8 particles 
Titer 
[copies/ml] 
1 rAAV2/8-hSyn-CIB1(81)-eGFP-CAAX 3.07 × 10
11
 
2 rAAV2/8-hSyn-CIB1(81)-eGFP-CAAX 2.16 × 10
12
 
3 rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry 7.25 × 10
10
 
4 rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry 1.06 × 10
12
 




The produced rAAV2/8 particles were validated in cultured primary cortical neurons. 
Each batch of virus was checked under a fluorescence microscope for expression of eGFP 
and mCherry proteins. All viruses successfully infected neurons in culture, as shown in 
Figure 3.4. The hSyn promoter was predicted to restrict expression of transgenes to neuronal 





Figure 3.4 Validation of rAAV2/8 encoding the photoactivatable TrkB system in cultured 
cortical neurons. The figures (A) and (B) show cortical primary neurons infected with rAAV2/8-
hSyn-CIB1(81)-eGFP-CAAX created in two separate batches. eGFP expression was validated and its 
expression was expected in the cell membrane. The figures (C) and (D) represent cortical neurons 
infected with two different batches of rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry, whereas 
the figure (E) demonstrates neurons transduced with rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-D387A-
T2A-mCherry. Both rAAV2/8-hSyn-TrkB(kd)-Cry2(535)-T2A-mCherry and rAAV2/8-hSyn-
TrkB(kd)-Cry2(535)-D387A-T2A-mCherry were validated based on mCherry fluorescence in 
cytosol. Cells were between 8 and 15 DIV and 48 h to 5 days post-infection. 
 
3.3.3 The TrkB photodimerizing system activates canonical signalling pathways in 
cortical primary neurons upon blue light stimulation 
 
As described in Chapter 2, the phosphorylation of ERK, AKT or PLCγ1 proteins can 
indicate the activation state of these proteins. To examine whether the photoactivatable TrkB 
system can activate the canonical signalling pathways in neurons upon light stimulation, the 
immunoblot analyses of endogenous ERK, AKT and PLCγ1 were performed. For this 
purpose, cortical neurons were infected with rAAV2/8 encoding TrkB(kd)-Cry2(535) or 
CIB1(81)-eGFP-CAAX, as presented in Section 3.2.6. Subsequently, a 30-s blue light 
stimulation was applied and cell lysates were blotted against suitable antibodies (see Section 
3.2.7). The activity of ERK, AKT and PLCγ1 was quatified using densitometric analysis as a 
ratio between the optical density for a phosphorylated protein and for a total protein. 
Firstly, the activation of ERK pathway was investigated. Upon exposure of a cortical 
cell population, co-infected with rAAV2/8s for both components (TrkB(kd)-Cry2(535) and 
CIB1(81)-eGFP-CAAX), to a 30-s blue light illumination, the level of phosphorylated 
ERK1/2 at T202/Y204 was increased 3.9 ± 0.7 times compared to the dark control (Fig. 3.5 
A and B). Consistently with the results obtained from HEK293A cells (see Section 2.3.2.4), 
cortical cells expressing only a single component, TrkB(kd)-Cry2(535), exhibited light-
mediated phosphorylation of ERK (4.4 ± 0.9 fold increase over the dark condition). The 
CIB1(81)-eGFP-CAAX component did not cause the elevation of ERK phosphorylation after 
light exposure. Non-infected neurons served as a control. These cells were treated with 
BDNF, which gave rise to the elevated phospho-ERK. The non-infected neurons exposed to 
the blue light stimulation did not display increased phosphorylation of ERK. Moreover, the 
viral infection did not lead to a significant increase in background ERK activity and did not 




Figure 3.5 Immunoblot analysis of endogenous ERK activity in primary cortical neurons 
expressing the photoactivatable TrkB system. (A) Representative immunoblot images show the 
level of level of phosphorylated protein (pERK) at Thr202/Tyr204 in the absence or presence of 30-s 
blue light illumination. The phosphorylation of ERK was examined 10 min after light exposure. To 
measure changes in total ERK, the antibody recognizing an epitope present in ERK1 and ERK2 
independent of phosphorylation was used. Cortical neurons co-expressing both components: 
TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-CAAX (TrkB(kd)-Cry2 + CIB1) showed 
increased phosphorylation of ERK upon blue light illumination in comparison with non-stimulated 
cells. A single component: TrkB(kd)-Cry2(535)-T2A-mCherry (here as: TrkB(kd)-Cry2) also caused 
the elevation of phospho-ERK upon light irradiation. The CIB1(81)-eGFP-CAAX component (here 
as: CIB1) did not trigger phosphorylation of ERK in the light state. As a control, non-infected cortical 
neurons treated with 100 ng/ml of BDNF were compared to the level of phospho-ERK in non-treated 
neurons. PMWM stands for protein molecular weight marker. (B) The summary bar graph quantifies 
ERK activation as a ratio between phosphorylated ERK and total ERK in all tested conditions (see 
Sections 3.2.7 and 3.3.3). “Cry+CIB” means that neurons were co-infected with both components: 
TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-CAAX; “Cry” represents neurons infected 
with TrkB(kd)-Cry2(535)-T2A-mCherry component only, whereas “CIB” – neurons infected with 
CIB1(81)-eGFP-CAAX only. Data are shown as mean ± SD from four independent cell cultures. 
***P<0.001, unpaired Student’s t-test. (C) The bar graph represents the level of total ERK within 
each group presented in (B). Results show no significant differences in total ERK levels between 
groups. Data are shown as mean ± SD from four independent cell cultures. 
 
The same experimental conditions were applied to assess the phosphorylation state of 
AKT at Ser473 in cortical cells upon light. Although in cortical neurons co-expressing 
TrkB(kd)-Cry2(535) and CIB1(81)-eGFP-CAAX the difference in the phospho-AKT was 
approximately 1.4-fold between light and dark conditions, it was not significant (Fig. 3.6 A 
and B; P = 0.060, unpaired Student’s t-test). When neurons were infected with rAAV2/8 
encoding TrkB(kd)-Cry2(535), the phosphorylation of AKT was not elevated significantly 
upon light illumination (P = 0.065, unpaired Student’s t-test). Similarly, the CIB1(81)-eGFP-
CAAX component did not cause an increase in AKT phosphorylation in the light state. As 
expected, the BDNF treatment of cortical cells led to approximately 3-fold increase over non-
treated control (Fig. 3.6 B). The overexpression of the photoactivatable TrkB did not elevate 
the background activity of AKT. Some changes in total AKT were observed across the 




Figure 3.6 Immunoblot analysis of endogenous AKT activity in primary cortical neurons 
expressing the photoactivatable TrkB system. (A) Representative immunoblot images show a level 
of phosphorylated AKT at Ser473 in the absence or presence of 30-s blue light illumination. The 
phosphorylation of AKT was examined 10 min after light exposure. The antibody that recognizes 
AKT independently of phosphorylation state was used to check any changes in total amount of AKT. 
Abbreviation: PMWM - protein molecular weight marker. (B) The bar graph quantifies AKT 
activation as a ratio between phosphorylated AKT and total AKT in all tested conditions (see Sections 
3.2.7 and 3.3.3). Cortical neurons expressing both components, TrkB(kd)-Cry2(535)-T2A-mCherry 
and CIB1(81)-eGFP-CAAX (TrkB(kd)-Cry2 + CIB1), did not exhibit a significant increase in AKT 
phosphorylation upon blue light illumination in comparison with non-stimulated cells (P = 0.060, 
unpaired Student’s t-test). A single TrkB(kd)-Cry2(535)-T2A-mCherry (here as: TrkB(kd)-Cry2) or 
CIB1(81)-eGFP-CAAX component (here as: CIB1), when used separately, did not cause a significant 
elevation in the phosphorylation of AKT in the light state (P = 0.065 and P = 0.77, respectively; 
unpaired Student’s t-test). As a control, non-infected cortical neurons treated with 100 ng/ml of 
BDNF were compared to the level of phospho-AKT in unstimulated neurons. The BDNF treatment 
led to the significant increase in AKT phosphorylation (**P<0.01, unpaired Student’s t-test). Data are 
shown as mean ± SD from three independent experiments. (C) The bar graph represents levels of total 
AKT within each group presented in (B). Data are shown as mean ± SD from three independent 
experiments. 
 
Finally, the phosphorylation level of PLCγ1 at Tyr783 was investigated in neurons 
expressing both TrkB(kd)-Cry2(535) and CIB1(81)-eGFP-CAAX. When these cells were 
stimulated with a single 30-s pulse of blue light, the phospho-PLCγ1 increased 5.8 ± 2 times 
compared to the dark state (Fig. 3.7 A and B). Similarly, the TrkB(kd)-Cry2(535) component 
alone led to the PLCγ1 phosphorylation upon light illumination (approximately 6.5-fold 
increase). The CIB1(81)-eGFP-CAAX alone did not cause the elevation in phospho-PLCγ1. 
The control BDNF treatment of non-infected neurons evoked PLCγ1 phosphorylation (Fig. 
3.7 A and B). The viral transduction did not change the baseline phosphorylation or the total 
level of PLCγ1 (Fig. 3.7 B and C). 
In summary, the photoactivatable TrkB system activated ERK and PLCγ1 pathways in 
neurons upon blue light exposure, as judged by ERK/PLCγ1 phosphorylation. However, 





Figure 3.7 Immunoblot analysis of endogenous PLCγ1 activity in primary cortical neurons 
expressing the photoactivatable TrkB system. (A) Representative immunoblot images show the 
level of phosphorylated PLCγ1 at Tyr783 in the absence or presence of 30-s blue light illumination. 
The phosphorylation of PLCγ1 was investigated 10 min after light exposure. The endogenous level of 
total PLCγ1 was also checked. Abbreviation: PMWM - protein molecular weight marker. (B) The bar 
graph quantifies PLCγ1 activation as a ratio between phosphorylated PLCγ1 and total PLCγ1 in all 
tested conditions (see Sections 3.2.7 and 3.3.3). Cortical neurons expressing both components, 
TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-CAAX (TrkB(kd)-Cry2 + CIB1), displayed 
a significant increase in PLCγ1 phosphorylation upon blue light illumination in comparison with non-
stimulated cells. Light irradiation of cells expressing the single TrkB(kd)-Cry2(535)-T2A-mCherry 
component (here as: TrkB(kd)-Cry2) caused the significant elevation of phosphorylated PLCγ1 (P = 
0.047, unpaired Student’s t-test). Exposing cells infected with CIB1(81)-eGFP-CAAX component 
(here as: CIB1) to light illumination did not cause the increase in the phosphorylation of PLCγ1. As a 
positive control, the level of phospho-PLCγ1 in non-infected cortical neurons treated with 100 ng/ml 
of BDNF was compared to the level of phospho-PLCγ1 in unstimulated neurons. The BDNF 
treatment led to the significant increase in PLCγ1 phosphorylation. Data are shown as mean ± SD 
from three independent experiments. *P<0.05, unpaired Student’s t-test. (C) The bar graph 
demonstrates levels of total PLCγ1 in each group presented in (B). The results indicated no significant 
differences between total PLCγ1 between groups. Data are shown as mean ± SD from three 
independent experiments. 
 
To investigate whether the phosphorylation of ERK and PLCγ1 upon light is mediated 
through a light-inducible interaction between Cry2-Cry2 and Cry2-CIB1, a rAAV2/8 with a 
light-insensitive Cry2 (Cry2_D387A) linked to TrkB(kd) was produced. Subsequently, this 
virus was tested in cortical neurons exposed to a single 30-s blue light pulse. The cortical 
cells expressing TrkB(kd)-Cry2_D387A alone or with CIB1(81)-eGFP-CAAX component 
did not exhibit the elevated phosphorylation of ERK (Fig. 3.8) and PLCγ1 (Fig. 3.9) after 
photostimulation, confirming that the activation of signalling pathways was triggered in 




Figure 3.8 The light-insensitive Cry2 mutant (Cry2_D387A) in TrkB system failed to activate 
ERK signalling pathway upon light illumination in cortical neurons. (A) Representative 
immunoblot images show ERK phosphorylation in cortical neurons infected with the TrkB system 
with a wild-type Cry2(535) (TrkB(kd)-Cry2_WT) or with a light-insensitive mutant of Cry2(535) 
(TrkB(kd)-Cry2_D387A) in the absence or presence of 30-s blue light illumination. Cells were 
harvested 10 min after light exposure. The TrkB tool was tested as a two-component system (with 
CIB1(81)-eGFP-CAAX) or as a single-component system. To investigate changes in total ERK, an 
antibody that recognizes ERK1 and ERK2 independently of phosphorylation state was applied. 
PMWM stands for protein molecular weight marker. (B) The summary bar graph demonstrates the 
quantification of ERK activation as a ratio between phosphorylated ERK and total ERK in dark/light 
conditions (see Sections 3.2.7 and 3.3.3). Cortical neurons expressing both components, TrkB(kd)-
Cry2(535)_WT and CIB1(81)-eGFP-CAAX (TrkB(kd)-Cry2_WT + CIB1), showed increased 
phosphorylation of ERK upon blue light illumination in comparison with non-stimulated cells. The 
single component: TrkB(kd)-Cry2(535)_WT also caused the elevation of phospho-ERK in light state. 
Neither two components, TrkB(kd)-Cry2_D387A + CIB1, nor TrkB(kd)-Cry2_D387A alone 
triggered phosphorylation of ERK upon light. Data are shown as mean ± SD from three independent 
experiments. **P<0.01, unpaired Student’s t-test. 
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Figure 3.9 The light-insensitive Cry2 mutant (Cry2_D387A) in TrkB system failed to activate 
PLCγ1 upon light illumination in cortical neurons. (A) Representative immunoblot images show 
PLCγ1 phosphorylation in cortical neurons infected with the TrkB system with a wild-type Cry2(535) 
(TrkB(kd)-Cry2_WT) or with a light-insensitive mutant of Cry2(535) (TrkB(kd)-Cry2_D387A) in the 
absence or presence of 30-s blue light illumination. Cells were harvested 10 min after light exposure. 
PMWM - protein molecular weight marker. (B) The summary bar graph shows the quantification of 
PLCγ1 phosphorylation (see Sections 3.2.7 and 3.3.3). Cortical neurons expressing both components, 
TrkB(kd)-Cry2(535)_WT and CIB1(81)-eGFP-CAAX (TrkB(kd)-Cry2_WT + CIB1), showed 
elevated phosphorylation of PLCγ1 upon blue light illumination in comparison with non-exposed 
cells. The single component, TrkB(kd)-Cry2(535)_WT, also caused the increase of phospho-PLCγ1 in 
light state. Both the two-component system with D387A mutant and the one-component system with 
the same mutation did not trigger phosphorylation of PLCγ1 upon light. Data are shown as mean ± 
SD from three independent experiments. *P<0.05, **P<0.01, unpaired Student’s t-test. 
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3.3.4 Effect of different blue light durations on the activation of ERK and PLCγ1 
pathways 
 
The light-mediated activation of ERK and PLCγ1 pathways was investigated in further 
experiments in which cortical neurons, transduced with rAAV2/8s encoding the TrkB system, 





remained unchanged, whereas a 1-s, 10-s and 30-s single light pulse was 
applied. Delivering these light pulses to cells gave rise to the increasing level of phospho-
ERK (Fig. 3.10) and phospho-PLCγ1 (Fig. 3.11). This demonstrated that the activation of 
ERK and PLCγ1 pathways is dependent on light and can be modulated by different length of 
light stimulation. As presented in Figure 3.10 and Figure 3.11, the single 30-s pulse caused 
the robust phosphorylation of ERK and PLCγ1. 
An inconsistency can be observed in Figure 3.11 B in which PLCγ1 was not 
significantly phosphorylated upon 30-s light illumination in neurons expressing both 
components of the TrkB system (TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-
CAAX), compared to the results in Figure 3.7 and 3.9. In each replicate of the experiment 
shown in Figure 3.11, the increasing duration of light caused the increasing level of phospho-
PLCγ1 in these neurons. However, when the data were pooled from these three independent 
experiments, no significant result was obtained for the stimulation of cells for 30 s (P = 0.60, 
using one-way ANOVA with Tukey’s multiple comparison test). This is inconsistent with the 
results presented in Figure 3.7 B and Figure 3.9 B in which 30-s light illumination caused the 
significant increase in the phosphorylated PLCγ1 in neurons expressing both components of 
the photoactivatable TrkB. The lack of significance in Figure 3.11 might be due to a high 
variability of the assay in three experiments. 
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Figure 3.10 Effect of blue light duration on the activation of ERK pathway. Cortical neurons 
infected with two components, TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-CAAX, or 
with TrkB(kd)-Cry2(535)-T2A-mCherry alone, were exposed to different durations of blue light 
stimulation (0 s, 1 s, 10 s, 30 s). The blue light intensity remained the same for each group and was 
36.8 mW/cm
2
. The phosphorylation of ERK was examined 10 min after light exposure. (A) 
Representative western blot images show the phosphorylation of ERK and total ERK proteins with 
increasing duration of blue light illumination. Abbreviation: PMWM stands for protein molecular 
weight marker. (B) The bar graph summarizes results from three independent cultures. Neurons 
expressing both components of the photoactivatable TrkB system (TrkB(kd)-Cry2 + CIB1), when 
stimulated with a single 30-s light pulse, showed a significant increase in ERK phosphorylation 
compared to non-stimulated cells (P = 0.0497, one-way ANOVA with a Tukey post hoc test). Cortical 
neurons infected with only one component (TrkB(kd)-Cry2) exhibited significant ERK 
phosphorylation when illuminated for 10 s and 30 s (*P<0.05, **P<0.01, one-way ANOVA with a 
Tukey’s post hoc test). Data are presented as mean ± SD from three independent experiments. 
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Figure 3.11 Effect of blue light duration on the activation of PLCγ1 pathway. Cortical neurons 
infected with two components, TrkB(kd)-Cry2(535)-T2A-mCherry and CIB1(81)-eGFP-CAAX, or 
with TrkB(kd)-Cry2(535)-T2A-mCherry alone, were exposed to different durations of blue light 
stimulation (0 s, 1 s, 10 s, 30 s). The blue light intensity remained the same for each group and was 
36.8 mW/cm
2
. The phosphorylation of PLCγ1 was examined 10 min after the light exposure. (A) 
Representative western blot images show the phosphorylation of PLCγ1 and total PLCγ1 with 
increasing duration of blue light illumination. PMWM - protein molecular weight marker. (B) The bar 
graph summarizes results from three independent cultures. Cortical neurons infected with only one 
component (TrkB(kd)-Cry2) exhibited significant PLCγ1 phosphorylation when were exposed to a 
30-s light pulse (*P<0.05, one-way ANOVA with a Tukey’s post hoc test). Data are presented as 
mean ± SD from three independent experiments. 
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3.3.5 The photoactivatable TrkB system can be expressed in the basolateral amygdala 
 
As shown in Figure 3.12, rAAV2/8s, encoding the components of the TrkB system (see 
Table 3.2), successfully infected the basolateral amygdala (BLA) brain region of freely 
behaving rats. The expression of both transgenes was detected in BLA by mCherry 
fluorescence (TrkB(kd)-Cry2(535)-T2A-mCherry) and eGFP fluorescence (CIB1(81)-eGFP-
CAAX). This validation was the first step to conduct in vivo behavioural studies which aim to 




Figure 3.12 Validation of rAAV2/8s encoding the photoactivatable TrkB system in BLA. The 
mCherry fluorescence in BLA region indicated the successful expression of TrkB(kd)-Cry2(535)-
T2A-mCherry (left panel), whereas the eGFP fluorescence demonstrated the expression of CIB1(81)-
eGFP-CAAX component (right panel). The experiment was conducted by Dr Zayra Millan as 
described in Section 3.2.8. 
 
3.3.6 The photoactivatable TrkB system can be used for controlling axon pathfinding 
upon light stimulation 
 
To further validate the photoactivatable TrkB system, we used a growth cone turning 
assay, as BDNF is a strong attractive guidance cue in cultured Xenopus spinal neurons (Ming 
et al., 1997). Moreover, BDNF/TrkB signalling is responsible for the formation of growth 
cone in motoneurons (Dombert et al., 2017). We hypothesized that the photoactivatable TrkB 
system can steer the growth cone in response to light in a similar manner to the 
pharmacological application of BDNF. 
DRG neurons were transfected with the photoactivatable TrkB system and used in the 
growth cone turning assay, as described in Section 3.2.9.  The preliminary results suggested 
that the growth cones expressing the two-component TrkB system (TrkB(kd)-Cry2(535)-
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T2A-CIB1(81)-eGFP-CAAX) exhibited either attractive or repulsive behaviour towards light 
(Fig. 3.13 C), dependent on the light stimulation protocol. More frequent and longer pulses (8 
× 10-s pulse every 2 min) evoked attraction, whereas less frequent and shorter pulses (3 × 2-s 
pulse every 5 min) caused repulsion. As expected, the light insensitive mutant of Cry2 
(TrkB(kd)-Cry2(535)-D387A-T2A-CIB1(81)-eGFP-CAAX) did not change the growth cone 
turning upon illumination (Fig. 3.13 C). The one-component TrkB system (TrkB(kd)-
Cry2(535)-T2A-eGFP) also did not alter growth cone motility with light (Fig. 3.13 C). The 
axon extensions were not changed in response to any light stimulation patterns or expression 
of the transgenes (Fig. 3.13 D). Taken together, these data suggested that the photoactivatable 





Figure 3.13 Growth cone turning can be steered by light. (A) The application of BDNF, an 
attractive guidance cue, can activate growth cone navigation towards the micropipette source of 
BDNF (Gasperini et al., 2009; Mitchell et al., 2012). This change in a trajectory of growth cone by 
BDNF is defined as an attraction, whereas the opposite behaviour is called a repulsion (not shown). 
(B) If the photoactivatable TrkB system can mimic the signalling pathway, we would expect that 
spatially limited light illumination can guide axon turning as well. Illustrations presented in A and B 
were adapted from Erdogan et al. (2016). (C) Axons sent out from DRG neurons, expressing 
TrkB(kd)-Cry2(535)-T2A-CIB1(81)-eGFP-CAAX (see Table 2.4; annotated in the figure as TrkB-
Cry2_WT + CIB1) could be steered dependent on the parameters of light stimulation. The growth 
cones turned towards the light source when longer stimulation was applied (8 × 10-s pulse every 2 
min), whereas they turned away from light when shorter stimulation was delivered (3 × 2-s pulse 
every 5 min). The attraction towards the light source is represented as a positive angle and the 
repulsion as a negative angle. The growth cones expressing either the light-insensitive TrkB system 
(TrkB(kd)-Cry2_D387A + CIB1) or the TrkB(kd)-Cry2 component did not show any preferential 
turning. The data are presented as mean ± SEM (P<0.05, **P<0.01, Mann–Whitney U-test). (D) Light 
stimulation did not alter axon extension in DRG cells expressing the TrkB system in any of the test 
configurations. The data are shown as mean ± SEM. The experiments were conducted by Dr 




Controlling the activity of TrkB with light opens new possibilities for investigating the 
spatial and temporal dynamics of intracellular signalling pathways in vivo. Furthermore, it 
might allow us to test causal connections between biochemical events and animal behaviours. 
As presented in Chapter 2, the TrkB receptor was successfully manipulated with light in 
HEK293A and HeLa cell lines. To fulfil the requirements for using the photoactivatable 
TrkB in vivo as a final goal, testing this system in cultured neurons was the subsequent step. 
To conduct experiments on cultured neurons and in behaving animals, the 
photodimerizing TrkB system was packaged into the rAAV2/8 vector. The AAV vector was 
chosen for several reasons: (1) it can transduce neurons in vitro and in vivo with low toxicity; 
(2) it can deliver transgene with high efficiency; (3) it enables a long-term transgene 
expression in neurons (Choi et al., 2014; Royo et al., 2008). Due to the limitation of DNA 
size that can be incorporated into AAV, the bicistronic vector with TrkB system (see Table 
2.4) was split into two separate AAV vectors: one encoding CIB1 component and second 
encoding TrkB(kd)-Cry2 (see Table 3.1). The size of CIB1(81)-eGFP-CAAX component was 
below the packaging limit allowing it to be inserted into the AAV backbone, derived from 
AAV2-oChIEF-tdTomato (Lin et al., 2009), without any changes in the regulatory elements 
(WPRE and poly(A)). However, the size of TrkB(kd)-Cry2(535)-T2A-mCherry insert 
required a truncation of the expression cassettes to package this larger transgene without 
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compromising infection efficiency (Choi et al., 2014). Moreover, both components remained 
under control of the hSyn promoter, which is known to restrict the expression to neuronal 
cells (Kugler et al., 2003a; Lin, 2013). The rAAV2/8s encoding both components of the TrkB 
system successfully infected cortical neurons in vitro. Moreover, these two transgenes were 
also successfully delivered into neuronal cells in the BLA region of freely behaving rats. The 
in vivo validation of the photoactivatable TrkB expression is a first step for further 
behavioural studies, which are aiming to examine the roles of BDNF and TrkB in learning 
and memory processes. 
Delivering the photoactivatable TrkB into cultured cortical neurons with high 
efficiency enabled us to assess the functional expression of the system upon light 
illumination. The western blotting analyses of phospho-ERK, phospho-AKT and phospho-
PLCγ1 upon blue light in neurons, expressing the two-component TrkB system, revealed that 
both ERK and PLCγ1 signalling pathways can be manipulated with light. On the other hand, 
light exposure did not result in the significant elevation of phospho-AKT. However, AKT 
was still translocated to the membrane in HEK293A cells upon light illumination, as shown 
in Figure 2.23. Consistent with the results presented in Chapter 2, the light-dependent 
activation of TrkB(kd)-Cry2 alone led to the phosphorylation of ERK and PLCγ1 in cortical 
neurons. Moreover, the overexpression of the photoactivatable TrkB did not significantly 
increase background ERK, AKT and PLCγ1 activities in neurons, which is an important 
requirement for any in vivo activation. BDNF treatment of non-transduced neurons was used 
as a positive control for the activation of ERK, AKT and PLCγ1. In these experiments, 
BDNF exposure evoked a larger effect than light illumination in neurons expressing the 
photoactivatable TrkB. This could be partly due to the manner in which cells were exposed to 
BDNF or light: neurons were treated with BNDF continuously for 10 min, whereas they were 
exposed to a brief 30-s pulse of blue light and incubated in dark for another 10 min after light 
termination. It can be speculated that a longer duration of light stimulation might evoke a 
larger effect, and results from experiments shown in Figures 3.10 and 3.11 support this. 
Another reason for the larger effect of BDNF could be that light was not delivered evenly to 
all cells, due to the physical arrangement of the culture dish over the light source (see Figure 
2.5). Hence some cells may have received insufficient light to fully activate Cry2. Finally, 
cultured neurons might also contain glia cells in which the effect of BDNF can be mediated 
by a pan-neurotrophin receptor p75 (Vignoli et al., 2016). The activation of p75 with BDNF 
was shown to trigger ERK1/ERK2 pathway in PC12 cells (Lad and Neet, 2003). 
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The photoactivatable TrkB system was able to alter the turning of the growth cone in 
cultured DRG neurons. Interestingly, we were able to steer growth cones to opposing 
directions with different amounts of light, with smaller ‘dose’ of light leading to repulsion 
and higher ‘dose’ leading to attraction. BDNF is generally regarded as an attractive guidance 
cue (Ming et al., 1997); therefore, it was expected that the photoactivatable TrkB, once 
activated with light, might steer the growth cone towards the light. The TrkB(kd)-Cry2 
component without the membrane anchored CIB1 was unable to steer growth cones in this 
assay, suggesting the observed turning might require intracellular Ca
2+ 
signalling since 
TrkB(kd)-Cry2 alone was able to phosphorylate ERK, PLCγ1 and to translocate AKT (see 
Figures 3.5, 3.7 and 2.26, respectively), but unable to evoke a rise in intracellular Ca
2+
 (see 
Figures 2.6 and 2.14). It is noteworthy that the activation of PKC by DAG, as the effect of 
PLCγ1 activity (not investigated in this project), might also play a role in the growth cone 
turning. It is speculated that the observed attraction and repulsion upon different light 
parameters might be associated with the magnitude of released Ca
2+
. It has been 
demonstrated that transient high concentration of Ca
2+
 can promote the attraction (via 
CaMKII activation), whereas low concentration of Ca
2+
 can cause repulsion (via calcineurin 
activation) (Forbes et al., 2012; Sutherland et al., 2014; Wen et al., 2004). Similarly, the 
different polarities of growth cone responses have been shown to be dependent on the mean 
BDNF concentration in a microfluidics-based assay (Joanne Wang et al., 2008). Altogether 
this raises the interesting questions of the roles of ERK and AKT in BDNF mediated-axon 
guidance in vivo. I speculate in this context that the immediate Ca
2+
 increase might have 
more rapid effects on turning and that ERK and AKT might play roles in downstream, or 
slower, signalling pathways that are important for sustaining or maintaining axon navigation 
towards its appropriate target. To support this speculation, further experiments are necessary, 
for instance, with growth cone expressing the TrkB system with different mutations within 
the intracellular domain of TrkB. 
Taken together, the results, presented in this chapter, show that the photoactivatable 
TrkB system can be delivered to neurons in vitro and in vivo through recombinant AAV 
vectors. This tool is functional in cultured neurons, either cortical or DRG, upon light 
exposure. However, it remains unclear whether endogenous TrkB in neuronal cells can 
compete or interfere with the signalling activated by the photoactivatable TrkB system. In the 
next step, it would be crucial to perform an immunoblotting experiment in which infected 
neuronal cells with the recombinant AAV vectors encoding the TrkB system will be 
stimulated with BDNF. This result will help to assess whether the photoactivatable TrkB can 
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disrupt the action of the endogenous receptors. Overall, these results suggest the possible 
application of this approach for investigating causal links between BDNF/TrkB signalling 

































Conclusions and future directions 
 
The TrkB-mediated activation of signalling pathways has a vital role in many 
neurobiological functions including development, regeneration and repair, learning and 
memory (De Wit et al., 2006; Martinez-Galvez et al., 2016; Minichiello et al., 1999). BDNF 
and TrkB have been implicated in multiple facets of synaptic plasticity, especially LTP, 
learning and memory formation (Korte and Schmitz, 2016; Minichiello, 2009). The quickly 
growing interest in demonstrating causal connections between biochemical pathways, 
synaptic plasticity and behaviours in vivo dictates a necessity for new tools. A 
photoactivatable TrkB might serve as an appropriate tool to probe such a link. A previous 
optogenetic approach for controlling TrkB (optoTrkB) (Chang et al., 2014) has limitations to 
be overcome for investigating biological questions in vivo. OptoTrkB is composed of the full-
length TrkB receptor with the intact extracellular domain that can still bind to endogenous 
BDNF, likely making cells hypersensitive to the endogenous ligand. Moreover, 
overexpression of optoTrkB in the membrane might cause the activation of receptors in the 
absence of stimulus (as stated by Chang et al. (2014) in Supplementary Figures 3a and 5a). 
Finally, the size of recombinant optoTrkB DNA limits the delivery methods into cells 
available for in vivo studies (Chang et al., 2014). To overcome these limitations, my thesis 
presents and validates a second-generation of the photoactivatable TrkB. This novel TrkB 
system was designed to be readily applicable in vivo for the manipulation of synaptic 
plasticity and animal behaviour in response to light. 
My photoactivatable TrkB has been intended as a two-component system, consisting of 
a cytosolic TrkB(kd)-Cry2 and CIB1 localized at the plasma membrane. These smaller 
components were packaged into AAV viral vectors. Moreover, the extracellular domain of 
TrkB receptor was excised to prevent endogenous BDNF binding. My experimental data are 
consistent with a model that light illumination leads to the oligomerization of TrkB(kd)-Cry2 
and the kinase domains can undergo autophosphorylation in a similar way to endogenous 
TrkB receptor upon BDNF binding (Fig. 4.1 A, B). The cytosolic TrkB(kd)-Cry2 is capable 
of phosphorylating TrkB downstream targets localized in the cytosol. The translocation of 
TrkB(kd)-Cry2 to the plasma membrane via the Cry2/CIB1 heterodimerization can activate 





Figure 4.1 Models for the action of the photoactivatable TrkB upon light illumination. (A) The 
two-component TrkB system acts at the plasma membrane. This model features triggering three 
main TrkB signalling pathways, involving phosphorylation of PLCγ1, ERK and AKT proteins. 
Importantly, the Cry2/CIB1 interaction localizes TrkB(kd) to the membrane such that activated 
phospho-PLCγ1 is in close proximity to its lipid substrate and can generate IP3, which can mobilize 
Ca
2+
 increase in cells. Phosphorylated ERK can be translocated from the cytoplasm to the nucleus. 
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AKT can be transported from the cytoplasm to the plasma membrane, where it might be 
phosphorylated (still to be investigated). (B) The one-component TrkB acts in the cytosol. In this 
model, TrkB-mediated phosphorylation of PLCγ1 and ERK occurs in the cytosol. Light stimulation 
can lead to functional responses of ERK and AKT (translocation), but although PLCγ1 is 
phosphorylated, it fails to evoke Ca
2+
 increase. Abbreviations: KD, kinase domain of TrkB; P, 
phosphorylation sites; PIP2, phosphatidylinositol-4,5-bisphosphate; IP3, inositol-1,4,5-trisphosphate; 
DAG, diacylglycerol. 
 
DAG). Models showing how the photoactivatable TrkB system acts in the cytosol and 
membrane are presented in Figure 4.1. Consolidating my Ca
2+
 imaging and western blot data, 
both ERK and PLCγ1 were phosphorylated by TrkB(kd)-Cry2 in the cytosol, and AKT was 
translocated from the cytosol to the membrane. However, only TrkB(kd)-Cry2 that is targeted 
to the membrane through interaction with membrane-anchored CIB1 was capable of 
elevating intracellular Ca
2+
, suggesting that PLCγ1 needs to be both phosphorylated and 
relocated to the membrane to exert its function. My results suggest that relocation is 
necessary for PLCγ1 to effectively access its substrate, PIP2, in the inner leaflet of the plasma 
membrane (Berridge and Irvine, 1984). The action of the photoactivatable TrkB at the plasma 
membrane reflects better the signalling of endogenous TrkB. 
Compared to the similar existing published work on an optogenetic system 
manipulating TrkA receptor (Duan et al., 2018) (see Fig. 2.2 C), the current work has 
provided more detailed insights into the mechanism of the tool’s action, highlighting that 
both oligomerization of Cry2 and heterodimerization of Cry2/CIB1 are necessary to activate 
signalling cascades to reflect the activity of endogenous RTKs. The oligomerization of Cry2 
is required for clustering RTK kinase domains to enable their autophosphorylation, whereas 
the Cry2/CIB1 heterodimerization restricts the activation of signalling to the membrane. This 
suggests that to control RTK signalling with other light-induced or chemical heterodimerizers 
that interact with 1:1 stoichiometry – such as the blue-light activated iLID/SspB (Guntas et 
al., 2015) and pMag/nMag (Kawano et al., 2015), the red-light activated BphP1-Q-PAS1 
(Redchuk et al., 2017), the chemically-induced iDimerize system (Takara Bio) – a tandem 
repeat of one of the binding partner at the membrane would be necessary to recruit two RTKs 
kinase domains to the membrane and simultaneously, to induce their autophosphorylation. 
This would have strong implications for developing future systems as more light- and 
chemically-induced systems are generated. 
This unexpected mode of action, in which both oligomerization and relocation of 
TrkB(kd)-Cry2 to the membrane is required for the intracellular Ca
2+
 elevation, brings the 
possibility of dissecting ERK, AKT and PLCγ1/Ca
2+
 signalling pathways. This is reflected in 
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our results on the growth cone turning, which showed that TrkB(kd)-Cry2 alone (ERK and 
AKT translocation, ERK and PLCγ1 phosphorylation, but no Ca
2+
 increase) was not 
sufficient to change the trajectory of growing axon (see Fig. 3.13). TrkB(kd)-Cry2 with the 
membrane CIB1 (ERK and AKT tranlocation, ERK and PLCγ1 phosphorylation, Ca
2+
 
elevation) did steer a growth cone upon light illumination. This suggests that immediate 
turning of the growth cone requires Ca
2+
 signal, whereas ERK and AKT may have other 
functional effects, possibly sustained at a delay time point (Carlson et al., 2011). 
This ability of dissecting specific signalling cascades of TrkB can be greatly beneficial 
for understanding the function of TrkB signalling during distinct phases of LTP and learning. 
Other useful tools include the TrkB kinase domain mutant that prevents PLCγ1 docking and 
Ca
2+
 elevation upon light illumination (see Fig. 2.13). Based on the growth cone behaviours 
observed in axon guidance upon light stimulation, a similar differential response in synapses 
could allow us to induce both LTP and LTD by simply using distinct light stimulation 
protocols and also to investigate roles of different signalling pathways in LTP. 
There are some outstanding questions of the roles of BDNF/TrkB in LTP, learning and 
memory that might be addressed with the optogenetic tool described in the current thesis. For 
example, testing whether activation of TrkB in the postsynaptic cells is sufficient to initiate 
and maintain LTP. Another question concerns the functional roles of ERK/AKT/PLCγ1 in 
structural LTP within the synapse. With the utilization of a truncated postsynaptic density 
protein 95 (PSD95) (Hayashi-Takagi et al., 2015) or the PSD95-targeting fibronectin 
intrabodies (Gross et al., 2013), it is potentially possible to target the CIB1 component 
specifically to the postsynaptic site, restricting the action of the TrkB system within the 
dendritic spines. This can be further spatially restricted by using a two-photon excitation 
approach, which was shown to induce Cry2/CIB1 heterodimerization (Kennedy et al., 2010). 
Given the known involvement of TrkB in structural LTP (Harward et al., 2016), anchoring 
the TrkB system in dendritic spines might give a new insight into whether TrkB activity is 
sufficient to enlarge spines and if it can efficiently enhance learning in behaving animals. 
This potential experiment would test the theory of Hayashi-Takagi et al. (2015) that the major 
loci of memory traces are dendritic spines. 
Enhancing BDNF/TrkB signalling potentially has a therapeutic potential, as a 
dysfunction of this signalling has been reported in Alzheimer’s disease (Connor et al., 1997), 
Huntington’s disease (Ferrer et al., 2000) and Parkinson’s disease (Parain et al., 1999). 
Searching for a novel treatment is even more relevant due to the fact that BDNF does not 
cross the blood-brain barrier efficiently and has a short lifetime in blood so its delivery to 
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target regions is difficult (Pan et al., 1998; Pilakka-Kanthikeel et al., 2013). Another 
interesting aspect of learning and memory that could be investigated by using the 
photoactivatable TrkB system is extinction of fear memories. The BDNF/TrkB signalling 
pathway is involved in the mechanism underlying memory extinction (Li et al., 2017). It can 
have also potential therapeutic application in treatment of patients with post-traumatic stress 
disorder whose memory extinction is impaired (as reviewed by Andero and Ressler (2012)). 
Although there is a very long route to use the photoactivatable TrkB system as a therapeutic 
strategy, its application for studying learning and memory might improve our knowledge of 
these processes. 
To summarize, the work presented in this thesis adds a new approach to the optogenetic 
toolkit. The photoactivatable TrkB system can act as a two-component or a single component 
system, enabling the investigation of the different biochemical pathways’ functions. This 
approach activates the canonical signalling pathways in HEK cells and neuronal cells upon 
light stimulation. It can be expressed functionally in DRG neurons to steer growth cone 
turning with light. Finally, it can be packaged into recombinant AAV vectors for in vivo 
application. This opens new possibilities to examine processes connected with learning and 




















Appendix I: Key resources and reagents used in experiments described in Chapter 2 
and Chapter 3. 
 
Table A1 Key resources and reagents to examine the photoactivatable TrkB system in 
non-neuronal and neuronal cells. 
REAGENT OR RESOURCE SOURCE IDENTIFIER 
Antibody 
Anti-Phospho-Akt (Ser473) Cell Signaling Technology Cat#4060 
RRID:AB_2315049 




Cell Signaling Technology Cat#9106 
RRID:AB_331768 
Anti-p44/42 MAPK (Erk1/2) Cell Signaling Technology Cat#9102 
RRID:AB_330744 
Anti-Phospho-PLCγ1 (Tyr783)  Cell Signaling Technology Cat#2821S 
RRID:AB_330855 











DH5α Competent Cells Invitrogen Cat# 18265-017 
Chemicals and recombinant proteins 
Acetic acid Sigma-Aldrich Cat# 695092-2.5l 
Agar bacteriological Oxoid Cat# LP0011 
Agencourt CleanSEQ Beckman Coulter Cat# A29151 
Ampicillin Bio Basic Cat# AB0028 
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Antioxidant Invitrogen Cat# BT0005 
B-27 supplement (50X) Gibco Cat# 17504044 
BDNF  Invitrogen Cat# PHC7074 
Benzonase nuclease Sigma-Aldrich Cat# E1014-25KU 
BigDye Terminator v3.1 Cycle 
Sequencing Kit 
Applied Biosystem Cat# 4337455 
Bolt 4-12% Bis-Tris Plus gels Invitrogen Cat# NW04120BOX / 
NW04122BOX 
Bolt LDS Sample Buffer (4X) Invitrogen Cat# B0007 
Bolt MES SDS Running Buffer 
(20X) 
Invitrogen Cat# B0002 
Bolt Transfer Buffer (20X) Invitrogen Cat# BT00061 
BSA Bio-Rad Cat# 500-0007 
CaCl2 · 2H2O Sigma-Aldrich Cat# C3306-500G 
Chloroform Sigma-Aldrich Cat# C2432-500ML 
Collagen Advanced BioMatrix Cat# 5005-G 
Complete, Mini, EDTA-free 
Protease Inhibitor Cocktail 
Roche Cat# 04693159001 
D-Glucose Sigma-Aldrich Cat# G5767-500G 
DMEM (1X) Gibco Cat# 11885-084 
DMSO Sigma-Aldrich Cat# D4540-100ML 
DNA Ladder New England Biolabs Cat# N3200S 
DPBS Sigma-Aldrich Cat# D1408-500G 
DTT Goldbio Cat# DTT50 
EDTA Sigma-Aldrich Cat# E5134-500G 
Ethanol Sigma-Aldrich Cat# E7023-500ML 
Fetal Bovine Serum, qualified, 
Australia origin 
Gibco Cat# 10099141 
GlutaMAX supplement Gibco Cat# 35050061 
Glycine Sigma-Aldrich Cat# G8898-1KG 
HBSS solution (10X) Gibco Cat# 14185052 
HCl Merck Cat# 1.00319.2500 
HEPES Sigma-Aldrich Cat# H3375-250G 
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Millipore Cat# WBKLS0500 
Iodixanol solution Sigma-Aldrich Cat# D1556-250ML 
Isopropanol Sigma-Aldrich Cat# 59304-1L-F 
KCl Sigma-Aldrich Cat# P9541-500G 
KH2PO4 Sigma-Aldrich Cat# P9791-500G 
Methanol Merck Cat# 1060184000 
MgCl2 · 6H2O Sigma-Aldrich Cat# 63068-250G 
Molecular Biology Grade Water Sigma-Aldrich Cat# W4502-1L 
Na2HPO4 Sigma-Aldrich Cat# S3264-500G 
NaCl Sigma-Aldrich Cat# S7653-5KG 
NaOH Sigma-Aldrich Cat# S5881-500G 
Neurobasal medium Gibco Cat# 21103049 
Penicillin-Streptomycin solution  Sigma-Aldrich Cat# P4333-100ML 
Phenol red Sigma-Aldrich Cat# P3532-5G 
PhosSTOP Roche Cat# 4906845001 
Polyethylenimine (PEI) Sigma-Aldrich Cat# 408727-100ML 
Poly-L-lysine Sigma-Aldrich Cat# P4832-50ML 
PVDF, 0.2 µm Bio-Rad Cat# 1620177 
SDS Sigma-Aldrich Cat# L3771-500G 
SeeBlue Plus2 Pre-Stained 
Protein Standard 
Invitrogen Cat# LC5925 
Sodium Bicarbonate 7.5% 
solution 
Gibco Cat# 25080094 
Sodium deoxycholate Sigma-Aldrich Cat# D6750-25 
Sybr Safe DNA gel stain Invitrogen Cat# S33102 
Tri-Reagent  Sigma-Aldrich Cat# T9424-100ml 
Trizma base Sigma-Aldrich Cat# T6066-1KG 
Trypan Blue solution Sigma-Aldrich Cat# T8154-20ML 
TrypLE Express Gibco Cat# 12604-013 
Trypsin (1:250) powder Gibco Cat# 27250018 
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Tryptone Oxoid Cat# LP0042 
Tween-20 Sigma-Aldrich Cat# P2287-500ML 
U-73122 Sigma-Aldrich Cat# U6756 
X-tremeGENE 9 DNA 
Transfection Reagent 
Roche Cat# 06 365 787 001 
Yeast Extract Oxoid Cat# LP0021 
Critical commercial kit/assay 
AAV real-time PCR titration kit Takara Cat# 6233 
DC Protein Assay Kit II Bio-Rad Cat# 500-0112 
GenElute HP Plasmid Miniprep 
Kit 
Sigma-Aldrich Cat# NA0160 
Maxima H Minus First Strand 
cDNA Synthesis Kit  
Thermo Scientific Cat# K1651 
PureLink HiPure Plasmid 
Maxiprep Kit 
Invitrogen Cat# K210007 
PureLink HiPure Plasmid 
Midiprep Kit 
Invitrogen Cat# K210005 
RNeasy Mini Kit Qiagen Cat# 74104 
Zymoclean Gel DNA Recovery 
Kit 
Zymo Research Cat# D4002 
Enzymes for cloning 
AgeI-HF New England Biolabs Cat# R3552 
BamHI-HF New England Biolabs Cat# R3136 
BsiWI-HF New England Biolabs Cat# R3553 
ClaI New England Biolabs Cat# R0197 
EcoRI-HF New England Biolabs Cat# R3101 
HindIII-HF New England Biolabs Cat# R3104 
NheI-HF New England Biolabs Cat# R3101 
NotI-HF New England Biolabs Cat# R3189 
Phusion Flash High-Fidelity 
PCR Master Mix 
Thermo Scientific Cat# F-548 
SpeI-HF New England Biolabs Cat# R3133 
T4 ligase  Invitrogen Cat# 15224-017 
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XbaI New England Biolabs Cat# R0145 
Experimental models: cell lines 
HeLa cells ATCC  
HEK293A cells Invitrogen   
Recombinant DNA 
AAV2-oChIEF-tdTomato Made by Dr John Lin Cat# 50977 (Addgene) 
Oligonucleotides and gBlocks 
Gene Fragments 
IDT N/A 
pcDNA3.1-CMV Invitrogen N/A 
pcDNA3-CMV Invitrogen N/A 
pLenti-CMV University of California, 
San Diego 
N/A 
pMDG2.0 Kind gift from Prof Didier 
Trono 
N/A 
psPax2 Kind gift from Prof Didier 
Trono 
N/A 
PXR8 National Vector 
Biorepository 
 




ApE M. Wayne Davis, The 
University of Utah 
http://jorgensen.biology.ut
ah.edu/wayned/ape/ 
ImageJ Rasband, W.S., NIH, 
Bethesda, Maryland, USA 
https://imagej.nih.gov/ij/ 
LED Driver Control Panel 
V3.1.0 
Mightex  




OriginPro 8 OriginLab, Northampton, 
MA 
https://www.originlab.com 
N/A – not applicable 
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Appendix II: Protein sequences of the main components of the photoactivatable TrkB 
system. 
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